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Introduction: Inhalant use is the most prevalent form of illicit drug use among young 
(<8th grade) adolescents in the United States and inhalants share several characteristics with 
gateway drugs (alcohol, tobacco, and marijuana).  The purpose of this study was to determine 
whether, and if so, how the gateway hypothesis of drug use sequencing could be expanded to 
include inhalants for African American and white adolescents. In addition, the study 
examined whether various psychosocial characteristics could account for the transition from 
inhalant use to a later stage of drug use. 
Methods: Data were from a panel study on adolescents from 13 schools in three 
counties in North Carolina. The study focused on transitions from 6th to 7th grade (N = 
1,630) and from 7th to 8th grade (N = 3,344), and the analyses were conducted separately for 
African American males, African American females, white males, and white females to 
assess race and gender differences in drug use sequencing. Latent transition analysis (LTA) 
was used to identify models of drug use sequencing and to estimate drug use prevalence and 
the probabilities of transitioning from one drug use stage to another. Formal criteria for 
establishing gateway relationships were examined to determine whether inhalant use was 
operating as a gateway to other drug use. 
Results: For white males and African American males and females, there was no 
evidence that inhalants serve a gateway role. However, inhalant use preceded and increased 
iv 
the probability of marijuana use for a significant number of white females at both transition 
periods; formal criteria were met supporting inhalant use as a gateway to marijuana use for 
white females transitioning from 6th to 7th grade, and the probability of transitioning from 
inhalant use to marijuana use remained significant after controlling for a variety of 
psychosocial characteristics.  
Conclusions: This study was the first to formally evaluate the relationship between 
inhalant use and gateway drug use. The finding that inhalants appear to play an important 
role in gateway drug use sequencing for white females, coupled with findings from recent 
studies that suggest inhalant use has increased among female adolescents, supports an 
increased focus on inhalant use. 
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 CHAPTER 1  
INTRODUCTION 
1.1 Purpose 
This dissertation investigates where and how inhalant use fits within drug use 
sequences and whether there is evidence for a gateway role for inhalant use in four 
adolescent groups: white males, white females, African American males, and African 
American females. Longitudinal data for white and African American adolescents collected 
from a general population sample of adolescents in grades 6 through 8 were used to examine 
the relationship between inhalants and the drugs commonly defined as gateway drugs: 
alcohol, tobacco (cigarettes), and marijuana.  
1.2 Statement of the Problem 
Inhalants are volatile substances that produce chemical vapors that can be inhaled to 
induce a psychoactive effect. Inhalants include a broad variety of widely available substances 
such as gasoline, glue, shoe polish, and spray paint. Although inhalants are not socially 
normative or marketed like alcohol and tobacco, they are easily accessible by youth, are often 
not perceived as harmful (Johnston, O’Malley, & Bachman, 1998), and are widely used by 
young adolescents (Substance Abuse and Mental Health Services Administration, 2008; 
Johnston, O’Malley, Bachman, & Schulenberg, 2005, 2007; Wu, Pilowsky, & Schlenger, 
2004; Johnston, O’Malley, & Bachman, 2001).  
It has been posited that inhalant use may operate as a gateway to later drug use 
(Edwards & Oetting, 1995). The idea that certain drugs serve as gateways to later illicit drug 
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use (Kandel, 1975, 2002; Kandel, Yamaguchi, & Chen, 1992) stems from the nearly 
ubiquitous finding that, among individuals who use, a standard drug use sequence is 
commonly followed: from the use of legal (for adults), widely available, and socially 
accepted and marketed substances (alcohol and tobacco), to marijuana, and then to other 
illicit drugs (e.g., cocaine, heroine). According to the gateway hypothesis, the use of a 
gateway drug significantly increases the probability of using a drug later in the sequence.  
Inhalants may serve as a gateway to other drugs because of their pharmacological 
effects. Inhalants have been demonstrated to enhance dopamine activity in the brain’s 
pleasure center in ways similar to other drugs of abuse (Riegel, Ali, & French, 2003), and 
people who use inhalants can develop cravings associated with dependence (Anthony, 
Warner, & Kessler, 1994; Howard, Cottler, Compton, & Ben-Abdallah, 2001). Given the 
wide availability of inhalants and the typical early age of first use, it is conceivable that 
inhalants may serve to introduce adolescents to the pleasurable sensations associated with 
increased dopamine activity, possibly increasing the likelihood of future drug-seeking 
behavior.  
In support of this possibility, inhalant use has been identified as a key correlate of 
injection drug use and polydrug use (Dinwiddie, Reich, & Cloninger, 1991a; Schutz, 
Chilcoat, & Anthony, 1994; Johnson, Schutz, Anthony, & Ensminger, 1995). Inhalant use 
before age 16 has been shown to predict later heroin use after controlling for other risk 
factors (Johnson et al., 1995), and use before age 18 has been associated with later illicit drug 
use and binge drinking (Bennett, Walters, Miller, & Woodall, 2000; Sakai, Hall, Mikulich-
Gilbertson, & Crowley, 2004).  
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Together, the findings concerning inhalants’ pharmacological effects and association 
with illicit drugs suggest a potentially important gateway role for inhalants in adolescent drug 
use sequencing. But critics of the gateway hypothesis suggest that factors such as drug 
availability, perceived peer drug use, and an underlying proclivity to engage in problematic 
or sensation-seeking behaviors better explain the sequencing of drug use in adolescents and 
that the standard gateway pattern being observed is actually an artifact representing drug 
availability, personality attributes, and social norms (Morral, McCaffrey, & Paddock, 2002; 
Golub & Johnson, 2002a; Agrawal, Neale, Prescott, & Kendler, 2004b; Tarter, Vanyukov, 
Kirisci, Reynolds, & Clark, 2006).  
In order to evaluate the potential gateway role of inhalants, it is necessary to 
demonstrate both that inhalant use significantly increases the probability of using other drugs 
and that the relationship between inhalant use and drug use transitions remains significant 
after accounting for factors such as perceived drug availability, perceived peer drug use and 
attitudes, sensation seeking and delinquency, academic achievement, and parental (mother’s) 
disapproval of drug use.  
1.3 Study Research Questions 
This dissertation investigated the role inhalants play in adolescent gateway drug use 
sequencing. To this end, the following research questions were examined: 
1. Can the gateway hypothesis be extended to include inhalants for African 
American and white, male and female adolescents in grades 6 through 8? 
2. Does the probability of transitioning from inhalant use to other drug use remain 
after controlling for demographic factors and key psychosocial predictors of 
adolescent drug use? 
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1.4 Analytic Approach 
The gateway hypothesis suggests that drug use progresses through a series of 
sequential discrete stages. To address the study research questions, latent transition analysis 
(LTA) (Lanza, Flaherty, & Collins, 2003), an analytic approach to measuring longitudinal 
discrete-stage models, was used. LTA is an extension of latent class analysis to repeated 
measures that allows for the estimation of the prevalence of stages and the incidence of 
transitions to different stages over time (Lanza et al., 2003).  
As a latent variable model, LTA provides a way of statistically modeling transitions 
between latent states while adjusting for measurement error, thereby producing more 
accurate model parameters (Collins, 2006). An additional benefit of this latent variable 
approach is that it accounts for respondents who recant earlier responses, a significant 
problem in longitudinal data analysis. Observations from individuals who report ever using a 
drug at one time but report never using that same drug at a later time are treated as 
measurement error in LTA. This approach is preferable to commonly used tactics such as 
removing inconsistent reporters from the data set or forcing consistent reports by recoding 
the responses (Collins, 2006). 
To examine the stages and transitions of drug use onset, several latent transition 
models were estimated for two periods of transition: from 6th to 7th grade and from 7th to 
8th grade. These analyses were conducted separately for white males, white females, African 
American males, and African American females to identify models that best fit the data for 
each group and to determine whether patterns of drug use differed by race and gender. Drug 
use stages were defined by the ever or never use of inhalants and the three drugs widely 
recognized as gateway drugs: alcohol, tobacco (cigarettes), and marijuana. Because of the 
relatively young sample and the corresponding rarity of illicit drug use, and because this 
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study focused on the relationship between inhalants and the gateway drugs, the use of other 
illicit drugs was not included.  
Final model parameters were used to assess the prevalence of stage membership at 
each grade and the probability of transitioning from one stage to another, conditional on 
baseline stage membership. This approach allowed for the investigation of where, or 
whether, inhalants fit in gateway drug use sequencing and whether the use of inhalants is 
associated with an increased probability of progressing to a more advanced drug use stage.  
Several sociodemographic and psychosocial variables were included as predictors of 
the transition probabilities between inhalants and other drugs to assess the strength of the 
relationship between inhalant use and gateway drug use transitions, while controlling for 
possible competing factors (i.e., perceived drug availability, perceived peer drug use, 
sensation seeking and delinquency, academic achievement, and parental [mother’s] 
disapproval of drug use).  
1.5 Significance 
This dissertation is the first study to evaluate the relationship between inhalant use 
and the use of gateway drugs in a longitudinal, general population sample of adolescents. 
Like tobacco, alcohol, and marijuana, inhalants are a widely available class of drugs, and 
they are used by a significant number of adolescents with an apparent early average age of 
initiation. Inhalants have neurological and physiologic effects similar to other drugs, and 
inhalant users report “benefits” of use similar to those reported for other drugs. Although 
inhalants have been shown to be strongly associated with heroin use and other severe forms 
of drug abuse, no study to date has explored the prospective relationship between inhalants 
and the gateway drugs. Using an adolescent sample and an analytic approach uniquely suited 
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to testing a stage-based model based on the gateway hypothesis, this dissertation provides a 
preliminary understanding of the role inhalants play in adolescent drug use sequencing. 
 CHAPTER 2  
BACKGROUND AND LITERATURE REVIEW 
2.1 Definition of Inhalants 
Inhalants are volatile substances that produce chemical vapors that can be inhaled to 
induce a psychoactive effect (National Institute on Drug Abuse [NIDA], 2005a). The term 
“inhalants” is used to describe a broad variety of widely available substances whose main 
defining characteristic is that they are rarely, if ever, taken by any route other than inhalation 
(NIDA, 2005a). Because of the large capillary surface area of the lungs and the quick 
dispersal of blood from the lungs to the brain, inhalation rivals intravenous injection, in terms 
of intensity, as a means of drug delivery.  
Although commonly listed as an illicit drug in reports and articles, inhalants are 
omnipresent at home, work, and even at school and in most cases can be legally obtained by 
adolescents. The purchase and possession of inhalants is usually legal, and most of the 
common household and commercial products abused as inhalants are not regulated under the 
Controlled Substances Act. Although no federal policy specifically focuses on inhalant 
abuse, as of 1995, 43 states had passed statutes specifically directed at inhalants (Harwood, 
1995). Most of these laws seek to limit access to inhalable products or to change the nature of 
the inhalable products (e.g., adding irritants to make inhalation uncomfortable). North 
Carolina has enacted laws making it illegal to abuse certain inhalants, possess certain 
products for abuse, or sell or transfer such products for abuse and requiring warning labels on 
inhalable products (Harwood, 1995). However, none of the specific products regulated by the 
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state are among the most commonly abused. These efforts are not widely enforced, 
evaluated, or notably successful (Harwood, 1995). 
Because the broad definition of inhalants encompasses such a wide range of 
substances, categorization of inhalants varies, and many surveys treat all forms of inhalants 
as a single class. NIDA (2005a) classifies inhalants into four general categories: volatile 
solvents, aerosols, gases, and nitrites. 
Volatile solvents, the most commonly abused category of inhalants among 
adolescents (Substance Abuse and Mental Health Services Administration [SAMHSA], 
2004), are found in a large number of widely available, inexpensive products commonly 
found in the home or in industrial settings (NIDA, 2005a). This class includes liquids that 
vaporize at room temperature, such as paint thinner and paint remover, gasoline, glues, 
correction fluid, and felt-tip marker fluid. Glue, shoe polish, and toluene are the most 
commonly used inhalants among youth aged 12 or 13: in 2002 and 2003, 4.3% of youth 
reported lifetime use of at least one of these substances. The second most commonly used 
inhalants are gasoline or lighter fluid, with 3.3% of youth aged 12 or 13 reporting lifetime 
use (SAMHSA, 2005). 
Aerosols are sprays that contain propellants and solvents (NIDA, 2005a). Spray 
paints, deodorant, and hair sprays are commonly abused sources, with 4.2% of youth aged 12 
or 13 reporting lifetime use (SAMHSA, 2005).  
Gases are found in household products such as butane lighters, propane tanks, 
whipped cream dispensers, and refrigerants. This category also includes medical anesthetics, 
such as ether, chloroform, halothane, and nitrous oxide. Nitrous oxide or “laughing gas” is 
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commonly abused and is found not only in medical settings but also in whipped cream 
dispensers and nitrous oxide products used to boost octane levels in racing cars. 
Nitrites differ from the other three categories of inhalants in that they act primarily as 
vasodilators and muscle relaxants. In contrast, other inhalants act directly on the central 
nervous system and are abused primarily for their ability to alter mood. Nitrites include amyl 
nitrite, a prescription drug used in the treatment of some heart problems; butyl nitrite, sold in 
incense and room deodorizers; and isobutyl nitrites (commonly referred to as “poppers”) 
(Newell, Mansell, Spitz, Reuben, & Hersh, 1985). Because of their ability to dilate blood 
vessels, inhaled nitrites increase the heart rate and produce a sensation of heat and excitement 
that lasts for several minutes (NIDA, 1998). For this reason, nitrites often are used as sexual 
enhancers. Another distinguishing factor of nitrites is that nitrite inhalants appear to be more 
commonly abused by adults than by adolescents, with one study reporting a mean age of 25.6 
years for first nitrite use (Lange et al., 1988). Abuse of nitrites has been widely studied in 
populations of gay and bisexual men, among whom nitrite use appears to be particularly 
common. One study found that 69% of gay men living in Baltimore and Washington, DC, 
reported lifetime use of nitrites (Lange et al., 1988). However, nitrites are used by a 
considerable number of adolescents, particularly adolescents in treatment for substance 
abuse. One study found that 43% of youth in substance abuse treatment reported a history of 
nitrite inhalant use (Schwartz & Peary, 1986). 
2.2 Physical Effects and Consequences of Inhalant Use 
The immediate effects of inhalant use are generally short-lived, lasting 5 to 15 
minutes; the products are easy to conceal; and inhalants are not tested in drug screenings, so 
inhalant use by adolescents is likely not visible to caregivers. Indeed, adolescent inhalant use 
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usually comes to light only when self-reported by the adolescent or when an adolescent 
presents with medical problems associated with inhalant use.  
Effects from inhaling mirror alcohol inebriation and include mild stimulation, loss of 
inhibition, and distorted perceptions. Research suggests that inhalants, particularly toluene 
(found in gasoline, spray paint, and glue), enhance dopamine activity in the brain’s pleasure 
center in much the same way as other drugs of abuse (Riegel et al., 2003).  
The wide availability of inhalants may make them an attractive alternative to alcohol, 
particularly for older children and young adolescents. Because inhalant use produces rapid 
intoxication, and because the effects generally wear off quickly, inhalant use is easier to 
conceal than many other drugs of abuse. In an unpublished summary of findings from an 
inhalant focus group project involving 93 Massachusetts youth, with and without experience 
with inhalants, respondents indicated several perceived advantages of inhalants over other 
drugs (Wolfe, 1995). These youth indicated that inhalants cause a desirable “trippy” high, are 
readily available, can be used without arousing suspicions, are legal and inexpensive, and 
take effect quickly. The respondents also indicated that they believed they could better 
control the high they received from inhalants (Wolfe, 1995).  
One study assessed the perceived physical and psychological effects of using 
inhalants among 285 adolescents from juvenile correction facilities in Virginia (McGarvey, 
Clavet, Mason, & Waite, 1999). When asked to describe the “good things and bad things” 
experienced while using inhalants, 61% indicated that euphoria (e.g., feeling carefree, happy, 
amused, high) was an effect of inhalant use and 39% reported hallucinations as an outcome, 
suggesting possible reasons adolescents choose to use inhalants. Results from this study also 
suggested that adolescent inhalant users are likely to associate with friends who use inhalants 
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and that most adolescents obtain and use inhalants at their home or at a friend’s home 
(McGarvey et al., 1999). 
Even a single experimentation with inhalants can be dangerous, in some cases 
causing permanent organ damage or even death. The brain, lungs, kidneys, heart, and liver 
are all at risk from inhalant use, and death from asphyxiation, suffocation, seizure, coma, 
choking, and injuries from accidents related to loss of motor control have been reported. 
“Sudden sniffing death,” a syndrome characterized by irregular and rapid heart rhythms 
resulting in heart failure, has been associated with even a single session of prolonged 
inhalation (NIDA, 2005a). From 1996 to 1999, an estimated 240 people nationwide died 
from inhalant abuse, most often as a result of the toxic effects of gas fumes or trauma that 
was a consequence of the altered state of the user (Bowen, Daniel, & Balster, 1999).  
Symptoms associated with withdrawal, including anxiety, sweating, nausea, and 
restlessness, are experienced by some users. Most inhalants produce a rapid high that 
resembles alcohol intoxication. If taken in sufficient amounts, inhalants can produce 
anesthesia, a loss of sensation, and even unconsciousness (NIDA, 2005a). Other possible 
short-term effects include belligerence, apathy, and impaired judgment and functioning. 
Inhalant users may demonstrate symptoms such as dizziness, slurred speech, nausea, 
vomiting, and lethargy shortly after use. Depression, muscle weakness, lack of coordination, 
and a series of withdrawal symptoms are all associated with long-term or continued inhalant 
abuse. 
Most inhalants are extremely toxic, potentially causing widespread and long-lasting 
(sometimes irreversible) damage to the brain, central nervous system, and other organs. 
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Extensive destruction of nerve fibers in the brain similar to that found in diseases such as 
multiple sclerosis is evident in some chronic inhalant abusers (NIDA, 2005a). 
2.3 Sources of Data on Adolescent Inhalant Use 
The three primary nationally representative surveys that address adolescent drug use 
behaviors—the National Survey on Drug Use and Health (NSDUH), the Monitoring the 
Future (MTF) study, and the Youth Risk Behavior Survey (YRBS)—include information 
about adolescent inhalant use. These surveys provide national inhalant use prevalence 
estimates and trend information dating back many years. 
NSDUH (formerly the National Household Survey on Drug Abuse [NHSDA]) is a 
household survey of individuals aged 12 years and older that is sponsored by SAMHSA. 
From 1979 to 1991, the survey was conducted every 3 years, and since then it has been 
conducted annually. Data collection occurs throughout the calendar year. 
MTF has been conducted annually since 1975 and is funded through grants from 
NIDA to the University of Michigan Survey Research Center. Eighth, 10th, and 12th grade 
students from more than 400 public and private secondary schools are surveyed in the spring 
of each year. Survey administration occurs within the classroom. 
YRBS is a national survey of students enrolled in high school (grades 9 through 12), 
conducted by the Centers for Disease Control and Prevention (CDC) (2006). Surveys are 
conducted every 2 years and provide data representative of public and private high schools in 
the United States. Like MTF, YRBS is administered in classrooms in the spring. 
Differences in rates across the three studies are commonly reported, although overall 
trends over time are generally similar (see Banken, 2004; Fendrich & Johnson, 2001; Fowler 
& Stringfellow, 2001; Harrison, 2001; Brener, Grunbaum, Kann, McManus, & Ross, 2004). 
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Differences are likely due to a range of factors, although two commonly posited reasons are 
survey setting (household versus school) and question wording.  
For most substances, NSDUH consistently reports the lowest prevalence estimates 
and YRBS reports the highest, with YRBS and MTF generally being closer to one another 
than to NSDUH (Fendrich & Johnson, 2001). This discrepancy is at least partially attributed 
to the fact that NSDUH is conducted in a household setting (Volkow, Fowler, & Wang, 
2003), whereas YRBS and MTF are school-based surveys. However, this pattern appears to 
be less pronounced in the case of inhalants.  
Question wording has been posited as a plausible reason for the discrepancy between 
NSDUH and the other two surveys. In a study on the effects of question wording on 
prevalence rates, Brener et al. (2004) found that the approach used by NSDUH, which uses a 
series of questions that explicitly list 10 separate inhalable substances plus an open-ended 
option for any other products inhaled, produced the largest prevalence estimates for 
inhalants. YRBS and MTF assess inhalant use specifically as sniffing glue, breathing the 
contents of aerosol spray cans, or inhaling any paints or spray to get high. The authors 
conclude that respondents to the YRBS and MTF surveys may not consider all possible 
inhalants when answering (Brener et al., 2004). Further evidence for the importance of 
question wording comes from a study of inhalant use in Texas, where 24% of 7th graders 
indicated that they sometimes “sniffed” or “huffed” one or more of a large list of common 
inhalants. But when the same youth were later asked a general question about their “inhalant 
use,” about one-half of those 24% indicated that they had never used inhalants (Fredlund, 
1992). 
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NSDUH asks respondents to report their lifetime, past year, and past month use of 
inhalants, as well as their age at first use of inhalants. NSDUH, which defines inhalants as 
“liquids, sprays, and gases that people sniff or inhale to get high or to make them feel good,” 
also records the types of inhalants that are commonly used. These include glue, shoe polish, 
or toluene; gasoline or lighter fluid; spray paint; correction fluid, degreaser, or cleaning fluid; 
lacquer thinner or other paint solvents; other aerosol sprays; amyl nitrite, “poppers,” locker-
room odorizers, or “rush” (isobutyl nitrite); lighter gases (Jackowski et al., 2005); nitrous 
oxide or “whippets”; and halothane, ether, and other anesthetics. The category of inhalants 
most frequently reported by youth is glue, shoe polish, or toluene; however, among youth 
who have used an inhalant, more than 50% have used more than one type in their lifetime 
(SAMHSA, 2003). 
Aside from these national surveys, information on adolescent inhalant use comes 
largely from clinical samples from substance abuse or other treatment centers (e.g., 
Dinwiddie, Reich, & Cloninger, 1991b; Johnson et al., 1995; Sakai, Mikulich-Gilbertson, & 
Crowley, 2006) or special populations such as antisocial, delinquent, and/or incarcerated 
youth (e.g., Howard & Jenson, 1999; Mackesy-Amiti & Fendrich, 1999; McGarvey, 
Canterbury, & Waite, 1996) and minorities (Mosher, Rotolo, Phillips, Krupski, & Stark, 
2004), in particular Native American adolescents (e.g., Beauvais, Wayman, Thurman, 
Plested, & Helm, 2002; Howard, Walker, Walker, Cottler, & Compton, 1999; Novins & 
Baron, 2004; Novins, Beals, & Mitchell, 2001).  
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2.4 Epidemiology of Inhalant Use 
2.4.1 Age of Initiation 
The mean age of first use of inhalants varies between surveys, but it is generally 
between 11 and 13 years (Wu, Pilowsky, & Schlenger, 2005; Costello, Erkanli, Federman, & 
Angold, 1999). Findings from NSDUH suggest that, for very young adolescents, inhalants 
are among the most commonly tried drugs. Data from the 2003 NSDUH indicate that a 
higher percentage of youth aged 12 or 13 had used inhalants than marijuana in the past year 
(SAMHSA, 2004). Likewise, data from the MTF survey show that, in 2004, 17.3% of 8th 
graders had used inhalants in their lifetimes, compared with 16.3% reporting use of 
marijuana (Johnston et al., 2005). In part because inhalant use appears to peak during early 
adolescence, this study focuses on the transitions from 6th grade to 7th grade and from 7th 
grade to 8th grade.  
2.4.2 Current Prevalence of Inhalant Use 
Inhalant use among adolescents is prevalent, with inhalants being the most widely 
used illicit drug among young (< 14 years old) adolescents (SAMHSA, 2008; Johnston et al., 
2005, 2007; Wu et al., 2004) and second to marijuana among 8th and 10th graders in the 
United States (Johnston et al., 2001). Among past year illicit drug users aged 12 or 13, 45.5% 
had used inhalants, whereas 28.4% had used marijuana (SAMHSA, 2008). More than 1 
million Americans become new inhalant users annually (SAMHSA, 2003), and inhalants 
appear to be among the only drugs showing evidence of increasing use among adolescents in 
the United States (Johnston et al., 2005). More than 2 million U.S. teenagers have used 
inhalants to get high at some time in their lives (Wu et al., 2004).  
As previously noted, prevalence estimates from the three primary national surveys on 
adolescent drug use differ. In 2005, the MTF study reported estimated prevalence of lifetime 
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(ever) use of inhalants for 8th, 10th, and 12th graders as 17.1%, 13.1%, and 11.4%, 
respectively (Johnston, O’Malley, Bachman, & Schulenberg, 2006a). The 2005 prevalence 
estimates from NSDUH for the same grades were 11.9%, 11.4%, and 11.3%, respectively 
(SAMHSA, 2006). Prevalence estimates from the 2005 YRBS were 14.1% of 9th graders, 
13.2% of 10th graders, 11.4% of 11th graders, and 10.1% of 12th graders (CDC, 2006).  
Consistent with all three data sources is the seemingly nonsensical finding that 
lifetime use prevalence estimates for inhalants decline as adolescents age, although the 
decline is much sharper for the two school-based surveys (YRBS and MTF). Conceptually, 
the rate of lifetime use should increase or stay stable over time, as is seen for trends of other 
drugs. One possible explanation is that inhalant use is disproportionately common among the 
school drop-out population and that NHSDUH, which potentially includes school dropouts, 
better captures that population. It also has been noted that older respondents may be less 
prone to report inhalant use because inhalants are seen as an “immature” class of drugs and 
are less socially acceptable (Kurtzman, Otsuka, & Wahl, 2001; Johnston, O’Malley, 
Bachman, & Schulenberg, 2006a).  
Although national estimates suggest that inhalants are one of the most commonly 
tried substances, recent use measures (e.g., past month) suggest that consistent or chronic use 
of inhalants is rare. In 2005, only 1.4% of 8th graders, 1.2% of 10th graders, and 0.3% of 
12th graders in NSDUH reported past month use of inhalants (SAMHSA, 2006). The rates 
for the same grades were higher for MTF (4.2%, 2.2%, and 2.0%, respectively), but they 
were still low relative to alcohol, cigarettes, and marijuana (Johnston et al., 2006a). YRBS 
does not include a past month measure of inhalant use.  
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2.4.3 Trends in Inhalant Use 
Adolescent inhalant use peaked in 1995. At that time, nearly 22% of 8th graders 
sampled in the MTF survey reported ever having used an inhalant. In response, the 
Partnership for a Drug-Free America conducted a well-funded, widely distributed national 
media campaign highlighting the health consequences of inhalant abuse. Although not 
formally linked solely to the media campaign, abuse of inhalants decreased substantially 
among 8th, 10th, and 12th graders after 1995, according to the MTF survey (NIDA, 2005b). 
Further evidence of a potential effect of the campaign is reflected in a decrease in the number 
of 8th and 10th graders who believe that inhalant abuse is dangerous in the years following 
the end of the campaign (NIDA, 2005b).  
According to the 2004 MTF survey (Johnston et al., 2005), the abuse of most drugs 
among adolescents in the United States declined significantly in the past 3 years. These 
declines were not realized for inhalants, however. Past-year inhalant use increased from 2003 
to 2004 for all students surveyed, and lifetime inhalant abuse among 8th graders increased 
from 15.8% in 2003 to 17.3% in 2004, the second year in a row an increase was reported 
(Johnston et al., 2005).  
2.5 Prevalence of Inhalant Use in North Carolina 
YRBS provides state-level estimates for a wide range of licit and illicit drugs, 
including estimates of lifetime inhalant use. In 2003, 15.4% of North Carolina 9th through 
12th graders reported lifetime inhalant use, a percentage significantly higher than the national 
average from this survey of 12.1%. By 2005, the prevalence of lifetime inhalant use had 
dropped to 11.9%, although the differences between years and between North Carolina and 
the United States were not statistically significant (CDC, 2006).  
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2.6 Demographic Correlates of Inhalant Use 
2.6.1 Gender 
In general, gender does not appear to be strongly associated with inhalant use, and 
prevalence appears to be similar for males and females, although in some studies females 
have higher prevalence rates at earlier grades. Data from the 2005 NSDUH suggest that an 
equal number of male and female respondents ages 12 to 17 have ever used inhalants 
(10.5%) and have used inhalants in the past month (1.2%) (SAMHSA, 2006). However, 
whereas past-year inhalant use among males remained stable between 2002 and 2005, it 
increased among females from 4.1% in 2002 to 4.9% in 2005 (SAMHSA, 2007). Results 
from the 2005 YRBS showed a significantly higher prevalence rate for 9th grade females 
(17.3%) than males (11.0%), but the difference was not significant at 12th grade (CDC, 
2006). Data from the 2005 MTF suggest that the prevalence of inhalant use is higher for 
females than for males in the 8th grade (19.1% versus 14.9%) and 10th grade (14.5% versus 
11.6%) but not in the 12th grade (9.3% versus 13.7%).  
Using combined data from the 2000 and 2001 NHSDA, Wu, Pilowsky, and Schlenger 
(2004) found no difference in inhalant abuse among 12- to 17-year-olds based on gender, an 
almost unique finding among drugs of abuse—in most cases, adolescent males are more 
likely than females to use illegal drugs. However, the percentage of 18- to 25-year-old males 
who abused inhalants within the past month was more than twice that of females in the same 
age group, suggesting that long-term use of inhalants is more common among males. 
It has been posited that adolescent males’ “overall higher likelihood of involvement 
with drugs may relate to their more frequent exposure to situations in which these drugs are 
available. Inhalants may be an exception because boys and girls have the same level of 
access to them” (NIDA, 2005b, p. 7). The finding of gender similarity in inhalant use 
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highlights the potential importance of availability and access as predictors of adolescent 
inhalant use. More generally, Van Etten and Anthony (2001) found that across age, race, 
region, and urban status subgroups, after controlling for opportunities to use drugs, women 
were as likely as men to initiate drug use.  
No identified studies have determined whether drug use sequencing that includes 
inhalants differs between males and females. For example, females have similar rates of 
inhalant use but generally lower rates of other substance use than males; therefore, it is 
feasible that inhalants may play a more important “gateway” role for females.  
2.6.2 Race/Ethnicity 
As is the case with most drugs of abuse, African American adolescents tend to have 
substantially lower inhalant use rates than whites and Hispanics. Data from the 2005 NSDUH 
and YRBS suggest that whites and Hispanics have similar lifetime prevalence rates, whereas 
African Americans’ rates are significantly lower. Among 9th through 12th graders in the 
2005 YRBS, 13.4% of whites, 13.0% of Hispanics, and only 6.8% of African Americans 
reported lifetime ever use of inhalants (CDC, 2006). Similar findings are reported for the 
2005 NSDUH, although the discrepancy is not as pronounced: 10.8% of whites, 10.2% of 
Hispanics, and 9.4% of African Americans aged 12 to 17 reported lifetime use of inhalants 
(SAMHSA, 2006). While it is well established that African American and white adolescents 
differ in terms of prevalence of drug use, it remains untested whether there are fundamental 
differences in drug use sequencing between the two groups, particularly when inhalants are 
considered. Given the higher prevalence rates for inhalant use among white adolescents, it is 
hypothesized that inhalant use will play a more prominent role in drug use sequencing for 
white adolescents.  
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2.7 Characteristics of Adolescent Inhalant Users 
Beauvais and Oetting (1987) have proposed that inhalant users can be classified into 
three general categories: inhalant-dependent adults, polydrug users, and young inhalant users. 
Inhalant-dependent adults tend to use inhalants predominantly and have done so for an 
extended period of time. They generally have very poor prognoses, including high rates of 
heavy use of other drugs and poor physical and mental health. Polydrug users may use a 
wide array of substances, and inhalants are often used when their drugs of choice are not 
available. Polydrug users can be any age, although they are typically between the ages of 15 
and 18. Polydrug users represent a wide range of characteristics reflecting in part their 
primary drug of choice, and they tend to have profiles similar to others who abuse their 
primary drug of choice. They are likely to have significant antisocial propensities. Young 
inhalant users represent the relatively widespread experimental use by adolescents who tend 
to be very young (typically between the ages of 12 and 13). They are likely to be 
experimenting with other drugs, particularly drugs commonly referred to as gateway drugs—
alcohol, cigarettes, and marijuana—although the sequencing and possible prospective 
relationships between these drugs has not been investigated in younger adolescents, the 
period most likely to be associated with experimenting and initiating the use of gateway 
drugs. 
In general, inhalant users are likely to report family problems and impaired family 
functioning (McGarvey et al., 1996, 1999; Morita et al., 1996; Tapia-Conyer, Cravioto, 
Delarosa, & Velez, 1995), while parental monitoring and knowledge of the health risks of 
inhalants appear to be strong protective factors (Ramirez et al., 2004). Inhalants are often the 
first substance used by youth incarcerated in juvenile detention facilities (Young, Longstaffe, 
& Tenenbein, 1999). Inhalant use has been found to be strongly associated with antisocial 
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personality disorder (Compton et al., 1994; Dinwiddie, Reich, & Cloninger, 1990) and 
depression (Kelder et al., 2001; Sakai et al., 2004), and inhalant users are more likely than 
nonusers to have serious problems in school (Oetting & Webb, 1997). Academic 
performance appears to be an especially strong correlate of inhalant use (Mackesy-Amiti & 
Fendrich, 2000). 
The association between inhalant use and deviant behavior is particularly noteworthy. 
Although deviant behavior has generally been associated with any drug use, this association 
is stronger for inhalant use than for any other drug (Mackesy-Amiti & Fendrich, 1999; 
Mosher et al., 2004), leading some authors to suggest that inhalant use is categorically 
different from other drug use and that inhalant use may have more in common with general 
delinquent behaviors than with other drug use (Mackesy-Amiti & Fendrich, 1999). 
Youth attending alternative high schools appear to be much more likely to use 
inhalants. Lifetime prevalence estimates from national samples suggest that about 17% of 8th 
through 12th grade students have used inhalants (Johnston et al., 2005). But the estimates for 
adolescents attending alternative high schools are much higher. Among students completing 
the national Alternative High School Youth Risk Behavior Survey (ALT-YRBS) in 1998, 
27% reported lifetime use of inhalants (Grunbaum et al., 2000). Results from a later study of 
alternative high school students from Texas were nearly identical: prevalence of lifetime 
inhalant use was 28% (Fleschler, Tortolero, Batumler, Vernon, & Weller, 2002). Among this 
population, weapon carrying, suicidal ideation, alcohol/tobacco use, marijuana use, and 
cocaine use were all strongly associated with inhalant use. In a multivariate model including 
these items and demographic characteristics, the odds of using alcohol or tobacco were 7.7 
times greater for lifetime inhalant users than for abstainers. The odds of using marijuana 
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(10.3 times greater) and cocaine (17.2 times greater) were even more striking (Fleschler et 
al., 2002) and seem to suggest that inhalant users, even among a high-risk population, are at 
particularly high risk for serious drug involvement.  
Friends’ use of drugs has consistently been shown to be one of the strongest 
predictors of drug use. Beuvais, Wayman et al. (2002) found this to be the case with 
inhalants as well, finding that peer sanctions against use, peer use, and peer encouragement 
to use were all significant predictors of recent use (i.e., use in the past 30 days) and lifetime 
use, the relationship being much stronger for use in the past 30 days and for non-Latino white 
adolescents (relative to American Indian and Mexican American adolescents). The strongest 
peer predictor of inhalant use was the degree to which friends are perceived to use them 
(assessed by a question asking how many of their friends sniff glue, gas, or other inhalants). 
This predictor was again most strongly associated with past 30 day use and was strongest for 
non-Latino white students and weakest for American Indian students. A white student 
reporting friends who used inhalants was 17.87 times more likely to be using inhalants than a 
student who did not have friends who use (Beauvais, Wayman, et al., 2002). The authors 
concluded that the particularly strong effects of peers on recent (past 30 days) use may reflect 
“peer clustering,” where adolescents who continue to use inhalants may select a sphere of 
friends who are also using (Beauvais, Wayman, et al., 2002; Oetting & Beauvais, 1986). 
Another well established possible explanation for the strong relationship between perceived 
peer use and adolescent use is projection, where adolescents believe that their friends and 
peers do what they do themselves. This phenomenon tends to inflate the relationship between 
perceived peer use and adolescent substance use (Prinstein & Wang, 2005; Norton, 
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Lindrooth, & Ennett, 2003; Krueger & Stanke, 2001; Kandel, 1996; Bauman & Ennett, 1996; 
Marks, Graham, & Hansen, 1992).  
One epidemiologic study (Mosher et al., 2004) has demonstrated how unique 
characteristics define inhalant users, when compared with users of other drugs. Although 
Mosher et al. found that some of the more consistent characteristics of youth who abuse 
drugs (e.g., low parental attachment, drug use by parents, low school achievement) were also 
common among young inhalant users, one of the most widely reported predictors of 
substance use—peer or friend use of the substance (Beauvais, Wayman, et al., 2002)—was 
not a significant predictor of inhalant use. 
However, the scale measure of “friend’s drug use” used in this study did not include 
an item for friend’s use of inhalants. Although general drug use among peers may not 
influence inhalant use, peer inhalant use very well may (Beauvais, Wayman, et al., 2002). It 
seems likely that youth who are experimenting with inhalants are associating with other 
youth who are as well (Oetting & Donnermeyer, 1998). It also should be noted that this study 
was focused on minority adolescents. It is reasonable to expect that drug-using cultures and 
patterns of use may differ among different racial/ethnic and cultural groups. 
According to the latest MTF survey (2005), only 38.7% of 8th graders believe it is 
dangerous to try inhalants once or twice, a number that has declined for the past 3 years. 
Notably, these results mirror the rising rates of inhalant use among this population during the 
same period. Adolescent perceptions of the harm involved in using drugs have been shown to 
have a strong, inverse relationship with the use of a number of drugs (Johnston et al., 1998), 
although this relationship has not been demonstrated directly for inhalants. In one of the only 
studies to assess the relationship between perceived harm from using inhalants and inhalant 
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use, Beauvais, Jumper-Thurman, Plested, and Helm (2002) found that perceived harm from 
occasional use of inhalants was a significant predictor of inhalant use, although this factor 
was weaker than other predictors included in analyses, primarily dealing with peer influence.  
2.8 Theoretical Perspectives on Drug Use Sequencing  
2.8.1 The Gateway Hypothesis  
In 1970, Dr. Robert DuPont, drug czar under President Richard Nixon, used the term 
“gateway drug” to define drugs that when used appear to lead to the use of more progressive 
and dangerous substances (Kandel, 2002). Often called “Stage Theory,” the gateway 
hypothesis has played a major role in understanding how adolescents transition through a 
surprisingly consistent sequence of drug use (Kandel & Yamaguchi, 1985, 1999, 2002; 
Kandel et al., 1992; Kandel, 1975, 1988; Kandel & Logan, 1984; Kandel & Faust, 1975).  
The basic premise of the gateway hypothesis is that the use of various classes of 
drugs follows definite pathways, suggesting that an individual who participates in one drug 
behavior is at risk of progressing to another (Wu et al., 2004). Kandel and Jessor (2002) 
identified three primary propositions of the gateway hypothesis. The first proposition is that 
there is a developmental sequence of involvement with different classes of drugs, such that 
initiation into drug use begins with legal and widely available drugs (tobacco and alcohol). 
Marijuana use is seen as a bridge between these legal substances and the use of other illicit 
drugs. Support for this proposition is strong, with numerous studies replicating the general 
sequence during the past 30 years (e.g., Kandel & Yamaguchi, 1985, 1999, 2002; Kandel et 
al., 1992; Kandel, 1975, 1988; Kandel & Logan, 1984; Kandel & Faust, 1975; Graham et al., 
1991; Collins et al., 1994; Collins, Graham, Rousculp, & Hansen, 1997; Hyatt & Collins, 
2000).  
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The second proposition is that the use of a drug earlier in the sequence is associated 
with an increased risk or likelihood of use of a drug later in the sequence; as with the first 
proposition, there is strong empirical evidence to support this second proposition (e.g., Guo 
et al., 2002; Hawkins, Hill, Guo, & Battin-Pearson, 2002; Kandel, 1975, 2003; Kandel & 
Faust, 1975; Kandel et al., 1992; Ellickson, Hays, & Bell, 1992). 
The third proposition is the most controversial and, according to some researchers, 
the most abused proposition. It states that the use of a drug earlier in the sequence causes the 
use of a drug later in the sequence. This proposition is often cited among intervention 
planners and during policy debates as a rationale for focusing efforts and resources on the 
prevention of gateway substances. After years of study and review, Kandel and Jessor (2002) 
concluded that support for the third proposition is lacking, largely due to the inherent 
difficulties in establishing causality and that “interpretations of the gateway hypothesis 
should be restricted to the propositions about sequencing and association…The causation 
proposition is without evidential support at this time” (p. 372).  
Yamaguchi and Kandel (1984b) caution that the notion of a gateway sequence of 
drug use does not imply that these stages are universal or uniformly necessary, and they point 
out that not all individuals progress through the gateway sequence. Most stop at occasional 
alcohol and/or tobacco use: “The existence of stages of progression…does not necessarily 
imply causal linkages among different drugs since the observed sequences could simply 
reflect the association of each class of drugs with different ages of initiation and/or individual 
attributes rather than the specific effect of the use of one drug class on the use of another” 
(Yamaguchi & Kandel, 1984b, p. 671). Despite this caveat, it is clear that the gateway 
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hypothesis has been interpreted and used as evidence that the use of gateway drugs causes 
the use of illicit drugs. 
The gateway hypothesis of substance use posits a progressive and hierarchical 
sequence of drug use stages. According to the gateway hypothesis, a substance user begins 
his or her use by first using alcohol or tobacco, substances that are legal for adults, 
prevalently used, widely available, and heavily marketed. The next substance in the sequence 
is marijuana, followed by other illicit drugs. A central tenet of the gateway hypothesis is that 
the use of a drug in an early stage is a necessary but not sufficient precursor to the use of a 
drug in a later stage. Not all users progress through the stages; many will end their use at an 
early stage, and the use of a drug early in the sequence does not alone predict advancement to 
a later stage. But users of drugs such as heroin, cocaine, and crack will almost invariably 
have used marijuana, having first used alcohol and/or tobacco. 
This sequencing has been extremely consistent in adolescent studies using 
representative or large school- and community-based samples (Kandel & Yamaguchi, 2002; 
Kandel et al., 1992; Kandel, 1975; Kandel & Faust, 1975; Golub & Johnson, 2001; 
Federman, Costello, Angold, Farmer, & Erkanli, 1997). In a seminal study spanning 20 
years, early use of alcohol and cigarettes was the strongest predictor of progression to 
marijuana and other illicit drugs after controlling for a number of theoretical and empirical 
predictors of substance use (Kandel et al., 1992). The vast majority of this literature, 
however, has been based on retrospective data. Few studies have used prospective 
approaches to estimate substance use progression probabilities (Guo et al., 2002; Hawkins, 
Hill, Guo, & Battin-Pearson, 2002; Kandel, 1975, 2003; Kandel & Faust, 1975; Kandel et al., 
1992; Ellickson, Hays, & Bell, 1992).  
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No study to date has prospectively assessed whether or where inhalants fall within the 
gateway sequence. In many ways, inhalants resemble alcohol and tobacco; they are even 
more widely and readily available than either alcohol or tobacco and are legal to purchase 
and own in most states. Because inhalants are strongly associated with other drug use and are 
typically tried at an early age, it has been posited that inhalants may be an unidentified 
gateway drug, although some have argued that inhalants are better conceptualized as being a 
marker for later problematic use.  
Although the gateway hypothesis has been prominent in the substance abuse research 
literature, particularly among substance abuse policy advocates and intervention planners, 
there continues to be significant debate regarding the utility of the hypothesis in explaining 
drug use progression. Competing literature suggests that common, underlying factors 
associated with the use of various drugs provides a better explanation of drug use 
progressions.  
Because many drug use prevention activities and policies are founded and designed 
on the belief that the prevention of gateway drug use may lead to the prevention of illicit 
drug use, it has been possible to test the gateway hypothesis via natural experiments. Studies 
that assess the impact of variations in exposure to policies aimed at reducing supply and 
increasing prices of gateway drugs (via tax increases, restrictive use laws, increased law 
enforcement) or interventions aimed at reducing demand for gateway drugs (for instance, via 
health promotion efforts such as anti-tobacco, -alcohol, or -marijuana media campaigns) may 
provide indirect evidence for or against the gateway hypothesis.  
If a gateway drug is causally linked to subsequent illicit drug use, policies and 
interventions that limit the use of the gateway drug will eventually affect demand for the 
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illicit drugs. Conversely, if a common factor model rather than the gateway model is more 
appropriate, policies and interventions targeting gateway drugs are not likely to affect the use 
of other drugs and may actually lead to substitution, whereby individuals switch to a 
substitute drug when supply of their drug of choice is diminished.  
Findings that policies or interventions aimed at tobacco, alcohol, or marijuana use are 
influencing rates of drug use later in the gateway sequence would support the gateway 
hypothesis. For instance, Pacula (1998) demonstrated that higher cigarette prices associated 
with changes in cigarette excise tax policies have a negative, significant effect on current 
decisions to use marijuana and alcohol and that increases in the beer tax or the legal drinking 
age decrease the demand for marijuana by at least as much as they decrease alcohol 
consumption. Farrelly, Bray, Zarkin, and Wendling (2001) found evidence that higher 
cigarette taxes are linked with decreased intensity of marijuana use and may have a modest 
effect on the probability of use, especially among males. They concluded that a 10% increase 
in cigarette prices would lead to a 5.4% decrease in total marijuana use. Beenstock and 
Rahav (2002) also found support for the gateway effect of cigarette consumption on 
marijuana use in Israel. Using a natural experiment, they randomly varied cigarette smoking 
rates by birth cohort and cigarette prices and were able to demonstrate that people who grew 
up when cigarettes were relatively cheap were more likely to smoke and to start smoking 
younger. As a causal consequence, they were more likely to initiate marijuana use and 
initiate earlier. Their findings did not support a gateway effect for marijuana on illicit drug 
use, however.  
In contrast, other notable studies have found that certain drugs operate as substitutes 
rather than complements, as evidenced by increases in the use of one drug as a result of 
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changes in access to another. For instance, Picone, Sloan, and Trogdon (2004) found in an 
older adult population that while smoking bans (in public places) led to a decrease in alcohol 
consumption among females, higher cigarette prices (associated with the tobacco settlement 
of 1998) led to an increase in alcohol consumption for males and females. They explained 
this apparent disparity in findings by suggesting that smoking bans in bars might keep social 
drinkers away and subsequently reduce their opportunities to consume alcohol. Describing a 
potential unintended consequence of alcohol policy, DiNardo and Lemieux (2001) found that 
while increasing the legal minimum drinking age slightly reduced the prevalence of alcohol 
consumption, the same policy appeared to slightly increase the prevalence of marijuana 
consumption. They concluded that alcohol and marijuana may serve very similar short-term 
purposes to the user, making them potential substitutes for each other. 
Literature on the effects on illicit drug use of health promotion interventions aimed at 
gateway drugs also provides some evidence supporting the gateway hypothesis. Graham, 
Marks, and Hansen (1991) examined 1-year prevention data and demonstrated that students 
exposed to a normative education campaign were less likely to transition from a lower-
ranked class of drug use to a higher-ranked class. Spoth, Reyes, Redmond, and Shin (1999) 
found that students receiving a family-focused intervention were less likely to transition from 
nonuse to drug use compared with students in a control group. Scheier, Botvin, and Griffin 
(2001) examined drug progression in a cohort of middle school students participating in a 
school-based drug prevention trial over a 4-year period. They found that program effects 
disrupted drug progression by decreasing alcohol and cigarette use over 1 year and reducing 
cigarette use over a 2-year period.  
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Botvin, Scheier, and Griffin (2002) summarized 20 years of research on the effects of 
Life Skills Training, a multicomponent prevention approach, concluding that preventing the 
use of substances hypothesized to occur at the very beginning of the developmental 
progression (tobacco and alcohol use) not only deters the use of those substances but also 
deters the use of marijuana and of at least some illicit drugs. Similarly, Pentz and Li (2002) 
found that early program effects of a multicommunity-based drug prevention trial on gateway 
drug use mediated later effects on amphetamine use.  
Biglan and Smolkowski (2002) evaluated the effects of a smoking prevention 
intervention that targeted influences posited to affect only smoking. They posited that this 
would provide a relatively clean test of the gateway hypothesis, as tests of more general 
prevention approaches include interventions that are likely to have direct effects on illicit 
drugs. They found that in intervention communities the increase in alcohol use was 
approximately zero while there was a significant increase in alcohol use in the control 
communities across 5 years of assessment. Likewise, they found that while marijuana use 
increased in control communities, the rate of increase was significantly slowed in the 
intervention communities. These findings suggest that the intervention aimed specifically at 
preventing cigarette smoking may have had an impact on alcohol and marijuana use as well.  
Collectively, these results suggest that a relatively stable progression of drug use best 
characterizes the experience of most drug users. Individuals who progress to the use of illicit 
drugs have almost invariably first used alcohol and/or tobacco and marijuana. Although it is 
unclear whether the use of a gateway drug causes later illicit drug use, the temporality and 
association between gateway drug use and later illicit drug use is strong and robust. Limited 
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evidence from intervention and policy studies suggests that efforts to reduce the initiation 
and use of gateway drugs can have an impact on the use of illicit drugs.  
2.8.2 Common Liability Models of Drug Use 
Critics of the gateway hypothesis, often citing general theories of problem behavior 
including Problem Behavior Theory (Jessor & Jessor, 1977), the general theory of crime 
proposed by Gottfredson and Hirschi (1990), and other social psychological delinquency 
theories (Rebellon & Van Gundy, 2006), have adopted a “common cause” view of drug use. 
A common cause argument posits that drug use is simply a manifestation of an underlying 
individual propensity for deviance coupled with opportunities to use certain substances. 
According to this critique, the gateway sequence simply reflects social norms, availability, 
and opportunity. Gateway drugs (tobacco and alcohol in particular) are used first because 
they are the most widely available and most accepted by society. Particular substances 
selected by an individual may reflect differences in opportunity for use. Supporting the 
potential importance of availability of drugs for explaining the progression to polydrug use, 
Collins et al. (1998) found that drug offers and drug availability were significantly predictive 
of simultaneous polydrug use.  
Common liability models suggest that early substance use is just one marker of a 
broader underlying construct of developmental difficulties. Morral, McCaffrey, and Paddock 
(2002) used a simulation study to demonstrate that the presumptions of the gateway 
hypothesis as it relates to the progression from marijuana use to illicit drug use can be 
explained completely by the order in which opportunities to use marijuana and illicit drugs 
occur and by assuming a general propensity to use drugs.   
Findings from the simulation study did not disprove the existence of a marijuana 
gateway effect, but they did demonstrate that the primary evidence supporting gateway 
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effects was equally consistent with an alternative model of adolescent drug use initiation in 
that the use of marijuana has no direct effect on later illicit drug use. Accounting for a 
general propensity to use drugs completely explained the association between marijuana use 
and illicit drug use. The authors concluded that marijuana policies would have little effect on 
illicit drug use rates unless they affected the individual’s underlying propensity to use drugs 
(e.g., by increasing general self-efficacy or academic achievement) or reduced access to 
illicit drugs. Support for Morral et al.’s findings and for the “common factor” model has been 
presented in epidemiological studies (Agrawal, Neale, Prescott, & Kendler, 2004a; Tarter et 
al., 2006). 
Of note are several studies suggesting that the gateway sequence, robust when applied 
to general population samples, is less consistent when applied to certain specific populations. 
Variations in the typical gateway sequence have been noted for different generations (Fisher, 
Mackinnon, Anglin, & Thompson, 1987) and ethnic/cultural groups (Guerra, Romano, 
Samuels, & Kass, 2000; Novins et al., 2001). Significant differences in drug use sequencing 
have been reported for clinical samples of drug- or alcohol-dependent individuals (Golub & 
Johnson, 1994; Martin et al., 1996). In an analysis of data from the Arrestee Drug Abuse 
Monitoring program, Golub and Johnson (2002) found that drug use progressions varied 
significantly from the traditional gateway sequence for a significant percentage of daily illicit 
drug using criminal offenders. This finding led the authors to posit that, although the use of 
gateway drugs may be an important risk factor or perhaps risk marker for future illicit drug 
use among high-risk populations, the use of gateway drugs may not be a central cause of 
illicit drug use (Golub & Johnson, 2002b).  
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Polydrug users may also represent a unique population characterized by different 
drug use sequencing. Although prospective data on this question are lacking, Novins et al. 
(2001) found that 75% of rural American Indian adolescents who had retrospectively 
reported ever using three or more substances reported a sequence of first use that was 
inconsistent with the gateway hypothesis, leading the authors to conclude that the traditional 
formulation of the gateway hypothesis may not be applicable to polydrug users. Youth who 
initiated their substance use before age 13 were also less likely to report a sequence of use 
that was consistent with the gateway hypothesis. In a later longitudinal study using the same 
sample, Novins and Baron (2004) found that, compared with any other group, individuals 
who initiated their substance use with marijuana and/or inhalants were at far greater risk for 
progressing to the use of an illicit drug, and multiple classes of drugs, “later” in the gateway 
sequence.  
Although these studies of rural American Indian adolescents did not support the 
specific gateway hypothesis, they did find that, in general, most youth used alcohol, 
marijuana, and/or inhalants before using other illicit drugs, a finding that may reflect the 
higher rates of inhalant use among both polydrug users and American Indians. Unfortunately, 
because the survey instrument did not differentiate tobacco misuse from the ceremonial use 
of tobacco, the authors were unable to include tobacco use in their analyses. The results from 
these studies are clearly not generalizable to a general population sample and may reflect the 
distinctly different drug use patterns of this population. 
It has been suggested that inhalant use may be more closely related to delinquency 
than to the use of other drugs (Sakai et al., 2004) and that inhalants may serve as an early 
marker for particularly problematic behavior (Howard & Jenson, 1999; Borges, Walters, & 
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Kessler, 2000; Kelder et al., 2001; Mackesy-Amiti & Fendrich, 2000; Sakai et al., 2004; Wu 
et al., 2004). This finding would seem to support a basic premise of “common cause” 
models—that rather than reflecting a unique set of predictors, the use of drugs (along with 
other problematic behaviors) is a result of an underlying propensity for problem behavior. An 
implication of this premise is that interventions should be aimed at a wide range of risk 
behaviors rather than at a single substance or class of substances. 
Several common liability factors have been consistently cited. Although 
operationalized in various ways, it has been argued that a general propensity or liability to 
engage in problem or delinquent behavior, and not the use of a gateway drug, predicts 
transitions to drug use (Jessor, 1991; Donovan, Jessor, & Costa, 1988; Jessor & Jessor, 1977; 
Rebellon & Van Gundy, 2006; Jones & Quisenberry, 2004; Benda, 2002; Vazsonyi, 
Pickering, Junger, & Hessing, 2001; Pratt & Cullen, 2000; Kirisci, Vanyukov, & Tarter, 
2005; Vanyukov et al., 2003). Factors such as an individual’s risk-taking or sensation-
seeking propensity (Hittner & Swickert, 2006; Yanovitzky, 2005; Robbins & Bryan, 2004; 
Martin et al., 2004; Slater, 2003; Hansen & Breivik, 2001; Donohew et al., 1999) or lack of 
self-control (Smith, 2004; De Li, 2004; De Wit & Richards, 2004; Wills & Dishion, 2004) 
are thought to increase the likelihood of engaging in problem behaviors, including drug use.  
Problem Behavior Theory (Jessor & Jessor, 1977; Donovan & Jessor, 1985; Jessor, 
1987, 1991; Donovan et al., 1988; Costa, Jessor, & Donovan, 1989; Donovan, Jessor, & 
Costa, 1991) often serves as the foundation of common cause arguments against the gateway 
hypothesis. In Problem Behavior Theory, variables related to social control (e.g., parental 
disapproval and monitoring of drug use, neighborhood access to drugs) and social modeling 
(e.g., peer drug use), an individual’s personality and psychosocial characteristics (e.g., 
35 
sensation seeking), and an individual’s behavior system (e.g., high involvement in problem 
behaviors and low involvement in conventional behaviors) are thought to interact to 
determine an adolescent’s overall level of problem behavior propensity.  
In this framework, an adolescent’s involvement in any one problem behavior 
increases the risk for involvement in other problem behaviors. But whereas in the gateway 
hypothesis the use of one drug is thought to directly increase the risk of using other drugs, the 
relationship is viewed as indirect in Problem Behavior Theory. Specifically, it is the 
opportunities associated with engaging in problem behaviors (e.g., affiliating and interacting 
with deviant peers, having access to different substances) and the psychological “meaning” 
of the behaviors (e.g., rebelling against social conventions, seeking independence from 
parents) that explain the high covariance between problem behaviors.  
2.8.3 Reconciling the Gateway Hypothesis and Common Liability Models 
In truth, these challenges to the gateway hypothesis are not necessarily 
incommensurate with it. Although a few studies have illustrated patterns of drug use that are 
not entirely consistent with the most commonly described gateway sequences, even 
opponents of the gateway hypothesis note that the general sequence—transitions from widely 
available and socially acceptable substances to illicit drugs—is remarkably consistent across 
studies and populations. Whereas the gateway hypothesis suggests that the use of a particular 
drug directly increases the probability of using a drug later in the sequence, a common 
liability argument suggests that the ordering of drugs used simply reflects the social norms 
and opportunities to use associated with each drug.  
According to the gateway hypothesis, the use of a drug early in the sequence 
(particularly alcohol and marijuana) is a necessary but not sufficient precedent for the use of 
illicit drugs. Proponents of a common liability model argue that the sequencing of drugs is 
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merely an artifact; alcohol and tobacco are the first drugs used simply because they are the 
most widely available, and individuals who progress to illicit drug use do so for reasons 
related to an underlying propensity. Under both models, however, the stages of drug use 
remain similar and are robust across a wide range of samples. In addition, both viewpoints 
highlight the importance of drug availability and opportunities to use as at least partially 
explaining the gateway role seen for alcohol, tobacco, and marijuana. The key distinction is 
that, according to the gateway hypothesis, the use of a gateway drug increases the likelihood 
of using another drug, perhaps through direct pharmacologic or neurological effects 
associated with use of the gateway drug. Put simply, according to the gateway hypothesis, 
the use of a gateway drug produces direct effects that lead to an increased probability of later 
drug use.  
This dissertation does not seek to reconcile or directly contrast the gateway 
hypothesis with the common liability theories. To do so would likely require animal-based 
molecular, biological, and pharmacological experiments to explore questions of causation 
(Kandel, Yamaguchi, & Klein, 2006). But by exploring the role that inhalants—perhaps the 
most widely available class of drugs of abuse—play in drug sequencing, this dissertation 
tests a key assumption underlying both the gateway hypothesis and the common cause 
theories: that drug availability (in part) predicts how early in the drug use sequence a drug is 
used. Furthermore, this dissertation separately tests the association between inhalant use and 
other drug use stages and transitions while controlling for demographic characteristics and 
several key components cited by proponents of a common cause model, including perceived 
drug availability, perceived peer drug use, sensation seeking and delinquency, academic 
achievement, and parental (mother’s) disapproval of drug use.  
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According to the gateway hypothesis, a gateway drug should have a direct and 
significant impact on probabilities of transitioning to later drug use. Conversely, a common 
liability model suggests that, when taking into account underlying individual characteristics 
and drug use opportunities associated in general with an increased risk of drug use, the 
prospective relationship between a gateway drug and later drug use transitions will diminish. 
By first examining whether inhalants operate as a full or partial gateway to the established 
gateway drug marijuana and then testing whether the relationship between inhalant use and 
other drug use remains after adjusting for theorized common liabilities, this dissertation 
examines the potentially predictive role inhalants play in gateway drug use pathways.  
2.9 Preliminary Evidence of a Gateway Relationship between Inhalant Use and 
Other Drug Use 
2.9.1 Similarities between Inhalants and Other Drugs 
As with other drugs of abuse, people who use inhalants can build up tolerance (Ron, 
1986), develop cravings associated with dependence (Anthony et al., 1994; Howard et al., 
2001), and experience significant withdrawal symptoms (Brouette & Anton, 2001). The signs 
of addiction suggest that inhalants operate similarly to other drugs of abuse. Inhalants have 
been demonstrated, primarily in animal studies, to produce effects similar to ethanol 
(alcohol) and other central nervous system depressants (Knisely, Rees, & Balster, 1990; 
Rees, Knisely, Breen, & Balster, 1987; Rees, Knisely, Balster, Jordan, & Breen, 1987; 
Bowen & Balster, 1997a, b; Wiley, Bowen, & Balster, 2001; Bowen & Balster, 1998a, b; 
Balster, Bowen, Evans, & Tokarz, 1997; Bowen, Wiley, & Balster, 1996; Bowen, Wiley, 
Jones, & Balster, 1999; Balster, 1998). It appears plausible, albeit untested, that early use of 
inhalants may condition an individual’s brain to crave drug-associated effects. A similar 
hypothesis has been forwarded to explain the apparent gateway effects of tobacco, alcohol, 
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and marijuana (Hall & Lynskey, 2005; Kelley & Rowan, 2004; Solinas, Panlilio, & 
Goldberg, 2004; Lindsay & Rainey, 1997).  
Comparing the clinical features of inhalants, methamphetamine, alcohol, and nicotine 
dependence, Miyata et al. (2004) found that the characteristics of inhalant dependence were 
very similar to those found for the other substances. In particular, inhalants were similar to 
methamphetamine and alcohol and greater than nicotine in terms of subjective effects 
(pleasant feelings associated with the drug) and withdrawal (craving). The intensity of drug 
seeking was similar between inhalants, methamphetamine, and nicotine; alcohol was higher. 
In terms of social disturbance and particularly acute psychic and physical disorder, 
methamphetamines and inhalants showed the most significant influence, whereas nicotine 
showed the least. Although the focus of this study was primarily on determining how 
nicotine dependence relates to dependence on other drugs, it is evident that inhalants present 
similar clinical characteristics to other drugs of dependence. 
Indeed, evidence is mounting that inhalants act on the same areas of the brain as do 
cocaine, amphetamines, and other addictive drugs. Recent animal studies have demonstrated 
that toluene, a solvent contained in gasoline, spray paint, and glue, enhances dopamine 
activity in the brain’s pleasure center, the nucleus accumbens, in much the same way as do 
other drugs (Koob, 1992, 2002; Leshner & Koob, 1999; Wise, 1998; Wise & Bozarth, 1982, 
1984; Riegel, Ali, Torinese, & French, 2004; Riegel et al., 2003; Riegel & French, 2002). 
Nonhuman primates lever-press to receive bursts of toluene vapor (Weiss, Wood, & Macys, 
1979) just as they actively seek other addictive drugs. This evidence has led some researchers 
to conclude that inhalants fit squarely in the same category as other drugs of abuse (Riegel et 
al., 2003). To the extent that drug-seeking behavior in general is linked to a desire for the 
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euphoria associated with increased dopamine activity in the brain, it seems conceivable that 
inhalants could serve to introduce an individual to these sensations and increase the 
likelihood of future drug use. 
2.9.2 Previous Studies on the Relationship between Inhalant Use and Other Drug Use 
A growing body of evidence suggests a clear and consistent association between the 
use of inhalants and the use of other drugs. Several studies have suggested that inhalant use 
serves as a marker for other serious drug problems, such as cocaine, heroin, and intravenous 
drug use (Bennett et al., 2000; Dinwiddie, Reich, & Cloninger, 1991a; Johnson et al., 1995; 
Schutz et al., 1994; Novins & Baron, 2004). The majority of these studies have explored 
associations between inhalant use and other drug use or related behaviors using cross-
sectional data, precluding an assessment of temporality. But evidence from these studies 
suggests that the early use of inhalants by adolescents may serve as a “red flag” for the 
development of later illegal drug use (Storr, Westergaard, & Anthony, 2005).  
2.9.2.1 Longitudinal Studies 
Only two identified studies have longitudinally investigated the role of inhalants in 
predicting subsequent use of other drugs (Johnson et al., 1995; Storr et al., 2005), although 
neither study examined the prospective relationships between adolescent inhalant use and the 
use of gateway drugs typically used earlier in drug use sequences. Johnson et al. (1995) 
found that African American youth living near Chicago with a history of any inhalant use by 
age 16 were more than nine times more likely to begin heroin use by age 32, after controlling 
for other risk factors, including marijuana use, dropping out of high school, alcohol use, 
cigarette use, family income during childhood, and adult area of residence. Notably, with 
marijuana and inhalants included in the multivariate model, cigarette and alcohol use—
highly significant predictors in bivariate models—were no longer significant, suggesting that 
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any association between cigarettes/alcohol and later heroine use may be fully mediated by 
the intermediate use of inhalants and marijuana. The authors concluded that inhalants are an 
important marker for the development of later more serious drug involvement in the form of 
heroin use.  
Because Johnson et al. (1995) focused on the specific prospective relationship 
between inhalants and heroin, while controlling for alcohol, tobacco, and marijuana use, 
relationships between these other drugs and inhalant use were not described. Thus, no 
conclusions regarding inhalants as a potential gateway drug were offered. Importantly, the 
sample included relatively few users of inhalants and heroin, yielding unstable relative risk 
estimates and wide confidence intervals. Indeed, inhalant use rates have consistently been 
lower for African Americans than for all other racial/ethnic groups (Wu et al., 2004). 
Furthermore, inhalant use was measured only at baseline, when the participants were an 
average age of 16. There is evidence that inhalant use peaks at an earlier age and that early 
inhalant use is particularly predictive of later illicit drug use (Storr, Westergaard, and 
Anthony, 2005).  
Storr, Westergaard, and Anthony (2005) replicated and expanded upon Johnson et al. 
(1995) by examining estimates of relative risk of opiate use (heroin or opium) subsequent to 
the use of inhalants at an earlier age (14 years old) among a larger and more diverse sample 
of adolescents living in urban areas within a large metropolitan area. The findings were 
consistent with other studies showing that early inhalant use is associated with later heroin 
use or injection drug use (e.g., Dinwiddie, Reich, & Cloninger, 1991b; Johnson et al., 1995). 
Adolescents who used inhalants prior to age 14 were nearly three times as likely to start 
using heroin or opium by young adulthood compared with adolescents who had not used 
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inhalants by age 14, after controlling for gender, early signs of aggression and misbehavior, 
family social status, and race/ethnicity.  
Storr, Westergaard, and Anthony (2005) further explored whether inhalant use was a 
unique predictor of excess risk of opiate use or whether early inhalant use is better 
conceptualized as part of a more general susceptibility trait, defined by the authors as early 
onset use of multiple drugs (alcohol, inhalants, tobacco, and marijuana). Comparing two 
nested structural equation models, they found that including early onset of inhalant use did 
not improve the fit of a model that included a direct regression path from opiate use to the 
early onset multiple drug use trait. The authors concluded that the link between early inhalant 
use and later opiate use may not reflect a direct causal link. Instead, early inhalant use could 
serve as an indicator of a more general susceptibility trait. Such a view would be concomitant 
with problem behavior theory (Jessor & Jessor, 1977) and other work on general 
susceptibility trait models (Morral et al., 2002). 
Additional plausible interpretations of these study findings are evident. The approach 
directly tested whether early onset of inhalant use uniquely predicted later opiate use above 
and beyond the prediction provided by the general susceptibility measure. The fact that, 
when entered alone, early onset inhalant use led to an increased relative risk estimate and that 
this relationship disappeared when a general susceptibility trait was included in the model 
could suggest a mediated effect between inhalant use and later opiate use. It is possible that 
inhalants served as an initial or early marker of susceptibility. Although it appears that 
inhalants are one of the earliest drugs tried (Wu et al., 2004), no study to date has attempted 
to determine where in a drug use sequence inhalants belong. Early onset inhalant users may 
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be more likely to try other drugs early, subsequently placing them at higher risk for later 
illicit drug use. Results to date do not provide an adequate test of this possibility. 
2.9.2.2 Nationally Representative Samples 
Inhalant users appear to represent a group at particularly high risk for progression to 
substance use disorders and related problems. Wu, Pilowsky, and Schlenger (2005) used 
pooled nationally representative data from the 2000 and 2001 NHSDA to examine the 
likelihood of progression to substance use disorders among adolescents (ages 12 to 17) who 
used both marijuana and inhalants compared with those who used either marijuana or 
inhalants and those who used other drugs but not marijuana and inhalants.  
Adolescent users of both marijuana and inhalants, who constituted 16% of all lifetime 
drug users in the sample, were much more likely to report lifetime use of most substances, a 
finding consistent with earlier studies (Novins & Baron, 2004; Novins et al., 2001). Ninety-
seven percent of respondents in this group reported ever use of alcohol, compared with 91% 
in the marijuana only group, 60% in the inhalants only group, and 55% in the other drugs 
only group. The contrasts were even more striking for other substances. Twenty-seven 
percent of the marijuana and inhalants group had used cocaine/crack; the next highest 
prevalence was 7% in the marijuana only group. Prevalence rates in the marijuana and 
inhalants group were five times higher than in any of the other drug use groupings for heroin 
and two to three times higher for hallucinogens, sedatives, stimulants, and tranquilizers (Wu 
et al., 2005).  
Among adolescents who reported any use of a drug in their lifetime, the prevalence 
estimates of past year alcohol and drug abuse were alarmingly high and significantly higher 
among adolescents who had used both marijuana and inhalants than among adolescents who 
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had used just one of the two drugs. Thirty-five percent of the lifetime marijuana and inhalants 
users reported past year alcohol dependence, and 39% reported past year drug use disorders. 
The next highest prevalence rates were found among the marijuana-only group, with 17% 
reporting alcohol disorders and 16% reporting drug disorders (Wu et al., 2005).  
Also notable in this study was the very high prevalence of multiple drug use among 
users of both marijuana and inhalants. Within this group, 73% reported ever using three or 
more drugs. In a related study using the same NHSDA pooled data set (2000–2001), Wu, 
Pilowsky, and Schlenger (2004) found that 49% of adolescents who had ever used three or 
more classes of other drugs had ever used inhalants. Only 4% of lifetime inhalant users 
reported no use of other drugs, suggesting an important association between inhalant use and 
polydrug use (Wu et al., 2004). Taken in whole, these results from a nationally representative 
sample illustrate clearly that youth who use both marijuana and inhalants have the highest 
prevalence of alcohol and drug use disorders and lifetime polydrug use. Even after 
controlling for several known and suspected determinants of drug abuse and dependence, 
results from this study reveal that the use of both marijuana and inhalants may signal an 
early, heightened risk for serious alcohol and drug abuse and dependence (Wu et al., 2005).  
As found in other national surveys (Johnston et al., 2005), the Wu et al. (2005) study 
found that inhalant use was more prevalent than marijuana or other drug use among young 
adolescents (aged 12 to 13 years), and the mean reported age at first inhalant use was also 
younger than for marijuana (11.8 years versus 13.8 years). Although it is not possible with 
these cross-sectional data to determine whether inhalant use typically precedes marijuana use 
among adolescents who use both, these data do provide some tantalizing evidence that 
inhalants may play an important role in a particularly serious form of drug use sequencing. 
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An earlier study based on data from the 1990 NHSDA focused on the relationship 
between inhalants and injection drug use (Schutz et al., 1994). Results controlling for a wide 
range of sociodemographic characteristics and history of marijuana use suggested that 
adolescents with a history of inhalant use were 5.4 times more likely to inject drugs. Similar 
to the findings from Wu, Pilowsky, and Schlenger (2005), the odds of injecting drugs were 
significantly increased for adolescents with a history of both inhalant and marijuana use: 88 
times the odds relative to those who had never used either drug (Schutz et al., 1994).  
Although the majority of youth who use inhalants give it up over time (chronic 
dependency appears to be rare), among the minority who do go on to regular inhalant use and 
dependence, a wide range of other problem behaviors are exhibited (Wu et al., 2004). In an 
analysis of data from 36,859 adolescents between the ages of 12 and 17 from the 2000 and 
2001 NHSDA, Wu et al. (2004) found that adolescents with inhalant abuse diagnoses were 
significantly more likely to have already abused inhalants by age 13 or 14 and to have abused 
two or more other drugs besides inhalants. Compared to youth with no abuse of inhalants, 
youth with an abuse disorder (defined by the DSM-IV as having one or more inhalant-related 
problems in the past year but not meeting the criteria for dependence) were 5 times more 
likely to have used two other illegal drugs in the past year and 18 times more likely to have 
used three other illegal drugs. Youth classified as having a dependence disorder (defined as 
having three or more drug-related problems in the past year) were 12 times more likely to 
have used two other drugs and 24 times more likely to have used three other drugs in the past 
year. Although these data were cross-sectional and the findings associative rather than 
prospective, it is clear that inhalants play a potentially important role in adolescent drug use 
patterns.  
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Among youth aged 12 or 13 interviewed for the 2003 NSDUH who had used 
inhalants in their lifetimes, 35.4% had used another illicit drug, compared with 7.5% of youth 
in this age group who had never used inhalants (SAMHSA, 2005). Further evidence of the 
potential role of early inhalant use in drug use pathways comes from retrospective studies of 
adults aged 18 to 49 interviewed for the 2002 and 2003 NSDUH. Adults who reported early 
use of inhalants (before age 13) were more than three times more likely to be classified with 
dependence on or abuse of alcohol or an illicit drug in the past year than adults who had 
never used inhalants (35.2% versus 10.1%) (SAMHSA, 2005).  
According to 2002 NSDUH data, adolescents who reported past year inhalant use 
were 3 times more likely to report using other illicit drugs during the same period 
(SAMHSA, 2003). The association between past year inhalant use and the use of the most 
serious illicit drugs (hallucinogens, cocaine, and heroin) is even more pronounced. 
Adolescents who had used inhalants in the past year were more than 7 times more likely to 
have used hallucinogens (22.6% versus 3.0%) and cocaine (12.5% versus 1.6%) than 
adolescents who had not used inhalants. Although overall past-year heroin use is low, 
adolescents who reported past-year inhalant use were 17 times more likely to report heroin 
use during the same period than adolescents who did not (SAMHSA, 2003).  
These results suggest that inhalant use may be an important potential marker for other 
serious illicit drug use. Indeed, among this sample, heroin and cocaine use was nearly 
nonexistent among youth who had not also used inhalants. These data are cross-sectional, 
precluding sequential analyses. However, the fact that past-year inhalant use in this survey 
peaked at age 14 or 15 (4.9%) and that data from the 2003 NSDUH indicate that a higher 
percentage of youth aged 12 or 13 had used inhalants than marijuana in the past year 
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(SAMHSA, 2004), suggests that inhalants may be one of the earliest drugs used by lifetime 
polydrug users.  
2.9.2.3 Clinical and Special Population Samples 
A study of substance use among college students (Bennett et al., 2000) compared 
early (prior to age 18) inhalant users with early marijuana users who did not use inhalants 
and students who reported no early use of either marijuana or inhalants. Both early inhalant 
users and early marijuana users were substantially more likely to report early use of cocaine, 
opiates, and hallucinogens. The rates of early use of these drugs were two to three times 
greater for early inhalant users than for early marijuana users, and early inhalant users 
consistently showed the highest rates of problematic patterns of drinking and substance use 
and of recent (past year and past month) cigarette smoking, marijuana use, and other illicit 
drug use. Among this sample of college students, inhalants were associated with greater use 
rates and odds ratios for alcohol and drugs during the college years, above and beyond the 
association with early marijuana use (Bennett et al., 2000).  
Notably, this study did not include a group classification for early users of both 
inhalants and marijuana (Wu et al., 2005), although the early inhalant use group did not 
exclude early marijuana use (or early use of other drugs). Thus, this study does not provide 
solid evidence that inhalants represent a unique risk for later drinking and drug use. 
Moreover, the data from this study relied on retrospective recall to define the early use of 
inhalants and marijuana. Early inhalant use was surprisingly low in this population (5.2%). A 
consistent finding from nationally representative studies is that reported lifetime use rates for 
inhalants decline as adolescents age, suggesting that older respondents forget or consciously 
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deny early use of inhalants, which may have occurred several years prior to assessment 
(Johnston et al., 2005).  
Very few nationally representative studies of adolescent inhalant use have been 
conducted. Much of what is known about inhalant use and the apparent association between 
inhalant use and other drug use has come from studies of clinical samples, primarily 
adolescents and/or adults in treatment programs for substance and behavior problems. For 
example, Sakai et al. (2004, 2006) considered inhalant use and dependence among 
adolescents ages 13 to 19 in a residential day treatment program, finding that inhalant use 
was strongly associated with other substance abuse and dependence (alcohol, hallucinogens, 
nicotine, cocaine, and amphetamines) and with criteria for lifetime major depression, 
previous suicide attempts, and conduct disorder. Notably, the authors found no significant 
differences in these variables between inhalant users and individuals meeting DSM-IV 
criteria for inhalant dependence (Sakai et al., 2004). In contrast to other national and clinical 
sample studies (e.g., Wu et al., 2005; Young et al., 1999; Novins et al., 2001), inhalant use in 
this small clinical sample occurred late in relation to nicotine, alcohol, and marijuana, leading 
the authors to conclude that inhalants do not serve as a gateway drug in most cases but that 
the use of inhalants at any time may indicate a particularly high-risk profile (Sakai et al., 
2004, 2006).  
A cross-sectional study of a sample consisting of adult alcoholics, felons, and a 
control group (Dinwiddie, Reich, & Cloninger, 1991a) produced similar results, where 
significant proportions of users of any drugs reported early inhalant use, and 93% of those 
who reported early inhalant use had used three or more classes of drugs. Inhalant users in this 
sample began using drugs earlier, and the use of inhalants increased the odds of other drug 
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use by 5 to 10 times. Because this study relied on retrospective recall and the sample was 
clinical and nonrepresentative, these findings should be viewed with caution. However, the 
findings add support for an important association between inhalants and the use of other 
drugs.  
A study of adolescent inmates in a juvenile detention facility found, in contrast with 
Sakai et al. (2004), that even among a particularly high-risk sample, inhalants were the 
substance with the earliest first reported use, an average age of 9.7 years (Young et al., 
1999). Young et al. (1999) also found that the traditional gateway sequence, beginning with 
alcohol and tobacco, progressing to marijuana, and then to cocaine, hallucinogens, and 
opiates, operated within this sample. However, among the subsample of youth who had used 
inhalants, this was the first class of drug used, preceding cigarettes by 1.5 years. This study is 
one of the only identified that directly seeks to identify the location of inhalants within the 
gateway drug use sequence. However, its cross-sectional design and reliance on retrospective 
recall of age of first use introduces potential recall bias and precludes any assessment of 
actual transitions from the use of one class of drugs to another.  
2.9.3 Summary of Evidence of a Gateway Relationship between Inhalants and Other 
Drugs 
Taken together, evidence from longitudinal, nationally representative, and clinical 
research suggests a potential gateway relationship between inhalants and other drugs. Given 
that inhalants are typically tried during late childhood or early adolescence, it appears that 
inhalants commonly precede the use and abuse of other drugs. Inhalants produce effects that 
are physiologically, neurologically, and qualitatively similar to other drugs, and given that 
inhalants are widely available and easily accessed by young adolescents, it is plausible that 
inhalants may serve as an initial entrée into drug use. While the question of whether inhalant 
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use actually predicts future drug use patterns remains largely untested, some feel that the 
evidence in favor of inhalants as a gateway drug is clear: “As the new gateway drug, it is 
critical that research and prevention efforts pay special attention to the etiology of inhalant 
use” (Edwards & Oetting, 1995, p. 26). 
 
 CHAPTER 3  
DISSERTATION RESEARCH QUESTIONS AND HYPOTHESES  
1. Can the gateway hypothesis be extended to include inhalants for African American 
and white, male and female adolescents in grades 6 through 8?  
Latent transition analysis (LTA) is used to identify the stages and transitions of drug 
use onset that best fit the patterns present in the data for this study sample of African 
American, white, male, and female adolescents in grades 6 through 8 from (primarily rural) 
North Carolina.  
Although a general model of gateway drug use involving alcohol, cigarettes, and 
marijuana (Figure 3.1) has been widely described (Kandel & Yamaguchi, 2002; Kandel, 
1975, 2002; Collins, 2002; Kandel et al., 1992; Yamaguchi & Kandel, 1984a; Kandel & 
Faust, 1975; Ellickson et al., 1992), the potential role of inhalants in drug use sequencing has 
not been formally assessed. For this reason, models of gateway drug use that include 
inhalants are estimated and compared to determine (a) whether inhalants “belong” in the 
gateway sequence and (b) which model best fits the data.  
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The literature on inhalants and adolescent drug use, although not extensive, suggests 
that early adolescent inhalant use may be an important stage in drug use progression for some 
adolescents. Inhalants produce effects similar to alcohol and other drugs and have been 
shown to operate on the same areas of the brain. Inhalants are one of the earliest drugs tried 
and the most widely available class of drug, present in most households or available for legal 
purchase. Proponents of the gateway hypothesis and common liability theories both maintain 
that the wide availability of alcohol and tobacco at least in part explains their gateway role; a 
similar relationship may exist between inhalants and drug use progressions.  
For instance, it is possible that, for a proportion of adolescents, initiating inhalant use 
will precede, and increase the likelihood of transitioning to, marijuana use. A general 
representation of this alternate model, presented in Figure 3.2, includes seven discrete stages 
of drug use: (1) never use; (2) alcohol only; (3) cigarettes only; (4) alcohol and cigarettes; (5) 
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alcohol, cigarettes, and marijuana; (6) alcohol, cigarettes, and inhalants; and (7) alcohol, 
cigarettes, inhalants, and marijuana. 


















This model revises the traditional gateway model by adding two stages, thus positing 
that seven drug use stages best represent the onset process among adolescents and that 
inhalant use is an important component of adolescent drug use sequencing. This hypothetical 
model suggests that there is a subpopulation of adolescents, those who experiment with 
inhalants, who follow a slightly modified gateway process and for whom inhalants act as a 
gateway to marijuana use. LTA is used to identify the stages and transitions that best 
represent the data.  
There is reason to suspect that gateway drug use models that include inhalants may 
differ between male and female and between African American and white adolescents. For 
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instance, whereas male and female adolescents appear to have very similar rates of inhalant 
use, females typically have lower rates of use for other drugs. This suggests that inhalants 
may be more important for females than males. Moreover, recent evidence suggests that 
inhalant use is increasing among females while remaining stable among males (Substance 
Abuse and Mental Health Services Administration [SAMHSA], 2007).  
African American adolescents typically report lower rates of drug use than whites in 
nationally representative surveys, and this is true for inhalants as well. While a good deal of 
early research on the gateway hypothesis has suggested that the general sequence is typically 
robust across racial/ethnic groups (e.g., Yamaguchi & Kandel, 1996), it remains unclear and 
untested whether drug use sequencing is consistent across these groups when inhalants are 
considered. African American adolescents may have lower prevalence rates for each drug but 
still follow the same general drug use sequence as white adolescents; conversely, the number 
and type of drug use stages may be distinctly different for African Americans.  
To determine whether the same model of drug use sequencing fits across gender and 
for both African American and white samples, the process of model selection was first 
conducted separately for each of the four subsamples: (1) white males, (2) white females, 
(3) African American males, and (4) African American females. As noted earlier, inhalant 
use is significantly more prevalent among white adolescents than African American 
adolescents, suggesting that analyses of drug use sequencing that includes inhalant use may 
differ by race. Similarly, relative to males and in comparison to other drug use, inhalant use 
is particularly prevalent among female adolescents; it is possible that inhalants may serve a 
more prominent role in drug use sequencing for females. These potential differences would 
be obscured if the analyses were conducted on the full sample.  
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The following main hypotheses related to research question one were tested: 
1. Hypothesis 1.1: Inhalant use will precede marijuana use for a significant 
number of adolescents. 
2. Hypothesis 1.2: The probability of transitioning from inhalant use to 
marijuana use is significantly greater than the probability of transitioning from 
marijuana use to inhalant use, suggesting a partial gateway relationship. 
3. Hypothesis 1.3: Drug use sequencing models will differ by race and gender; 
inhalants will play a more important role for white and female adolescents.  
2. Does the probability of transitioning from inhalant use to other drug use remain 
after controlling for demographic factors and key psychosocial predictors of 
adolescent drug use? 
Critics of the gateway hypothesis argue that, although it is clear that most drug users 
begin their use with gateway drugs like alcohol, cigarettes, and marijuana, there is limited or 
equivocal evidence suggesting that the use of a gateway drug independently increases the 
likelihood of using other drugs. True experimental designs would be required to assess 
questions of causality, but these designs are not feasible (or ethical) in the case of drug use.  
In lieu of an experimental design, three criteria for assessing the causal influence of 
the use of one drug on the use of other drugs have been proposed (Kandel & Jessor, 2002). 
The first criterion is evidence that those who use a drug or drugs are significantly more likely 
to have used the supposed gateway drug. The second criterion is evidence that the use of the 
gateway drug typically precedes the use of the other drugs; the probability of transitioning 
from the gateway drug to the other drug(s) should be significantly greater than the probability 
of transitioning from the use of the later drug(s) to the supposed gateway drug (Maldonado-
Molina, 2005).  
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The third criterion is evidence that the association between early gateway drug use 
and later other drug use remains significant after controlling for potentially confounding 
variables, particularly factors that might be common causes of both gateway and later drug 
use. No identified studies have investigated inhalants as a gateway drug, and few studies 
have explored whether the transition probabilities between drugs remain after controlling for 
the influence of potentially confounding variables thought to represent common liabilities for 
drug use (Rebellon & Van Gundy, 2006; Tarter et al., 2006). 
The number and variety of potential variables that could plausibly explain drug use 
behaviors is large, and an attempt to control for all possible predictors is beyond the scope of 
this study. However, several key factors cited by proponents of a “common cause” 
explanation of drug use, and based in large part on Problem Behavior Theory (Jessor, 1991), 
are apparent. These include perceived drug availability, perceived peer drug use and 
attitudes, parental disapproval of drug use, academic achievement, and an individual’s 
propensity to engage in sensation-seeking and risky/delinquent behavior.  
The LTA approach applied to the primary research questions above provides a 
flexible approach for examining patterns of drug use over time and for testing hypotheses 
about the order of progression between drugs and the transition probabilities from one drug 
use stage to another. Recent enhancements to LTA software also make it feasible to assess 
whether transition probabilities between inhalant use and other drug use persist after 
controlling for other factors.  
A final model for white females was identified and selected that included a transition 
between an inhalant use stage and a marijuana use stage, facilitating an “LTA with 
covariates.” In this framework, covariates representing demographic and psychosocial factors 
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thought to represent liabilities for drug use (Tarter et al., 2006) were added to the model 
explicitly as predictors of the transition probability from inhalant use to other drug use. If 
inclusion of the covariates causes a substantial decrease (toward zero) in the transition 
probability, then this would be evidence that the transition probability is largely the effect of 
covariates, rather than a direct effect of inhalants. Conversely, if the transition probability 
remains after controlling for the covariates, then this would be compelling evidence that the 
relationship between inhalants and other drugs is indeed predictive. The following main 
hypothesis was tested: 
1. Hypothesis 2.1: The probability of transitioning from inhalant use will remain 
after controlling for baseline drug use, demographic factors, and common 
liability variables. 
 
 CHAPTER 4  
METHODS 
4.1 Study Design 
This research is a secondary analysis of data derived from the Context of Adolescent 
Substance Use Study (Context Study) (NIDA Grant No. R01 DA16669, UNC IRB #99-830). 
The Context Study is a cohort-sequential study of adolescents followed from grades 6, 7, and 
8 to grades 8, 9, and 10. The dissertation study sample includes all white and African 
American adolescents who completed a survey during at least one of five data collection 
times and for whom data were available for at least grades 6 or 7. The data used for this 
dissertation were coded and de-identified to ensure participant confidentiality. This 
dissertation research was determined to be exempt from institutional review board (IRB) 
approval by the University of North Carolina at Chapel Hill, Office of Research Ethics, IRB 
(UNC IRB #: 06-0483).  
4.2 Overview of the Context of Adolescent Substance Use Study 
The Context Study is a longitudinal investigation of intrapersonal and contextual 
factors that influence adolescent substance use and other problem behaviors. This school-
based study involved adolescents from the public schools in three counties in North Carolina 
classified as nonmetropolitan areas, with lower than average median household incomes and 
with greater proportions of African Americans than in the general U.S. population.  
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The Context Study used a cohort-sequential design, wherein three grade cohorts 
(grades 6, 7, and 8 at first assessment) were assessed twice annually. Data collection began in 
spring 2002 and ended in spring 2004.  
Unlike standard longitudinal and cross-sectional designs, a cohort-sequential design 
allows for the modeling of longitudinal sequences covering a wide range of ages during a 
condensed study time frame (Andrews, Tildesley, Hops, Duncan, & Severson, 2003). In the 
case of the Context Study, data from five grades (6 through 10), with ages ranging from 11 to 
17, are available.  
4.3 Adolescent Sample and Data Collection 
Adolescents enrolled in three public school systems in North Carolina were entered 
into the study in spring 2002, when they were 6th, 7th, and 8th graders, and completed the 
study as 8th, 9th, and 10th graders, respectively. The school systems were in three 
predominantly rural counties. The sample frame included eight middle schools, two 
comprehensive K–8 schools, six high schools, and three alternative schools with middle and 
high school grades. The high schools were not included until Wave 2 when the first 8th 
graders transitioned from middle school. Data collection was timed to coincide with the 
beginning and end of the school year. At each data collection wave, all enrolled students at 
the targeted grade levels, except for those in self-contained classrooms for students with 
limited English language reading skills, were eligible for the study. Thus, students new to the 
study were enrolled at each wave of data collection. Across the five assessments, a total of 
6,891 unique cases completed the survey. Response rates at the five waves were 88.4%, 
81.3%, 80.9%, 79.1% and 76.0%, respectively (Table 4.1).  
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Table 4.1 Context Study Questionnaire Administration 
Wave 1 2 3 4 5 
Date Spring 2002 Fall 2002 Spring 2003 Fall 2003 Spring 2004 
Grades 6, 7, 8 7, 8, 9 7, 8, 9 8, 9, 10 8, 9, 10 
No. schools 13 19 19 19 19 
Adolescent 
survey 
N = 5,220 
(88.4%) 
N = 5,060 
(81.3%) 
N = 5,059 
(80.9%) 
N = 5,017 
(79.1%) 
N = 4,676 
(76.0%) 
 
Parents could refuse their child’s participation by calling a toll-free number or 
mailing a refusal form. Written assent was obtained in school from adolescents by trained 
data collectors who also provided instructions.  
School-based data collection was scheduled in advance, and at least one makeup day 
for absentee students was scheduled each wave at each school. Trained data collectors 
followed a written protocol for describing the study, obtaining assent, and giving instructions 
for completing the adolescent questionnaires. Adolescents completed the self-administered 
questionnaire in classrooms or larger group settings (e.g., cafeteria) in approximately 1 hour. 
Teachers stayed in classrooms to help maintain order, but they did not answer questions 
about the study or walk around the classroom. To ensure privacy, data collectors spread the 
students around the classroom and instructed students not to talk with each other. Students 
put their questionnaires in envelopes before returning them to the data collectors.  
4.4 Analysis Samples 
Original data for the Context Study were organized by study wave. The Context 
Study used an accelerated cohort design in which three grade-based cohorts was followed for 
a constant period of time. For this study, data were reshaped to represent grade-in-school, a 
more natural and more clearly interpreted temporal measure that is consistent with literature 
on adolescent development (Singer & Willett, 2003). The Context Study includes five waves 
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of data, collected twice a year, once in the spring and once in the fall (see Table 4.1). Data 
from Waves 2 and 3 and from Waves 4 and 5 were collapsed to represent a school year. 
Because respondents initially vary in grade, observed measurement occasions will differ 
across individuals. As illustrated in Table 4.2, not only are 6th graders potentially re-
interviewed at 7th and 8th grades, but concurrent samples of 7th and 8th graders were 
potentially re-interviewed at grades 8 and 9 and grades 9 and 10, respectively. The advantage 
of this design is that it allows for the modeling of change over a longer temporal period using 
fewer waves of data (Singer & Willett, 2003). However, because there is no overlap at the 
earliest and latest grades (only one cohort is interviewed for these grades), data are sparser at 
these grades. 
Table 4.2 Cohort Sequential Design of the Context Study 
 Grade  
Wave 6  7  8  9  10  
1 2,017 1,874 1,709 — — 
2 & 3 — 1,759 1,629 1,511 — 
4 & 5 — 23 1,718 1,511 1,243 
Total 2,017 3,656 5,056 3,022 1,243 
Note: Waves 2 & 3 and 4 & 5 were combined to represent school years. 
An original total sample of 6,891 adolescents participated at any wave of data 
collection. Students who were outside the typical age range of 11 through 17 years for the 
grades studied (n = 66, 1%) or who did not respond to any of the substance use measures at 
any time point (n = 4, 0.1%) were excluded, yielding a sample size of 6,821 (99%) for the 
entire study period.  
From this sample, African American (N = 2,431) and white (N = 3,435) adolescents 
were selected for inclusion; all others were dropped from the analysis sample. This yielded a 
sample of 5,866 respondents—85.1% of the original full sample. Finally, because this study 
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focused on transitions from 6th to 7th grade and from 7th to 8th grade, the sample was 
restricted to adolescents for whom data were available for at least 6th or 7th grade  
(N = 3,414). 
These analyses focus on four subsamples: white males, white females, African 
American males, and African American females, with two transition periods (6th to 7th grade 
and 7th to 8th grade). Therefore, a total of eight analysis subsamples were created. For each 
of the four 6th–7th grade data sets, only participants who responded to any of the substance 
use measures in 6th grade (baseline) were included (N = 1,630). Similarly, participants who 
responded to any of the substance use measures in 7th grade (N = 3,344) were included for 
the four 7th–8th grade data sets. Table 4.3 provides sample sizes and mean ages for the 
adolescents in each subsample. 
Table 4.3 Analysis Samples: Sample Size, Mean Age, and Attrition (%) 
Sample N 
Mean Age at 
Baseline (SD) Attritiona (%) 
6th–7th grade   
White males 464 12.12 (.54) 2.8% 
White females 464 11.97 (.45) 3.0% 
African American males 363 12.46 (.89) 7.4% 
African American females 339 12.21 (.65) 4.7% 
Total 1,630 12.17 (.66) 4.3% 
7th–8th grade   
White males 955 13.13 (.57) 6.2% 
White females 954 12.98 (.46) 4.4% 
African American males 703 13.47 (.83) 8.4% 
African American females 732 13.24 (.70) 5.6% 
Total 3,344 13.18 (.66) 5.7% 
a Attrition refers to the percentage of respondents present at baseline who were lost to follow-up at Time 2. LTA 




4.5.1 Drug Use Onset 
Four substance use items (lifetime alcohol, lifetime cigarette, lifetime inhalant, and 
lifetime marijuana) were used to measure an individual’s lifetime substance use stage. Items 
with multiple response options were recoded as dichotomous, and all items were recoded 
using a numbering scheme required by WinLTA and SAS PROC LTA, the software used for 
the study analyses. Table 4.4 presents the wording of the original items (manifest variables) 
and the coding scheme used for analysis. 
Table 4.4 Manifest Variables Measuring Latent Substance Use Onset 




Coding for WinLTAa 
Ever used alcohol  How much alcohol 
have you ever had 
in your life? 
0 = None at all, not even a sip 
1 = 1 or 2 sips, but not a whole 
drink 
2 = 3 or more sips, but not a 
whole drink 
3 = 1 to 2 whole drinks 
4 = 3 to 4 whole drinks 
5 = 5 to 10 whole drinks 
6 = 11 to 20 whole drinks 
7 = More than 20 whole drinks 
(Ever drank one or more 
sips) 
0 = Missing 
1 = No 
2 = Yes 
 
 
Ever used cigarettes How much have 
you ever smoked 
cigarettes in your 
life? 
0 = None at all, not even a puff 
1 = 1 or 2 puffs, but not a whole 
cigarette 
2 = 3 or more puffs, but not a 
whole cigarette 
3 = 1 to 2 whole cigarettes 
4 = 3 to 5 whole cigarettes 
5 = 6 to 20 whole cigarettes 
7 = More than 20 whole 
cigarettes 
(Ever smoked one or 
more puffs) 
 
0 = Missing 
1 = No 
2 = Yes 
 
 
Ever used inhalants Have you ever used 
any of the 
following in your 
life?...Inhalants 
0 = No 
1 = Yes 
0 = Missing 
1 = No 
2 = Yes 
Ever used marijuana Have you ever used 
any of the 
following in your 
life?...Marijuana 
0 = No 
1 = Yes 
0 = Missing 
1 = No 
2 = Yes 
a For SAS Proc LTA, coding is as follows: “.” = “missing,” 0 = “No,” and 1 = “Yes.” 
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Table 4.5 and Figures 4.1, 4.2, and 4.3 present prevalence estimates for the four drug 
use measures. Although white females have significantly lower prevalence estimates for 6th 
and 7th grade alcohol, cigarette, and marijuana use than white males, the prevalence of 
inhalant use is roughly equal. Additionally, inhalant use appears to increase throughout the 
study period (6th to 8th grade) for white females, whereas it plateaus in the 7th grade for the 
three other samples. Inhalant use at the 6th grade is significantly more prevalent than 
marijuana use for both white males and white females; marijuana use is more prevalent at the 
6th grade for African American males.  
Table 4.5 Drug Use Prevalence (%), by Grade 
 
































































































































































Note: 95% confidence intervals are shown in parentheses. 
 
66 










































































































































Response inconsistency is a common issue in longitudinal data. A particular form of 
response inconsistency, recanting, refers to cases where an individual denies a behavior after 
having admitted to it previously. Recanting is a common issue in longitudinal studies 
(Fendrich, 2005; Fendrich & Rosenbaum, 2003), and there is evidence that adolescents are 
more likely to recant on questions dealing with particularly stigmatized behaviors, including 
inhalant use and hard drug use (Percy, McAlister, Higgins, McCrystal, & Thornton, 2005). 
Differential rates of recanting could in part explain why inhalant use rates do not follow the 
trend of greater prevalence over time that the other drugs exhibit—older adolescents who 
may have reported inhalant use at an earlier age may no longer admit to inhalant use at a later 
age. 
Indeed, an analysis of the longitudinal response patterns to these items confirms the 
high degree of recanting present in the data, particularly for the inhalant use item (Table 4.6). 
Among respondents who ever reported using a drug during the study period and who had an 
opportunity to recant after first reporting use of that drug (e.g., were present at a subsequent 
survey administration), and across the four samples and two transition periods, the rate of 
recanting for the inhalant use item ranged from 28.5% (among white females in the 7th–8th 
grade sample) to 51.8% (among African American females in the 7th–8th grade sample). For 
the total sample, 47.1% recanted for inhalants, 21.9% recanted for marijuana, 17.4% recanted 





Table 4.6 Percentage of Respondents Recantinga Previous Self-Reported Drug Use 


























8.3 11.5 4.9 6.5 19.7 20.3 13.5 10.9 
Ever smoked 
a cigarette 
10.7 13.8 2.6 6.1 17.3 18.7 6.3 13.0 
Ever used 
inhalants 
32.6 34.3 38.6 28.5 40.0 38.6 50.0 51.8 
Ever used 
marijuana 
13.3 19.0 28.6 16.7 21.4 14.5 44.4 16.5 
a Recanting is defined as stating “never used” when the respondent indicated “ever use” at baseline. 
In the drug use onset modeling, transition probabilities are restricted to forward-
moving only. In other words, once a respondent indicates having ever tried a drug, movement 
back to a “never-use” stage is not permitted. Conceptually, the latent variable approach will 
treat responses that are inconsistent with this pattern as measurement error, highlighting an 
important advantage of this approach over traditional approaches. Given the high rates of 
recanting and subsequently inflated standard errors, estimates of inhalant use are likely to be 
extremely conservative.  
4.5.2 Independent Variables 
The second research question examined the strength of the relationship between 
inhalant use and subsequent drug use transitions by controlling for other factors that may 
predict drug use transitions. The data set used for this study included a wide range of 
psychosocial variables and scales that measure constructs that have been empirically and 
theoretically linked to adolescent substance use, offering the opportunity to control for a wide 
range of possibly competing factors. 
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Because these items were included in multivariate models, they were recoded so that 
higher scores indicate greater risk for all of the included variables. For instance, on a measure 
of the respondent’s mother’s degree of disapproval of drug use, the variable was recoded so 
that higher scores indicate lower degrees of disapproval. Age (a continuous measure) was 
included to control for possible heterogeneity of age within grades. 
This second analysis depends on the identification, in analysis 1, of a model (or 
models) that includes a transition from inhalant use to a more advanced drug use stage. In 
other words, it is possible that the second analysis will be limited to fewer than the four 
samples (if inhalants are not included in the selected transition model for a sample). 
Therefore, frequencies and any necessary data transformations for these covariates are 
reported in Chapter 5 (Results), specifically for samples that pertain to analysis 2. Each of the 
covariate measures is described briefly below. 
4.5.2.1 Risk-Taking Propensity 
Sensation seeking. A sensation-seeking scale was created from three items 
(Grasnick, Tittle, Bursik, & Arneklev, 1993). Respondents were asked to indicate the degree 
to which they agree or disagree with the following statements: “I like to test myself every 
now and then by doing something a little risky,” “I sometimes find it exciting to do things for 
which I might get in trouble,” and “Excitement and adventure are more important to me than 
security.” Scale reliability (Cronbach’s alpha) for this scale ranged from α = 0.78 to α = 0.85 
across the study waves. 
Problem behavior/delinquency. The measure of problem behavior was based on 
Farrell et al.’s Problem Behavior Frequency Scale (Farrell, King, White, & Valois, 2000). 
Fifteen items measuring the frequency of certain problem behaviors during the past 3 months 
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were combined and averaged into a single index representing general problem behavior. 
Respondents were asked how many times (0, 1–2, 3–5, 6–9, or 10 times or more) in the past 
3 months they had skipped school, damaged school or other property, cheated on a test, been 
in a fight where someone was hit, threatened a teacher, threatened someone with a weapon, 
spread a false rumor about someone, started a fight between other people, drove a car when 
drinking, gone to school but skipped classes, excluded someone from their group of friends, 
picked on someone, hit someone they were dating, threatened to hurt someone they were 
dating, and hit or slapped another kid. The items were recoded to the median of each 
frequency range (e.g., 1–2 was recoded to 1.5; 6–9 was recoded to 7.5) and were summed 
and averaged. Possible scores ranged from 0 to 10. Scale reliability (Cronbach’s alpha) for 
these measures ranged from α = 0.78 at Wave 1 to α = 0.92 at Wave 5, suggesting a reliable 
scale. 
4.5.2.2 Perceived Peer Drug Use Behavior and Attitudes  
Respondents were asked to indicate how many of their five closest friends they think 
drink alcohol, smoke cigarettes, use other kinds of tobacco, smoke marijuana, or use other 
drugs (cocaine, LSD, heroin, Ecstasy, or other). Response options were “none,” “one,” “a 
few,” and “most or all.” These items were summed to create a general measure of “friends’ 
drug use.” Scale reliability for this measure ranged from α = 0.81 to α = 0.87 across the study 
waves.  
To assess perceived peer attitudes about drug use, respondents were asked to report 
how they think their friends would feel if they (the respondent) (a) used alcohol, (b) got 
drunk, (c) smoked cigarettes, (d) used other kinds of tobacco, (e) smoked marijuana, or 
(f) used other drugs. Response options were “like it a lot,” “like it some,” “dislike it some,” 
73 
or “dislike it a lot.” These items were summed to create a general measure of “friends’ 
tolerance of drug use.” This measure was highly reliable, with Cronbach’s alpha scores 
ranging from α = 0.90 to α = 0.93 across the study waves. 
A descriptive norm measure of the perceived frequency of use of alcohol, cigarettes, 
other tobacco, inhalants, marijuana, and other hard drugs at the respondent’s school was 
included. Response options were “almost none,” “about one-quarter (25%),” “about half 
(50%),” “about three-quarters (75%),” and “almost all.” These items were combined into a 
single measure reflecting the perceived frequency of drug use at the school. Scale reliability 
for this measure ranged from α = 0.88 to α = 0.90 across the study waves.  
4.5.2.3 Perceived Availability of Drugs 
Respondents were asked to indicate how easy or hard it would be for them to get 
alcohol, cigarettes, other kinds of tobacco, inhalants, marijuana, and/or other drugs. Response 
options were “very hard,” “somewhat hard,” “somewhat easy,” and “very easy.” Responses 
for each of the six drugs were combined into a single measure of perceived general 
availability of drugs. Scale reliability for this measure across the study waves ranged from 
α = 0.88 to α = 0.90. 
4.5.2.4 Social Conformity 
Social values is an averaged scale measure of responses to three items. Respondents 
were asked to indicate how strongly they agree or disagree (5-point Likert scale) with the 
following statements: (a) “It is good to be honest,” (b) “People should not cheat on tests,” 
and (c) “In general, police deserve respect.” Response options ranged from “strongly agree” 
to “strongly disagree” (5-point Likert scale). Scale reliability was modest, ranging from 0.70 
to 0.73 across study waves. 
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Religiosity is the sum of two items. Respondents were asked to indicate “How 
important is religion to you?” (“Not at all important” to “Very important,” 4-point scale) and 
“How much do your religious beliefs influence what you do?” (“Not at all” to “Very much”). 
The scale reliability for these two items ranged from 0.72 to 0.81.  
4.5.2.5 Academic Achievement, School Attachment, and Academic Aspirations 
Academic achievement was measured with a grade point average score calculated as 
the average grade in each of four subjects: English/language arts, mathematics, history/social 
studies, and science. School attachment, developed by Battistich and Hom (1997), is an 
averaged scale made up of three items: (a) students in this school treat each other with 
respect, (b) students at this school are willing to go out of their way to help someone, and (c) 
my school is like a family. Scale reliability ranged from 0.80 to 0.87 across the study waves. 
Academic aspirations reflects the sum of two items asking the respondent to indicate how 
important or unimportant (a) finishing high school and (b) going to college are to them. 
Response options ranged from “very important” to “not at all important.” Scale reliability 
ranged from 0.64 to 0.76. 
4.5.2.6 Parental Influence 
Two measures of perceived parental disapproval of drug use (for the mother and the 
father) were available. The respondent was asked to indicate the degree to which the mother 
and/or the father would like or dislike it if the teen (a) drank alcohol, (b) smoked cigarettes, 
(c) used other forms of tobacco, or (d) used marijuana or other drugs. Responses for these 
four items were averaged for each parent (α = 0.85 to α = 0.93). However, because there 
were fewer missing cases for the mother variable, and because the correlation between the 
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mother and father variables was quite high (~.60), only the mother variable was included in 
these analyses. 
4.6 Analytic Approach  
4.6.1 A Testable Operationalization of the Gateway Hypothesis 
Kandel and Jessor (2002) identified three interrelated propositions that summarize 
current knowledge about the gateway hypothesis. In general, they maintain that questions 
related to the gateway hypothesis can be evaluated on the basis of evidence for (1) 
sequencing, (2) association, and (3) causality.  
The “sequencing” proposition refers to the notion that the use of drugs follows an 
ordered or hierarchical pattern. As described earlier, this proposition has strong empirical 
support, with multiple studies consistently finding that the substance use sequence starts with 
alcohol, then proceeds to cigarettes, then marijuana, and then illicit drugs such as cocaine or 
heroin (Hawkins et al., 2002; Kandel, 1975, 1988, 1998, 2002, 2003; Kandel & Yamaguchi, 
1985, 1993, 1999, 2002; Yamaguchi & Kandel, 1984a, 1984b, 1996; Chen & Kandel, 1995; 
Kandel et al., 1992; Kandel & Logan, 1984; Adler & Kandel, 1981; Kandel & Faust, 1975).  
The “association” proposition of the gateway hypothesis is that the use of some drugs 
is associated with a statistically significant increased risk for more advanced drug use. As 
with the sequencing proposition, there appears to be strong support for this proposition (e.g., 
Hansen & Graham, 1991; Wagner & Anthony, 2002; Yu & Williford, 1992; Merrill, Kleber, 
Shwartz, Liu, & Lewis, 1999; Lessem et al., 2006; Wagner & Anthony, 2002; Miller & Volk, 
1996; Pentz & Li, 2002; Botvin et al., 2000, 2002; Scheier et al., 2001). 
The final proposition, “causality,” suggests that the use of a gateway drug causes the 
later use of other drugs. As described earlier, given the significant practical barriers to 
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conducting causality studies with humans, the lack of evidence supporting this proposition is 
not surprising.  
To facilitate the testing of potential gateway relationships between substances, 
Maldonado-Molina (2005) proposed an operational definition of the gateway hypothesis that 
combines the first two propositions of the gateway hypothesis—sequencing and association 
(Kandel & Jessor, 2002)—with a methodological operationalization of the gateway 
hypothesis proposed by Collins (2002), who suggests that there is a gateway relationship 
between two drugs if (1) there is a clear temporality whereby the use of one drug precedes 
the use of the other drug, and (2) the probability of using one drug is significantly greater for 
someone who has first used the other drug than for someone who has not. According to 
Collins (2002), both of these conditions are necessary for a gateway relationship between 
drugs to exist.  
The operational definition of the gateway hypothesis proposed by Maldonado-Molina 
(2005) includes two possible gateway relationships: (1) a complete gateway relationship and 
(2) a partial gateway relationship. A complete gateway relationship between two drugs is 
indicated if the use of one drug (e.g., alcohol) precedes and increases the risk for the use of 
another drug (e.g., marijuana). A partial gateway relationship is indicated if one drug (e.g., 
alcohol) does not necessarily or always precede the use of another drug (e.g., marijuana) but 
significantly increases the likelihood of using the latter drug once used.  
For example, a 2003 study (Tullis, Dupont, Frost-Pineda, & Gold, 2003) suggested 
that among a college student sample, marijuana use often precedes the use of tobacco, 
leading the authors to suggest that marijuana may in fact be a gateway to tobacco use, rather 
than the other way around. Although marijuana may in fact be a gateway to tobacco in some 
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populations, it is also plausible that, while not always preceding marijuana use, the use of 
tobacco increases the risk of marijuana use. The order of sequence is an important but not 
sufficient condition for a gateway relationship between two drugs. A drug that does not 
universally precede another may still be a partial gateway if it increases the risk of later drug 
use. Given that inhalants are not widely used, it is unlikely that the use of inhalants will 
precede the use of other drugs for a majority of adolescents. However, it is conceivable that 
inhalant use will significantly increase the risk for later drug use for that subgroup of 
adolescents who use inhalants first, suggesting a potential partial gateway relationship 
between inhalants and other drugs. 
A series of probabilities can be empirically tested for each definitional component 
proposed by Maldonado-Molina (2005). Consider, for example, the potential relationship 
between inhalants and marijuana, in which inhalant use is posited to be a gateway to 
marijuana use. For a complete gateway relationship between these two drugs to exist, the 
probability of trying marijuana at Time 2, conditional on not having tried inhalants at Time 1, 
equals zero; in other words, everyone who tries marijuana at Time 2 had tried inhalants at 
Time 1. Additionally, the probability of trying marijuana at Time 2, conditional on having 
tried inhalants at Time 1, would be greater than zero, suggesting that inhalant use at Time 1 
has increased the probability of marijuana use at Time 2 (Maldonado-Molina, 2005).  
A partial gateway relationship between inhalants and marijuana exists if, even if 
inhalant use does not universally precede marijuana, the risk for marijuana use is increased 
once inhalants are used. Furthermore, evidence of a partial gateway relationship where 
inhalants serve as a gateway for marijuana use requires that having tried marijuana is not 
associated with an increased risk of inhalant use (Maldonado-Molina, 2005). 
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4.7 Latent Transition Analysis 
LTA (Collins, 2002b; Velicer, Martin, & Collins, 1996; Collins et al., 1994; Collins 
& Wugalter, 1992; Lanza et al., 2003) is an extension of latent class theory to longitudinal 
data. In latent class theory, latent variables are categorical, and individuals are sorted into 
mutually exclusive and exhaustive latent classes based on a set of categorical item responses, 
in a way that is similar to factor analysis for continuous variables. Latent class analysis 
identifies latent classes in data and estimates their prevalence, while simultaneously adjusting 
estimates for measurement error (Lanza et al., 2003).  
LTA offers a means for conducting analyses to explore models of stage-sequential 
development over time. LTA allows for the estimation of prevalence of stages (e.g., stages of 
drug use) and the incidence of transitions from one discrete stage to another over time (Lanza 
et al., 2003). A comprehensive overview of LTA is provided by Lanza, Flaherty, and Collins 
(2003).  
Although relatively new, LTA is an increasingly popular procedure for testing models 
of stage-sequential change. LTA has been used to test a wide range of stage-based models, 
including stages of smoking behavior based on the Transtheoretical (stages of change) model 
(Velicer et al., 1996; Martin, Velicer, & Fava, 1996), alcohol abuse and dependency (Guo, 
Collins, Hill, & Hawkins, 2000), children’s drawing development (Humphreys & Janson, 
2000), and sexual behaviors among injecting drug users (Posner, Collins, Longshore, & 
Anglin, 1996). The most common use of LTA to date has been to test stage-sequential 
models of substance use, often based on the gateway hypothesis (Lanza & Collins, 2006; 
Collins, 2002; Hyatt & Collins, 2000; Collins et al., 1997). 
LTA models may include both a dynamic part and a static part (all LTA models by 
definition include a dynamic part). The dynamic part of the model refers to the movement 
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(transition) through the stage sequence over time. For this dissertation, the dynamic part of 
the model refers to transitions in substance use stages (usually called latent statuses in LTA). 
It is possible to also include a static part of the model that does not change over time and that 
can be thought of as an exogenous, categorical predictor (grouping variable) that divides the 
sample into two or more groups or classes.  
This dissertation study does not include a static component. Rather, analyses are 
completed separately for four race/gender subgroups: white males, white females, African 
American males, and African American females. While it would be possible to include a 
static component representing these four groups, this approach would only allow for an 
examination of differences in stage prevalence and transition probabilities while assuming 
that one single stage model is appropriate for each group. However, it is possible that 
important differences in the number and types of stages exist for the different groups. The 
selected approach of analyzing the four groups separately allows for a direct assessment of 
the hypothesis that the stages and patterns of drug use sequencing differ by race and gender.  
As a latent variable approach, LTA can treat both the static and dynamic parts of the 
model as latent (unobserved and theoretically infallible), using multiple categorical manifest 
(observed, fallible) items. The use of multiple indicators increases the reliability of the 
measures by estimating random measurement error and removing this error from subsequent 
analyses, in a way conceptually analogous to structural equation modeling, thus yielding 
more reliable parameter estimates.  
4.7.1 Parameters Estimated in the LTA Model 
A total of five sets of parameters are potentially estimated for LTA models. These 
include estimates of the probability of membership in a certain fixed (static) group (class), 
the probability of membership in each stage of substance use, the probability of transitioning 
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to a higher level of substance use at a later time given the individual’s stage at the previous 
time, and the measurement quality of all manifest indicators of the latent classes and latent 
stages.  
The first set of parameters represents the probability of membership in each category 
of a grouping variable (latent class). These parameters are referred to as γ (gamma). This 
parameter is not required to run an LTA; inclusion of it allows for group comparisons in 
stage membership and transition probabilities. Again, the models to be tested in this 
dissertation research do not include a gamma (latent class) component.  
The probability of being in a certain stage of substance use is the second set of 
parameters estimated by LTA and is referred to as δ (delta). These parameters allow for 
hypothesis testing based on the relative risk ratio and the difference of proportions between 
the different latent classes (Lanza & Collins, 2002). It is possible to estimate the probability 
of membership in one stage (e.g., “no use”) compared with the probability of membership in 
a later stage (e.g., the “alcohol and cigarettes” stage). For this study, these parameters 
provide prevalence estimates for each stage of substance use.  
The third set of parameters estimated for this model are the τ (tau) parameters, which 
make up the transition probability matrix, reflecting the transition probabilities from one drug 
use stage to another, from one time to the next. In essence, the transition probability matrix 
illustrates the probability of transitioning to each stage of substance use at Time 2, given the 
stage of substance use at Time 1. These parameters are important for examining gateway 
relationships between drugs. For example, it is possible, using the transition probability 
matrix, to estimate the probability of using marijuana at a later stage conditional on having 
tried inhalants, but not marijuana, at the previous stage.  
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The fourth and fifth sets of parameters reflect the measurement of the latent variable 
model. An LTA with both a static (latent class/grouping variable) and a dynamic (latent 
transition) component produces two sets of estimates of measurement error. These 
parameters are referred to as ρ (rho). Parameters related to the probability of a given response 
to an item conditional on latent stage (i.e., drug use stage) and time are referred to as “big” ρ. 
Parameters representing the probability of a particular response to a particular item, 
conditional on latent class membership, are referred to as “little” ρ. Again, the models tested 
for this dissertation do not include a latent class component. Thus, three parameters are 
estimated for the current analyses: δ (delta), τ (tau), and ρ (rho). These parameters are listed 
and defined in Table 4.7. 
Table 4.7 LTA Parameters Estimated for This Study 
Symbol Definition 
δ (delta) Estimate of the proportion of the population in each latent stage at each 
measurement occasion 
τ (tau) The probability of being in a particular latent stage at Time 2, conditional on 
latent stage membership at Time 1 
ρ (rho) The probability of a particular item response, conditional on latent stage 
membership 
 
These parameters are conceptually similar to factor loadings in factor analytic models 
and are used to determine which stages reflect a high probability of using each drug, allowing 
for interpretation of each substance use stage in the model. Constraints on the ρ parameters 
can be modeled to ensure measurement invariance over time or across groups.  
4.7.2 Model Identification and Constraints in LTA Models 
In order for a model to be estimated, it must be “identified,” meaning at a minimum 
there is enough information in the data (Lix, Algina, & Keselman, 2003) to produce the 
number of parameter estimates specified in the model. Issues of under-identification can be 
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addressed by fixing or constraining certain parameters. No estimation is needed for a 
parameter fixed to a specified value, and parameters constrained to be equal require the 
estimation of only one parameter (Hyatt & Collins, 2000). Fixing or constraining certain 
parameters can also serve to specify and test nested models (for instance, one could compare 
a model where a transition from alcohol use to marijuana use is estimated freely versus a 
model where this transition is set to zero).  
Parameter constraints are most often placed on the τ (tau) and ρ (rho) components 
(Collins, Lanza, Schafer, & Flaherty, 2002). Constraints on the τ parameters allow a 
specified model of change to be tested over time. For instance, a drug use onset model 
suggests that movement from one latent drug use stage to another is unidirectional. It would 
be illogical for someone who has indicated having ever used a substance at one time point to 
later indicate having never used the same substance, although this form of recanting does 
occur frequently in longitudinal adolescent drug use surveys (Fendrich, 2005; Fendrich & 
Rosenbaum, 2003; Golub & Johnson, 2001; Kandel et al., 1992). When fixing the transition 
matrix so that all illogical transitions are set to zero (not estimated), all illogical transitions 
are treated as measurement error, resulting in more stable and reliable estimates.  
It is generally recommended that the ρ parameters (measurement parameters) for the 
latent transition model be constrained as equal across time points ensuring that the latent 
stages have the same meaning and are therefore more easily interpreted (Collins et al., 2002). 
The ρ’s can also be constrained so that only two (for dichotomous measures) ρ parameters 
are estimated for each item: one for the probability of responding “yes” when a “yes” is 
expected and one for the probability of responding “no” when a “no” is expected (Hyatt & 
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Collins, 2000). This latter constraint greatly reduces the number of parameters being 
estimated, thus increasing the likelihood that the model will be identified. 
4.7.3 Model Fit 
LTA produces model fit indices by comparing the response pattern proportions 
predicted by the model with the actual response patterns present in the data. LTA produces a 
goodness-of-fit statistic called G2, which expresses the degree of agreement between the 
predicted and observed proportions (Lanza & Collins, 2002). In theory, the G2 is distributed 
as chi-square, but for most LTA models this is not the case, and the distribution of G2 for 
these models is not known. A rough rule of thumb for assessing model fit is that if the value 
of the G2 is substantially less than the degrees of freedom, there is evidence that the model 
fits the data reasonably well (Hyatt & Collins, 2000). WinLTA produces a goodness-of-fit G2 
that is adjusted for missing data (Collins et al., 2002). This fit statistic allows for the direct 
comparison of nested models (Hyatt & Collins, 2000). 
In the case of non-nested model comparisons, as is the case when comparing models 
with a different number of latent stages (i.e., five stages versus six stages), it is necessary to 
assess relative model fit by identifying which of several competing models is optimal in 
terms of balancing fit and parsimony. Two penalized-likelihood criteria, the Akaike 
information criterion (AIC) and the Bayesian information criterion (BIC), can be used to 
assess relative fit for LTA models. Lower values on these criteria suggest a more optimal fit.  
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4.8 Using Latent Transition Analysis to Address the Research Questions 
4.8.1 Research Question 1: Can the Gateway Hypothesis be Extended to Include 
Inhalants for African American and White, Male and Female Adolescents in 
Grades 6 through 8?  
LTA provides a means for analyzing complex contingency tables for longitudinal 
data, and it is uniquely suited to testing models of stage-sequential change in drug use such 
as that proposed by the gateway hypothesis (Collins, 2002). Empirical model selection in 
LTA involves several steps, aimed at identifying a model that is both a parsimonious and an 
adequate representation of the data. Although the traditional representation of the gateway 
hypothesis provides some guidance, little is known about how inhalants may operate in 
gateway drug use sequencing. This is therefore an exploratory (versus confirmatory) LTA. 
The steps taken to conduct an LTA in order to address Research Question 1 are described 
below and illustrated in a flowchart in Figure 4.4.  
4.8.1.1 Model Selection 
An initial step in LTA involves fitting a series of models with different numbers of 
latent stages (latent statuses). In LTA, a latent categorical variable (i.e., drug use) is 
measured by a series of categorical manifest variables. Four separate manifest variables, one 
for each substance, have been dichotomized to represent the ever or never use of each 
substance. In this case, there are a total of 16 (24) possible unique stages of substance use.  
In this study, model estimation began with a four-stage model. Five-, six-, and seven-
stage models were subsequently estimated; for each of the four samples, models with eight or 
more stages either did not converge or included redundant stages. For African American 
males, a three-stage model was also estimated for the 6th–7th grade period, due to poor fit for 
the other models.  
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Figure 4.4 Model Selection Process Flowchart 
1. Estimate initial 4, 5, 6, 7, and 8 stage models
- freely estimate ρ parameters (but constrain 
equal across times)
- allow forward transitions only 
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parameters
2a. Exclude models 
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3. Examine relative fit 




4. Run data augmentation (100 
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estimates and standard errors
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(for the τ and ρ p rameters) on 
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Initial parameter constraints. In these initial models, the measurement parameters 
(ρ, Rho parameters) were estimated freely but constrained to be equal across both time 
points. These parameters represent the probabilities of responding “yes” or “no” to a 
substance use measure, conditional on time and stage membership, and provide a means of 
distinguishing the stages present for the particular model. For instance, a stage characterized 
by a high probability of responding yes to the alcohol item and no to all other items would 
represent an alcohol-only stage.  
For the purpose of this study, the ρ parameters were constrained to be equal across 
times. This approach assumes that the measurement of the latent variable remains stable over 
time (measurement invariance) ensuring that the meaning of the latent stage remains 
consistent and aiding in model interpretation.  
An additional constraint applied to these baseline models involved the transition (τ, 
Tau) matrix. Because all of the models being tested involve drug use onset—a “one-time” 
event—the Tau matrix was constrained to estimate only forward movement from Time 1 to 
Time 2; no backward movement was allowed. 
Delta (δ) parameters, which represent the unconditional probability of being in a 
latent stage at a given time of measurement, were freely estimated for all analyses. These 
parameters provide the estimated probability of being in the “alcohol + cigarettes” (AC) 
stage at Time 1, for instance.  
Assessing model fit. Two penalized log-likelihood test statistics, the AIC and the 
BIC, were used to identify the best relative model fit among the estimated baseline models. 
In the event that these two estimates identify the same model, that model is selected. 
However, in this study, these two estimates rarely agreed.  
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Double cross-validation was conducted on each of two randomly split samples for 
each study group and was used as an additional step to identify models with the best relative 
fit. Double cross-validation (Collins, Graham, Long, & Hansen, 1994) is recommended as an 
alternate means for assessing model fit, particularly in cases where data are incomplete 
(missing) or where multiple alternative models are being tested (Collins, Lanza, Schafer, & 
Flaherty, 2002).  
The following description of double cross-validation is provided by the Methodology 
Center at Penn State University 
(http://methcenter.psu.edu/index.php/component/content/348?task=view):  
 The process of crossvalidation involves splitting a sample into two (or more) 
subsamples, for example, Sample A and Sample B, and fitting a series of plausible 
models to each sample. Each model is fitted to Sample A (the calibration sample), the 
predicted response frequencies for each model are compared to the observed 
response frequencies in Sample B (the crossvalidation sample), and G2 is computed. 
Then the reverse is done; each model is fitted to Sample B (now the calibration 
sample), the predicted response frequencies for this model are compared to the 
observed response frequencies in Sample A (now the crossvalidation sample), and 
another G2 is computed. A model crossvalidates well if the G2 is relatively small when 
the estimated model is applied to a crossvalidation sample. When a series of models 
is tested, the model or models that crossvalidate best are considered best-fitting.  
Checking for model misspecification. In an effort to determine how stable the 
estimates for the various baseline models were, data augmentation (DA) was employed. 
Essentially, DA is a type of multiple imputation where the latent stages are treated as missing 
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data and random parameters based on the posterior distribution given the observed data are 
created. DA produces a sequence of plausible sets of LTA parameter estimates based on the 
observed data. The uncertainty present in the data results in a series of data sets that each 
contain randomly different values for the LTA parameters. The degree to which these values 
differ from the observed data is reflected in standard errors that are created when combining 
the multiply imputed data sets.  
The primary purpose of DA in LTA is to produce standard errors, which are not a 
byproduct of the expectation-maximization (EM) algorithm used in LTA. In most cases, 10 
imputed data sets are sufficient for producing reliable estimates in LTA models. However, 
DA has also been used here to examine the consistency of the estimates for the baseline 
models. For each of the models, 100 imputations were run and the results combined. Final 
Rho estimates from these combined estimates were examined to determine whether the 
original latent stages remained across the 100 random data sets. In several instances in this 
study, after applying DA, the number and/or type of latent stages present changed, suggesting 
that the selected model was inconsistent and that a simpler model (fewer stages) may be 
preferable. 
Another approach to diagnosing model misspecification is to examine model-based 
residuals. The residuals represent the difference between the observed and expected cell 
frequencies. A large residual for a particular response pattern can indicate that the model 
does not adequately measure the response pattern and may point to adjustments that can be 
made to improve model fit. However, although several large residual values were present for 
the selected models (not shown), the residuals were related to patterns that involved 
backward transitions (i.e., moving from ever use of a drug to never use of the same drug). It 
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is apparent that freeing the transition matrix to allow “backsliding” may improve the fit of 
the models, but that would be illogical for an onset model. 
Final model selection. In addition to the measures of relative fit described above, 
two additional criteria for model selection were used. First, after identifying consistent 
models using DA, the strength of the Rho parameters was examined. In cases where the 
relative fit between the models was not clearly distinguished by the relative fit measures 
(BIC, AIC, and cross-validation G2) , the strength of the freely estimated Rho parameters was 
assessed to determine how well the defined latent stages for each model are measured. 
Although there is a general preference to select more parsimonious models (fewer latent 
stages), if a more complex model has similar relative model fit plus stronger measurement 
qualities and more clearly defined latent stages, the more complex model should be selected. 
Second, similarly, a more complex model may be a closer approximation of the hypothesized 
model. Although the paucity of research and theory related specifically to the role of 
inhalants as a gateway drug mandates that this be an empirical study, the general gateway 
hypothesis suggests a potential gateway model, a hypothetical example of which is described 
in Chapter 3 and illustrated in Figure 3.2. If a clearly superior model was not identified based 
on the relative measures of model fit (AIC and BIC), a model with good overall and relative 
fit, strong measurement properties, and concordance with the hypothesized gateway model is 
selected as the final model.  
Final parameter constraints. Once a final model was selected, additional constraints 
were used to improve the stability and identification of the model and to ensure that the 
model allowed only for logical transitions. For each selected model, the ρ (Rho) parameters 
were constrained so that one estimate for the probability of a “yes” and one estimate for the 
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probability of a “no” response to a drug use question was estimated. The measurement 
invariance constraint remains in place. These constraints greatly reduce the number of 
parameters being estimated, increasing the likelihood that the model will be identified. The  
τ (Tau) matrix continues to be constrained to allow only forward-moving transitions. In some 
cases, depending on the latent stages present in the selected model, certain forward 
transitions are also constrained. Specific model constraints are described for each subsample 
in Chapter 5 (Results). 
Testing for measurement invariance. The models tested in these analyses all 
assume measurement invariance across time points. This is a common constraint made to 
ensure that the meaning of the latent stages is uniform across times and that changes in drug 
use sequencing represent actual changes in reported use, as opposed to changes in the 
meaning of the latent stages. To assess the extent to which measurement invariance holds, the 
model fit for the constrained model is compared to a model where measurement is free to 
vary between the time points. Because these two models are directly nested (the constrained 
model is a simplified version of the unconstrained model), the values of the G2 for each 
model can be directly compared using a χ2 difference test. If the difference is not significant, 
this supports the use of the more parsimonious model where measurement invariance is 
assumed.  
Final model identification. As a final test to determine whether the model selected is 
the best representation of the observed data, the constrained model for each subsample was 
analyzed using 100 random sets of start values (Lanza, Flaherty, & Collins, 2003). This 
approach is recommended to explore the presence of multiple modes. Ideally, all 100 
solutions would be identical, suggesting that the “global maximum of the likelihood” had 
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been maximized (Lanza, Flaherty, & Collins, 2003, p. 671). In no case for the current 
analyses was any solution identical for all 100 solutions. In this case, the frequency of the 
alternate solutions and the G2 for the alternate models were examined to select the final 
model—the optimal solution has likely been identified if the majority of the models converge 
to that same solution and it has the smallest log-likelihood value among the solutions 
obtained using the different random starting values (Lanza, Flaherty, & Collins, 2003). 
Obtaining final parameter estimates and standard errors. The WinLTA software 
used to run these analyses uses an EM algorithm to obtain maximum likelihood estimates for 
the parameters (Collins, Lanza, & Schafer, 2002). Standard errors are not a byproduct of the 
EM algorithm, precluding hypothesis testing. DA is a multiple imputation approach to 
missing data and has been shown to produce high-quality estimates and reliable standard 
errors (Schafer, 1997). After selecting a final LTA model, the EM maximum likelihood 
estimates were used as starting values for DA to multiply impute the latent variables. Results 
from these multiple imputed data sets were then combined to provide an overall estimate of 
the standard error for each parameter (Collins et al., 2002). Using this information, the 
probabilities of stage membership and transition probabilities can be directly compared. The 
DA estimates are reported as the final results for each model.  
The preceding section has described in detail the steps that were taken in the current 
study to identify and estimate models that provide the best relative fit to the data, after 
accounting for measurement error. This model selection process is illustrated in Figure 4.4.  
4.8.1.2 Using the LTA Results to Evaluate the Gateway Hypothesis 
A primary aim of this dissertation is to examine whether gateway relationships exist 
between inhalants and the drugs most commonly referred to as gateway drugs: alcohol, 
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cigarettes, and marijuana. The operational definition of the gateway hypothesis that 
distinguishes complete and partial gateway relationships based on conditional probabilities 
(Maldonado-Molina, 2005) served as a model for these analyses. 
The gateway hypothesis (Kandel & Jessor, 2002) suggests that it is significantly less 
likely that adolescents will progress to illicit drug use without first using one of the “legal” 
drugs. This proposition has been tested almost exclusively with alcohol and tobacco, 
although Collins et al. (1997) demonstrated that the heavy use of caffeine, another legal 
substance, may increase the likelihood of drug use onset. To date, no study has tested the role 
inhalants may play in the “sequencing proposition” of the gateway hypothesis.  
Using the results from the final selected LTA model, it is possible to test hypotheses 
about drug use sequencing, particularly the relationship between inhalants and the other 
gateway drugs. Certain drug use latent stages must be present in the data to facilitate testing 
of certain hypotheses. If for a final selected LTA model, inhalant use is only present as part 
of an “Alcohol + Cigarettes + Inhalants + Marijuana” (ACIM) stage, and not in a preceding 
stage, it will not be possible to test the hypothesis that inhalants serve a gateway role to 
marijuana use. The hypothesis that inhalants serve as a partial gateway to marijuana use 
would be rejected, and it would be concluded that inhalants do not serve any gateway 
function within this study population. If, however, the final model includes both an “Alcohol 
+ Cigarettes + Marijuana” (ACM) stage and an “Alcohol + Cigarettes + Inhalants” (ACI) 
stage, the probability of transitioning from inhalants to marijuana, and from marijuana to 
inhalants, can be directly compared. Likewise, if the final model includes an “inhalants only” 
stage, the probability of transitioning from inhalants to alcohol and cigarettes can also be 
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tested and compared with the opposite transitions (e.g., alcohol to inhalants) to determine 
which probability is greater.  
Using the definitions of complete and partial gateway relationships proposed by 
Maldonado-Molina (2005), it is possible to test what kind of gateway relationship exists 
between inhalants and the gateway drugs. To test for a complete gateway relationship for 
example, one estimates whether the probability of using alcohol, cigarettes, or marijuana at a 
later time, conditional on not having used inhalants at an earlier time, equals zero. The 
following three equations, adapted from Maldonado-Molina (2005, p. 17), provide as an 
example a test of the complete gateway relationship between inhalants and marijuana: 
      __ 
  Ρ(inht)>0   Equation 1 
 
  Ρ(mart’|inht)>0  Equation 2 
   __ 
  Ρ(mart’|inht) = 0  Equation 3 
 
where     __ 
Ρ(inht) is the probability of not trying inhalants at an earlier time, 
 
Ρ(mart’|inht) is the probability of trying marijuana at a later time conditional on 
having tried inhalants at an earlier time, and  
   ___ 
Ρ(mart’|inht) is the probability of trying marijuana at a later time conditional on not 
having tried inhalants at an earlier time. 
  
Equation 3 is the most stringent condition for establishing a complete gateway 
relationship between two drugs. For instance, according to this sample equation, everyone 
who tries marijuana has tried inhalants first. It is presumed that, in any adolescent sample, a 
significant proportion of marijuana users have never used inhalants. For this reason, inhalants 
are better considered as a potential partial gateway to marijuana use.  
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A partial gateway relationship is assessed by estimating whether the probability of 
using marijuana, cigarettes, or alcohol after using inhalants is greater than the probability of 
using marijuana, cigarettes, or alcohol without having first used inhalants, while at the same 
time the probability of using inhalants after using marijuana, cigarettes, or alcohol is equal to 
or less than the probability of using inhalants without having first used marijuana, cigarettes, 
or alcohol (Maldonado-Molina, 2005). Extending the example of inhalant and marijuana use, 
the following equations (Maldonado-Molina, 2005, p. 18) provide a test of a partial gateway 
relationship: 
   ___ 
  Ρ(mart’|inht) > Ρ(mart’|inht)  Equation 4 
     ___ 
  Ρ(inht’|mart) < Ρ(inht’|mart)  Equation 5 
 
where   
Ρ(mart’|inht) is the probability of trying marijuana at a later time conditional on 
having tried inhalants at an earlier time, 
  ___ 
Ρ(mart’|inht) is the probability of trying marijuana at a later time conditional on not 
having tried inhalants at an earlier time,  
 
Ρ(inht’|mart) is the probability of trying inhalants at a later time conditional on having 
tried marijuana at an earlier time, and  
 ___ 
Ρ(inht’|mart) is the probability of trying inhalants at a later time conditional on not 
having tried marijuana at an earlier time. 
 
Based on these equations, there is support for a partial gateway relationship between 
inhalants and marijuana if having tried inhalants is associated with an increased risk of trying 
marijuana, but having tried marijuana is not associated with an increased risk of trying 
inhalants (Maldonado-Molina, 2005).  
LTA provides a flexible approach to testing these equations (Maldonado-Molina, 
2005). Consider, for example, a test of the complete gateway relationship definition for 
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inhalants and marijuana. Equation 1 states that the probability of not using inhalants at Time 
1 is greater than zero. This probability can be assessed by summing the probability of 
membership in states that did not include the use of inhalants. Equation 2, which states that 
the probability of using marijuana at a later time conditional on having used inhalants at a 
previous time is greater than zero, is evaluated in LTA by estimating the proportion of 
adolescents who at Time 1 had used inhalants but not marijuana and who by a later time  
(t + 1) had initiated marijuana use.  
The final condition of a complete gateway relationship between inhalants and 
marijuana (Equation 3) states that the probability of using marijuana at a later time (t + 1) 
conditional on not having used inhalants at an earlier time (t) equals zero. Testing this 
equation requires estimating the probability of stage membership in a stage that includes 
marijuana at a later time (t + 1) conditional on the probability of membership in stages with 
no inhalant use at Time 1. This estimate is calculated by adding the products of the 
conditional probabilities of using marijuana at the later time (t + 1) given that inhalants have 
not been used at Time 1 (t) and the probability of stage membership in each substance use 
stage at Time 1 and dividing this product by the probability of not having used inhalants 
(Maldonado-Molina, 2005). 
Again, because inhalant use is not nearly as prevalent as alcohol or cigarette use, it is 
very unlikely that it will operate as a complete gateway to any substance, except perhaps for 
a small subgroup of adolescents. It is hypothesized, however, that inhalants may serve as a 
partial gateway to marijuana use because inhalants, while not always preceding marijuana 
use, may significantly increase the risk for later marijuana use. 
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The first condition supporting a partial gateway relationship is that the probability of 
using marijuana at Time 2 conditional on using inhalants at Time 1 is greater than the 
probability of using marijuana at Time 2 conditional on not having used inhalants at Time 1 
(Maldonado-Molina, 2005). This condition compares the probability estimates from 
Equations 2 and 3. Specifically, this condition is tested by calculating the difference between 
the two probabilities: the probability of using marijuana at Time 2 conditional on using 
inhalants at Time 1 minus the probability of using marijuana at Time 2 conditional on not 
having used inhalants at Time 1 (Maldonado-Molina, 2005). If this difference is significantly 
greater than zero, there is evidence in support of this condition. 
The final equation, and condition for a partial gateway relationship, is that the 
probability of using inhalants at a later time (t + 1) conditional on having used marijuana at 
an earlier time (t) is less than or equal to the probability of using inhalants at a later time 
(t + 1) conditional on not having used marijuana at an earlier time (t) (Maldonado-Molina, 
2005). To calculate the probability of using inhalants at a later time conditional on first using 
marijuana, one estimates the probability of membership in any stage that included inhalants 
at the later time (t + 1) conditional on membership in any stage with marijuana at Time 1.  
To satisfy the Equation 5 condition, the resultant probability of using inhalants at a 
later time conditional on the earlier use of marijuana needs to be less than or equal to the 
probability of using inhalants at a later time (t + 1) conditional on not having used marijuana 
at an earlier time (suggesting that the use of marijuana at Time 1 does not increase the 
probability of using inhalants at Time 2). This second part of the equation is estimated by 
calculating the probability of membership in a stage that includes inhalants at a later time  
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(t + 1) conditional on each stage that does not include marijuana at Time 1 (Maldonado-
Molina, 2005). 
4.8.2 Research Question 2: Does the Probability of Transitioning from Inhalant Use to 
Other Drug Use Remain after Controlling for Demographic Factors and Key 
Psychosocial Predictors of Adolescent Drug Use? 
Software for conducting LTA with covariates has been released recently as a beta 
version (version 1.1.5) in SAS®. In addition to the typical LTA parameters previously 
described, an LTA with covariates includes up to two additional sets of beta (β) parameters: a 
set representing logistic regression coefficients for the covariates predicting baseline stage 
membership and a set representing logistic regression coefficients for covariates predicting 
transitions over time.  
The purpose of this analysis was to determine whether the probability of transitioning 
from inhalant use to other drug use remains after controlling for other factors related to 
adolescent substance use. Therefore, this analysis at a minimum requires a transition model 
where a transition from inhalants to another drug use stage is present. The final models 
selected for each of the four samples (i.e., white males, white females, African American 
males, and African American females) and for both time points (6th to 7th grade and 7th to 
8th grade) determine whether Research Question 2 can be assessed: there must be evidence 
for a gateway relationship (in analysis 1) to facilitate analysis 2. In this study, the results 
(Chapter 5) indicate that this relationship exists only for white females (at both transition 
periods). Therefore, analysis 2 is focused solely on the white female samples. 
The final model selected for white females was extended to include covariates (Lanza 
& Collins, 2008). In an LTA-with-covariates, covariates are incorporated in the latent 
transition model using a logistic link function, and one or more covariates can be specified as 
covariates of (a) latent stage membership at Time 1(δ) and (b) transition probabilities from 
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Time 1 to Time 2. This results in two additional sets of β (beta) parameter estimates, which 
are logistic regression coefficients.  
When covariates are included, the δ and τ parameters are calculated as functions of 
the β parameters and the covariates. This feature allows for a direct analysis of Research 
Question 2. Recall that the transition probability τ for a standard LTA without covariates is 
interpreted as the probability of being in latent stage B at Time 2, given membership in latent 
stage A at Time 1. When one or more covariates are included, the τ estimate is conditional on 
both Time 1 stage and the effect of the covariate(s). The interpretation of τ in this case is the 
probability of being in latent stage B at Time 2, given membership in latent stage A at Time 1 
and the value of the covariate(s). It is therefore possible to assess the effect of the covariate 
on transition probabilities by comparing the parameter estimates from the basic LTA model 
with the estimates from the LTA-with-covariates model. If, after adding covariates to the 
model, a transition probability decreases substantially or disappears completely, this would 
be evidence that observed transition probability is more a function of the covariate than 
membership in the previous stage at Time 1.  
This analysis focused specifically on the transition from inhalant use to other drug 
use. As mentioned, only white females included latent stages necessary to test the gateway 
hypothesis. Described in detail in Chapter 5 (Results), the LTA model for white females 
includes an “Alcohol + Cigarettes + Inhalants” (ACI) stage and an “Alcohol + Cigarettes + 
Inhalants + Marijuana” (ACIM) stage. It is therefore possible to assess the effects of 
covariates on the transition probability from the ACI stage to the ACIM stage as a direct test 
of the hypothesis that inhalant use acts as a partial gateway to marijuana use. 
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A number of psychosocial variables (e.g., perceived peer drug use, perceived drug 
availability, sensation seeking and delinquency, academic aspirations, and parental 
[mother’s] disapproval of drug use) thought to represent common liabilities to drug use were 
included as covariates. Age was also included to account for possible heterogeneity of ages at 
each grade. The variables were first entered independently (bivariate analysis) to assess the 
independent effects.  
The bivariate analyses were followed with a series of multivariate analyses. Variables 
that were statistically significant (p < .05) and were associated with a decrease in the size of 
the transition probability were retained. The purpose of this analysis was to determine 
whether a combination of covariates that fully or mostly account for the probability of 
transitioning from the ACI stage to the ACIM stage could be identified. Covariates were 
ranked in order of their independent effect on the transition probability and a series of 
increasingly large models were estimated. The first model included just the one variable with 
the strongest effect on the transition probability. Subsequent models added one covariate at a 
time in order of the size of their effect on the transition probability. A finding that the 
transition probability remains significant after controlling for competing factors would be 
evidence of a unique gateway relationship between inhalants and marijuana. 
A review of the covariates indicated that the majority are heavily skewed (zero-
inflated) and this coupled with the sparseness of the contingency table being estimated 
prevented estimation in some cases (models failed to converge) and made interpretation of 
the results difficult. Dichotomizing the variables (based on a median or mean split) improved 
estimation and made interpretation clearer (“age” remains continuous). Details of the recoded 
covariates are presented in Chapter 5 (Results).  
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4.8.3 LTA Software 
The analyses were conducted using WinLTA (Collins et al., 2002), a free 
downloadable software designed to conduct latent class analysis (PROC LTA, 2007) and 
LTA. WinLTA handles missing data with a full-information maximum likelihood technique 
whereby the EM algorithm uses information from the model and incomplete data to estimate 
parameters iteratively (Hyatt & Collins, 2000).  
WinLTA is an extremely flexible and user-friendly software program that is 
especially well-suited for model testing and model comparisons. This relates in part to the 
flexibility of adding or removing specific model constraints. For instance, in the drug use 
onset model, the use of constraints specifies a model where only forward transitions are 
allowed.  
WinLTA does not include a feature to include covariates. A recently released beta 
version of an LTA procedure in SAS® (PROC LTA, beta version 1.1.5., 2007) allows for the 
estimation of LTA models with covariates. Separate sets of covariates can be specified for 
baseline and for each transition (e.g., Time 1 to Time 2). As in WinLTA, parameters are 
estimated by maximum likelihood using the EM algorithm, which allows for the estimation 
of models with missing data. Unlike WinLTA, SAS PROC LTA does not include a DA 
option; standard errors are not produced. Additionally, while the EM algorithim allows for 
missing data on the latent stage indicators, missing data on covariates are not allowed; any 
individual with missing data on a covariate included in the model was eliminated from the 
analysis (listwise deletion); this limitation may bias results for this study, as the percentage of 
cases dropped ranged from 4% for the 6th–7th grade transition to 11% for the 7th–8th grade 
transition.  
 CHAPTER 5  
RESULTS 
5.1 Research Question 1: Can the Gateway Hypothesis be Extended to Include 
Inhalants for African American and White, Male and Female Adolescents in 
Grades 6 through 8? 
5.1.1 Model Selection and Description 
The goodness-of-fit for latent transition analysis (LTA) models is assessed by 
comparing the response pattern frequencies predicted by the model with the response pattern 
frequencies observed in the data. The likelihood ratio statistic, G2, expresses the degree of 
agreement between the predicted and observed response pattern frequencies. For this study, 
four dichotomous variables representing reported ever use of alcohol, cigarettes, inhalants, or 
marijuana were measured at two time points. Therefore, a total of 256 (24*2) unique response 
patterns are possible.  
Reviewing the number of observed response patterns gives some indication of the 
degree of heterogeneity present within the samples. A small number relative to the sample 
size suggests that there is general similarity in the patterns of reported drug use for that 
sample; conversely, a large relative number of response patterns suggests variability in 
reported drug use and may signal a challenge to identifying a parsimonious model that 
adequately summarizes the observed response patterns. 
Tables 5.1 and 5.2 list the number of unique observed response patterns for each of 
the four subsamples for the 6th–7th grade and 7th–8th grade transition periods. A high 
relative number in the second column, “number of response patterns,” suggests greater 
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heterogeneity. By dividing the sample size by the number of response patterns, an estimate of 
the number of individuals within a sample who share the same response pattern is obtained 
(the fourth column in Tables 5.1 and 5.2). This number, found in the fourth column (“number 
of individuals sharing the same response pattern”), is an estimate of the number of 
individuals who share the same response pattern—thus, it is a measure of homogeneity, 
where high relative numbers indicate greater homogeneity. 
Table 5.1 Number of Unique Observed Response Patterns for Ever Use of Four 




Patterns Sample Size 
Number of 
Individuals 
Sharing the Same 
Response Pattern 
White males 78 464 5.9 
White females 68 464 6.8 
African American males 116 363 3.1 
African American females 79 339 4.3 
 
Table 5.2 Number of Unique Observed Response Patterns for Ever Use of Four 




Patterns Sample Size 
Number of 
Individuals 
Sharing the Same 
Response Pattern 
White males 123 955 7.8 
White females 96 954 9.9 
African American males 143 703 4.9 
African American females 130 732 5.6 
 
For the 6th–7th and 7th–8th grade samples, white females have relatively fewer 
unique response patterns, suggesting greater homogeneity of responses. African American 
males and females exhibit more variability in their response patterns than do white 
respondents. The issue is most pronounced for the 6th–7th grade transition: only about three 
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(3.1) individuals share each of the observed response patterns that are present among African 
American males, whereas approximately 7 (6.8) white females share each unique response 
pattern found in that population. This finding provides additional support for the decision to 
conduct analyses separately for each group—there is clearly a great deal of variation between 
groups in terms of the number of drug use patterns reported. The results, including model 
selection and description, for each of the four subsamples are presented separately below.  
5.1.2 White Males 
5.1.2.1 6th–7th Grade Transition 
Table 5.3 provides goodness-of-fit measures for various LTA models for white males 
transitioning from the 6th grade to the 7th grade. These estimates are for the general baseline 
models, with ρ (measurement) parameters that are freely estimated. The latent stage labels 
shown in Table 5.3 are based on the pattern of ρ parameters for each model.  
Table 5.3 Goodness-of-Fit for Various Models, White Males, 6th–7th Grade 





4 (N, A, AC, 
ACIM) 
171.01 (230) 221.01 324.51 177.846 219.495 
5 (N, A, AC, 
ACM, ACIM) 
140.74 (221) 208.74 349.49 183.094 235.458 
6 (N, A, C, AC, 
ACM, ACIM) 
120.31 (212) 206.31 384.32 189.162 233.439 
7 (N, A, C, I, AC, 
ACM, ACIM) 
95.65 (205) 195.65 402.64 179.261 226.558 
a Model labels are based on the ρ parameters for the model. 
N = 464 
Notes: A = alcohol; AC = alcohol + cigarettes; ACIM = alcohol + cigarettes + inhalants + marijuana; ACM = 
alcohol + cigarettes + marijuana; C = cigarettes; I = inhalants; N = no use. 
As a general rule of thumb, G2 values that are less than the degrees of freedom 
suggest a good overall fit. In this case, all of the models appear to fit the data well. The 
Akaike information criterion (AIC) and Bayesian information criterion (BIC) estimates are 
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inconsistent, designating different models as having the best model fit (lower scores indicate 
a better fit), in a pattern that is consistent across the other subsamples as well: AIC favors the 
most complex model (seven stages), whereas BIC favors the most parsimonious model (four 
stages). Cross-validation results, where lower G2 values suggest a better relative fit, provide 
support for the four-stage model; the four-stage model cross-validates best for both random 
samples. The general principle of parsimony—when all else is equal, favor the most simple 
acceptable model—also supports the selection of the four-stage model. 
Examining the strength of the measurement of the respective models is another step 
toward determining the best-fitting model. A more complex model may be desirable if the 
measurement of each latent stage is stronger than for a more parsimonious model. The ρ 
parameter estimates give an indication of the measurement for each stage. These parameters 
are similar to factor loadings in factor analysis, although they represent probabilities rather 
than loadings. Patterns of the ρ parameters are assessed to “label” the latent stages. Numbers 
close to one and close to zero suggest that membership in the latent stage is associated with a 
high probability of responding yes or no to the item. A probability of .50 suggests an equal 
probability of responding either yes or no, an indication of weak measurement. For the four-
stage model, the probability of responding “yes” to each of the four drug use items, given 
membership in one of the four stages, is presented in Table 5.4. Again, the latent stage labels 
are based on the pattern of ρ estimates. Numbers close to “1” represent a high probability of 
responding “yes” to a drug-use item conditional on latent stage membership, whereas 
numbers close to “0” represent a low probability (and conversely a high probability of 
responding “no” to a drug use item), given latent stage membership. 
105 
Table 5.4 Freely Estimated ρ Parameters for Response “Yes,” Four-Stage Model, 
White Males, 6th–7th Grade 
Item 
Latent Stage 







Ever used alcohol .02 .91 .74 .97 
Ever used cigarettes .02 .12 .97 .96 
Ever used inhalants .03 .11 .05 .68 
Ever used marijuana .00 .00 .12 .71 
Note: ρ parameters are constrained equal for both time points, so the estimates are the same for both grades. 
Similarly strong measurement of the latent stages was present for the five-, six-, and 
seven-stage models; no clear optimal model is identified. However, when each of these 
models was analyzed using data augmentation (DA) (with 100 imputations), additional 
support for the four-stage model emerged. The ρ (Rho) parameter estimates for the four-stage 
model suggest that the measurement of the four latent stages is consistent across imputations; 
that is, the same four stages are present, and the measurement quality is similar to that 
obtained in the original LTA. The more complex models were unstable across the imputed 
data sets. In fact, for each (five-, six-, and seven-latent stage) model, the same four stages 
present in the labeled four-stage model are the only ones that remain identifiable across the 
imputed data sets. Based on this collection of evidence, for white males transitioning from 
6th to 7th grade, the four-stage model was selected as the final model. The stages represent 
“No use” (N), “Alcohol only” (A), “Alcohol + Cigarettes” (AC), and “Alcohol + Cigarettes + 
Inhalants + Marijuana” (ACIM).  
Parameter constraints for the final model. To obtain final parameter estimates for 
the four-stage model and to ensure model identification, constraints were placed on the 
measurement (ρ) and transition (τ) matrices. The general pattern of constraints is similar for 
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each of the subsamples as is presented here as an example. Table 5.5 illustrates the 
constraints placed on the ρ parameters. The numbers listed in the table are arbitrary; for the 
WinLTA software, a “1” indicates that the parameter is freely estimated, and numbers greater 
than 1 can be used to create sets of equivalent estimates. Each “unique” number is freely 
estimated, whereas a single estimate is provided for cases where the same number is 
repeated. The matrix is constrained in order to estimate the probability of responding “yes” 
and the probability of responding “no” to a drug use item, conditional on latent stage 
membership. In this case, a total of 16 parameters are estimated, as opposed to a total 
possible number of 64 (32 x 2 time points) parameters. 
Table 5.5 Constraints on ρ Parameters for White Males, 6th–7th Grade 
 Latent Stage 














No use 2 7 11 15 
A 5 7 11 15 
AC 5 9 11 15 
ACIM 5 9 13 17 






No use 4 8 12 16 
A 6 8 12 16 
AC 6 10 12 16 
ACIM 6 10 14 18 
Notes: A = alcohol; AC = alcohol + cigarettes; ACIM = alcohol + cigarettes + inhalants + marijuana; ACM = 
alcohol + cigarettes + marijuana. 
Each unique number is freely estimated. Same numbers are constrained to be equal. For instance, the 
probability of responding “yes” to the alcohol ever use item given membership in the A, AC, or ACIM latent 
stage is constrained to be equal. This constraint ensures that the meaning of the alcohol use item is held 
constant across latent stages. Estimates are also constrained to be equal for both time points (measurement 
invariance). 
The transition matrix (τ) (Table 5.6) reflects the fact that this is an onset (ever-use) 
model. In this case, an individual is free to progress to a “later” drug use stage, but they 
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cannot revert to an earlier stage (e.g., someone who reported ever using alcohol at Time 1 
cannot be in the “no use” stage at Time 2). Based on the gateway hypothesis, it is assumed 
that, while an individual can transition from “no use” to one of the more advanced stages, the 
probability of transitioning will be greater for those who have tried alcohol or alcohol and 
cigarettes. 
Table 5.6 Constraints on τ Parameters for White Males, 6th–7th Grade  
 No Use A AC ACIM 
No use FR FR FR FR 
A 0 FR FR FR 
AC 0 0 FR FR 
ACIM 0 0 0 FR 
Notes: A = alcohol only, AC = alcohol + cigarettes, ACIM = alcohol + cigarettes + inhalants + marijuana; FR = 
freely estimated; 0 = fixed to zero (not estimated). 
To ensure that the final model, with the applied constraints, is the proper solution for 
the four-class model, the model was analyzed 100 separate times, using random start values. 
Two models emerged: the selected four-stage model and an alternate three-stage model (N + 
C + AC). The four-stage model was the most frequent solution: 63 of the 100 analyses 
supported the four-stage model. Additionally, the G2 associated with the four-stage model 
(336.68) was substantially lower than the G2 associated with the three-stage model (568.17).
 The assumption of measurement invariance was tested via a χ2 difference test for the 
difference between the model with the ρ parameters constrained to be equal (invariant) for 
both time points (G2 = 194.315, 238 df) and the model without the measurement invariance 
constraint (G2 = 186.110, 230 df). The difference of 8.205, with 8 degrees of freedom, is not 
significant (p = .4137), supporting the decision to constrain measurement across times.  
Final model results, white males, 6th–7th grade. To obtain final parameter 
estimates and standard errors, DA was conducted. Whereas DA was used earlier to assess the 
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stability of the unconstrained model across 100 imputed data sets, here DA was applied to the 
final constrained model, and the results were combined to generate final parameter estimates 
that take into account the uncertainty present across the imputed data sets.  
ρ parameters (model measurement). The final ρ parameter estimates, specifically the 
probability of responding “yes” to each item, along with 95% confidence intervals, are 
presented in Table 5.7. The values were constrained to be equal across time (measurement 
invariance), so the ρ parameters are the same for both time points. To achieve identification 
and model stability, additional constraints were imposed such that only two parameters were 
estimated for each item; the probability of responding “no” can be obtained by subtracting 
the parameters in Table 5.7 from 1.00. 
Table 5.7 Final ρ Parameter Estimates and 95% Confidence Intervals for Response 
“Yes,” Four-Stage Model, White Males, 6th–7th Grade 
Item 
Latent Stage 









.03 (.00, .13)  .88 (.83, .92) .88 (.83, .92) .88 (.83, .92) 
Ever used 
cigarettes 
.05 (.03, .10) .05 (.03, .10) .93 (.87, .97) .93 (.87, .97) 
Ever used 
inhalants 
.06 (.04, .08) .06 (.04, .08) .06 (.04, .08) .59 (.50, .68) 
Ever used 
marijuana 
.01 (.00, .02) .01 (.00, .02) .01 (.01, .02) .72 (.59, .82) 
Note: Point estimates and 95% confidence intervals based on data augmentation. 
Most of the parameter estimates are near 0 and 1, indicating that the latent variable 
“substance use” is being measured accurately. For instance, the probability of responding 
“yes” to the alcohol item given membership in one of the three alcohol use stages is .88 (95% 
CI: .83, .92). The relatively weak measurement of the inhalant use item (and to a lesser extent 
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the marijuana item) should be noted. The estimated probability that a respondent will indicate 
having tried inhalants when he has not in fact tried them is only .06. But the estimated 
probability of a respondent indicating that they have not tried inhalants when according to 
their latent stage they are expected to have tried them is .41 (1.0 – .59), suggesting that the 
latent stage ACIM does a poor job predicting inhalant use. Membership in the ACIM latent 
stage is associated with a .59 (95% CI: .50, .68) probability of responding “yes” to the 
inhalant use item and a .72 (95% CI: .59, .82) probability for marijuana. The confidence 
interval for the inhalants measure includes .50, indicating that the probability is not 
significantly different from an equal probability of a “yes” or “no” response given latent 
stage membership.  
δ parameters: probabilities of latent stage membership. δ parameters represent the 
probability of being in a certain latent stage. Table 5.8 and Figure 5.1 show the estimated 
proportion of adolescents in each of the four latent substance use stages in 6th and 7th grade. 
Table 5.8 Final δ Parameter Estimates for Four-Stage Model, White Males, 6th–7th 
Grade  
Latent Stage 6th Grade 7th Grade 
No use .49  .35 
Alcohol .26  .27 
Alcohol + cigarettes .16  .16 
Alcohol + cigarettes + inhalants + marijuana .09  .22 
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Note: N = no use; A = alcohol only; AC = alcohol + cigarettes; ACIM = alcohol + cigarettes + inhalants + 
marijuana.  
In 6th grade, roughly half of the white males in the sample are expected to be in the 
“no use” latent stage, whereas one-quarter are expected to be in the alcohol-only stage. 
Prevalence rate estimates for each of the four substances can be calculated by combining 
across stages with common substance use items. For instance, the prevalence estimate for 
alcohol use in 6th grade is (.26 + .16 + .09) = .51, suggesting that more 6th grade white males 
have tried alcohol than are in the “no use” stage. The overall prevalence estimate for 
cigarettes is .25, while, based on this model, the prevalence of inhalant use and marijuana use 
is identical at .09. However, as noted above, these results should be interpreted with caution 
given the relatively poor measurement of inhalant use. 
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δ estimates for grade 7 indicate that the number of 7th grade white males expected to 
be in the “no use” stage has decreased substantially from grade 6, whereas the number in the 
ACIM stage increased from 9% to 22%. The estimates for the “alcohol” and the “alcohol + 
cigarettes” stages are similar at both grades. 
τ parameters: transition probabilities. The τ parameters express the probability of 
transitioning from one latent stage to another between grade 6 and grade 7. The τ matrix is 
presented in Table 5.9. 
Table 5.9 τ Parameter Estimates and 95% Confidence Intervals, White Males,  
6th–7th Grade 
 Latent Stage in 7th Grade  
Latent Stage in 6th Grade N A AC ACIM 
Advance 
Rate 





















Alcohol + cigarettes + 
inhalants + marijuana 
(ACIM) 
— — — 1.0  
Overall advance rate     .267 
Notes: The τ parameter estimates represent the probability of transitioning to the column “latent stage in 7th 
grade,” conditional on membership in the row “latent stage in 6th grade.” 
Dash (—) indicates that parameter was fixed to zero to represent the onset model. 
Point estimates and 95% confidence intervals based on data augmentation. 
The probability of transitioning from the “no use” stage to one of the drug use stages 
is .283; roughly 72% of the non-users in 6th grade remained non-users in 7th grade. The 
largest probability for transition from the “no use” stage is to the alcohol stage, which is 
consistent with the generally reported gateway hypothesis, where alcohol is typically the first 
substance tried. The substantial probability (.065) of transitioning from “no use” directly to 
the most advanced stage (ACIM) is not predicted by the gateway hypothesis.  
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However, it is possible that the actual transition sequence from “no use” to ACIM is 
obscured by the year spacing used for this analysis. For instance, it is possible that an 
individual in the “no use” stage at 6th grade tried alcohol, then tried cigarettes, and then tried 
ACIM, all within the 1 year time frame, but those pathways would be obscured by the fact 
that assessments are for the 6th and 7th grades. Based on this model we might assume that 
inhalants and marijuana are tried so close together in time that we cannot tell which comes 
first, so they are essentially concurrent for this model. We know that alcohol is tried before 
cigarettes; nobody tried cigarettes without first trying alcohol (otherwise there would be a 
cigarettes-only [C] stage). We also know that cigarettes are tried before inhalants and 
marijuana, as evidenced by the AC stage and the fact that there is no AIM stage—no one 
used IM without having first used cigarettes. Therefore, the N to ACIM and the A to ACIM 
transitions should not be interpreted as representing the conditional probability of jumping 
directly from N or A to ACIM; rather, they should be interpreted as the conditional 
probability of proceeding from N to A to AC and then to ACIM.  
Interestingly, the advance rate for alcohol-only users in 6th grade was lower than for 
non-users. Only 23% of these individuals transitioned to a more advanced stage. In contrast, 
nearly 44% of individuals in the AC stage transitioned to the ACIM stage. The combination 
of alcohol and cigarette use in this sample is clearly associated with a significant increase in 
the probability of transitioning to the most advanced stage in the model. Figure 5.2 presents 
the final transition model for white males transitioning from 6th to 7th grade. 
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Figure 5.2 Final Four-Stage Model for White Males, 6th–7th Grade, with 
















Research Question 1 asks, “can the gateway hypothesis be extended to include 
inhalants for African American and white adolescents…?” These preliminary results suggest 
that the gateway model can be expanded to include inhalants for white males transitioning 
from 6th to 7th grade, as evidenced by the presence of the ACIM stage. Two of the study 
Hypotheses (1.1 and 1.2) for Research Question 1 can be examined here. Hypothesis 1.1 
states that “inhalant use will precede marijuana use for a significant number of adolescents,” 
whereas Hypothesis 1.2 suggests that inhalants will operate formally as a partial gateway to 
marijuana use. For this sample of white male adolescents transitioning from 6th to 7th grade, 
there is no evidence that inhalant use precedes, or is a gateway to, alcohol, cigarette, or 
marijuana use and therefore no evidence in support of these hypotheses.  
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The results suggest that marijuana and inhalants are rarely used without having also 
used the other; however, it is worth noting that all of the models except the four-stage model 
included a separate “alcohol + cigarettes + marijuana” (ACM) stage. The fact that these more 
complex models were not consistent or stable suggests that, although there is evidence that a 
separate stage (ACM) may exist in the study population, it is a rare stage, or that after 
accounting for measurement error, the current sample size may be insufficient to consistently 
detect it. Unlike previous studies of the gateway hypothesis, there is no evidence to suggest 
that a separate, cigarettes-only stage is warranted. 
5.1.2.2 7th–8th Grade Transition 
Table 5.10 provides goodness-of-fit measures for various LTA models for white 
males transitioning from 7th to 8th grade. Unlike the 6th–7th grade sample, all of the G2 
values are larger than the degrees of freedom, rough evidence that none of the models appear 
to fit the data especially well. Note that a seven-stage model was estimated, but a review of 
the ρ parameters suggested that two of the seven latent stages were redundant, so it was 
excluded. The stages present in the four-, five-, and six-stage model are the same as those 
identified for white males in the 6th–7th grade sample, which is evidence for the consistency 
of the models over time. 
The AIC and BIC estimates designate different models as having the best model fit, 
with the AIC favoring the six-stage model and the BIC favoring the five-stage model. Cross-
validation results are ambiguous; the six-stage model cross-validates best for one of the 
random samples and the five-stage model was the better fit for the other sample.  
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Table 5.10 Goodness-of-Fit for Various Models, White Males, 7th–8th Grade 





4 (N, A, AC, ACIM) 383.34 (230) 433.34 554.89 256.656 304.390 
5 (N, A, AC, ACM, 
ACIM) 
317.21 (221) 385.21 550.51 258.341 275.932 
6 (N, A, C, AC, 
ACM, ACIM) 
274.36 (212) 360.36 569.41 245.337 292.483 
Notes: A = alcohol; AC = alcohol + cigarettes; ACIM = alcohol + cigarettes + inhalants + marijuana; ACM = 
alcohol + cigarettes + marijuana; N = no use. 
N = 955. 
Model labels are based on the ρ parameters for the model. 
Seven-stage model included two redundant latent stages (only six unique latent stages). 
The ρ parameters for each model were examined to determine how well the latent 
stages are measured. In these baseline models, measurement is unconstrained—the ρ 
parameters are freely estimated (although the parameter estimates are held constant for the 
two time periods). Initial LTA estimates (not shown) for the four-, five-, and six-stage 
models indicate strong measurement of the latent stages, although the four-stage model had 
one weak ρ estimate: the probability of responding “yes” to the inhalant use item conditional 
on membership in a latent stage that includes inhalant use was estimated at .53—barely 
larger than chance. The five- and six-stage models have stronger initial measurement 
properties.  
For the five-stage model, the probability of responding “yes” to each of the four drug 
use items, given membership in one of the five stages, is presented in Table 5.11. The ρ 
parameters indicate overall strong measurement of five distinct stages. For instance, 
members of the “no use” stage have virtually zero probability of responding “yes” to any of 
the four drug use measures, as would be expected. Adolescents in the “alcohol + cigarette + 
marijuana” stage have very high probabilities of responding “yes” to the alcohol (.96), 
cigarette (.94), and marijuana (1.00) items.  
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Table 5.11 Freely Estimated ρ Parameters for Response “Yes,” Five-Stage Model, 
White Males, 7th–8th Grade 
Item 
Latent Stage 













.06 .95 .81 .96 .89 
Ever used 
cigarettes 
.02 .00 .82 .94 .86 
Ever used 
inhalants 
.02 .10 .03 .07 .80 
Ever used 
marijuana 
.00 .00 .05 1.00 .63 
Note: Item-response probabilities (ρ parameters) are constrained equal for both time points, so the estimates are 
the same for both grades. 
When each of these three models was analyzed using DA (with 100 imputations), the 
ρ (Rho) parameter estimates for the four- and five-stage models were consistent across 
imputations. However, the meaning of the latent stages changed for the six-stage model. 
Specifically, the single status for “cigarettes only” no longer existed, and only five distinct 
stages (the same identified in the original five-stage model) were interpretable, indicating 
that the six-stage model was unstable across the imputed data sets. Both the AIC and the BIC 
for the five-stage model suggest a better fit than for the four-stage model, and because the 
measurement for the five-stage model was good, it was selected as the final model for white 
males transitioning from 7th to 8th grade. The stages represent “no drug use” (N), “alcohol 
only” (A), “alcohol + cigarettes” (AC), “alcohol + cigarettes + marijuana” (ACM), and 
“alcohol + cigarettes + inhalants + marijuana” (ACIM).  
Parameter constraints for the final model. To obtain final parameter estimates for 
the five-stage model and to ensure model identification, constraints were placed on the 
measurement (ρ) and transition (τ) matrices in the same way as for the 6th–7th grade model 
117 
(with the addition of one stage). Table 5.12 illustrates the constraints placed on the ρ 
parameters. Table 5.13 provides the parameter constraints for the τ matrix.  
Table 5.12 Constraints on ρ Parameters for White Males, 7th–8th Grade 
 Latent Stage












Probability of responding 
“no” given latent stage 
membership 
No use 2 7 11 15 
A 5 7 11 15 
AC 5 9 11 15 
ACM 5 9 11 17 
ACIM 5 9 13 17 
      
Probability of responding 
“yes” given latent stage 
membership 
No use 4 8 12 16 
A 6 8 12 16 
AC 6 10 12 16 
ACM 6 10 12 18 
ACIM 6 10 14 18 
Notes: A = alcohol only, AC = alcohol + cigarettes, ACIM = alcohol + cigarettes + inhalants + marijuana. 
Each unique number is freely estimated. Same numbers are constrained to be equal. For instance, the 
probability of responding “Yes” to the alcohol ever use item given membership in any of the A, AC, ACM, or 
ACIM latent stages is constrained to be equal. This constraint ensures that the meaning of the alcohol use 
item is held constant across latent stages. Estimates are also constrained to be equal for both time points 
(measurement invariance). 
Table 5.13 Constraints on τ Parameters for White Males, 7th–8th Grade  
 No Use A AC ACM ACIM 
No use FR FR FR FR FR 
A 0 FR FR FR FR 
AC 0 0 FR FR FR 
ACM 0 0 0 FR FR 
ACIM 0 0 0 0 FR 
Notes: A = alcohol only, AC = alcohol + cigarettes, ACIM = alcohol + cigarettes + inhalants + marijuana; FR = 
freely estimated; 0 = fixed to zero (not estimated). 
To ensure that the final model, with the applied constraints, is the proper solution for 
the five-stage model, the model was analyzed 100 separate times, using random start values. 
The originally identified five-stage model was the most frequently obtained result, with 56 
out of 100 analyses producing the same result. It also had easily the lowest (best) G2 of 
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584.85. Two alternate models also emerged, one with just three distinct stages that was 
obtained 43 times (G2 = 949.22) and an alternate five-stage model that was obtained just once 
(G2 = 1471.82).  
The assumption of measurement invariance was tested via a χ2 difference test for the 
difference between the model with the ρ parameters constrained to be equal (invariant) for 
both time points (G2 = 360.168, 233 df) and the model without the measurement invariance 
constraint (G2 = 344.918, 225 df). The difference of 15.25, with 8 degrees of freedom, is not 
significant (p = .055), supporting the decision to constrain measurement across times.  
Final model results, white males, 7th-8th grade.  
ρ parameters (model measurement). The final ρ parameter estimates and 95% 
confidence intervals for white males in the 7th–8th grade transition period are presented in 
Table 5.14. As with the model for the 6th–7th grade transition, the majority of ρ parameters 
are close to zero and one, suggesting good measurement. Inhalant use (.81) is more strongly 
measured in this model.  
Table 5.14 Final ρ Parameter Estimates for Response “Yes,” Five-Stage Model, 
White Males, 7th–8th Grade  
Item 
Latent Stage 










Ever used alcohol .03 (.01, .14) .87 (.85, .90) .87 (.85, .90) .87 (.85, .90) .87 (.85, .90)
Ever used cigarettes .05 (.03, .08) .05 (.03, .08) .87 (.84, .90) .87 (.84, .90) .87 (.84, .90)
Ever used inhalants .05 (.04, .07) .05 (.04, .07) .05 (.04, .07) .05 (.04, .07) .81 (.71, .88)
Ever used marijuana .01 (.00, .01) .01 (.00, .01) .01 (.00, .01) .69 (.62, .74) .69 (.62, .74)
Note: Point estimates and 95% confidence intervals based on data augmentation. 
δ parameters: probabilities of latent stage membership. Table 5.15 shows the 
estimated proportion of adolescents in each of the four latent substance use stages in 7th and 
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8th grades. The most common latent stage at 7th and 8th grades is the “no use” stage. 
However, prevalence of the “no use” stage decreases sharply from 7th to 8th grade, from 
36% to 26%. By 8th grade, the ACIM stage (19%) is nearly as prevalent as the AC stage 
(20%). The prevalence of ever using alcohol is estimated to be (.25 + .17 + .09 + .12) = 63% 
in 7th grade and (.22 + .20 + .13 + .19) = 74% in 8th grade. The prevalence of ever using 
cigarettes is also high: 38% in 7th grade and 52% in 8th grade. The prevalence of marijuana 
use at 7th and 8th grades (21% and 32%, respectively), arrived at by summing the estimates 
for the ACM and ACIM stages, is greater than the prevalence for inhalant ever use (12%, 
19%). The general tendency of transitioning out of the “no use” and “alcohol-only” stages 
into the AC, ACM, and ACIM stages is illustrated in Figure 5.3.  
Table 5.15 Final δ Parameter Estimates for Four-Stage Model, White Males, 7th–8th 
Grade  
Latent Stage 7th Grade 8th Grade 
No use .36  .26 
Alcohol .25  .22 
Alcohol + cigarettes .17  .20 
Alcohol + cigarettes + marijuana .09 .13 
Alcohol + cigarettes + inhalants + marijuana .12  .19 
Note: Values do not sum to 1 due to rounding error. 
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Note: N = no use; A = alcohol only; AC = alcohol + cigarettes; ACM = alcohol + cigarettes + marijuana; ACIM 
= alcohol + cigarettes + inhalants + marijuana. 
τ parameters: transition probabilities. The transition probability (τ) matrix is 
presented in Table 5.16. Entries along the diagonal reflect the probability of remaining in the 
same latent stage for both grades; for example, non-users in 7th grade have roughly a 73% 
chance of being in the non-user stage again in 8th grade, whereas individuals in the ACM 
stage in 7th grade are almost certain (97%) to remain in the same stage in 8th grade. This 
latter probability is evidence that marijuana use rarely, if ever, precedes inhalant use in this 
sample. The highest probability of transitioning to the ACIM stage is among individuals in 
the “alcohol + cigarette” (14%) stage, followed by those in the “alcohol only” (12%) stage. 
Notably, these individuals are far more likely to transition to the ACIM stage than to the 
ACM stage; individuals in the “alcohol only” stage in 7th grade have (.119/.008) 14.9 times 
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greater probability and individuals in the “alcohol + cigarette” stage have (.136/.065) 2.1 
times greater probability of transitioning to the ACIM stage versus the ACM stage. Figure 
5.4 displays the selected transition model representing gateway drug use sequencing among 
7th–8th grade white males.  
Table 5.16 τ Parameter Estimates, White Males, 7th–8th Grade 
Latent Stage in 
7th Grade 
Latent Stage in 8th Grade  
N A AC ACM ACIM 
Advance 
Rate 
No use (N) .727  
(.65, .80) 
.091 








































— — — — 1.00  
Overall advance 
rate 
     .200 
Notes:  The τ parameter estimates represent the probability of transitioning to the column “latent stage in 8th 
grade,” conditional on membership in the row “latent stage in 7th grade.” 
Dash (—) indicates that parameter was fixed to zero to represent the onset model. 
Point estimates and 95% confidence intervals based on data augmentation. 
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Figure 5.4 Final Five-Stage Model for White Males, 7th–8th Grade, with 
















These results are similar to those obtained for the 6th–7th grade sample, although for 
7th–8th graders, the addition of the ACM latent stage appears to be necessary. As was the 
case for the 6th to 7th grade transition, results suggest that the gateway model can be 
extended to include inhalants (Research Question 1). Based on these results, Hypotheses 1.1 
and 1.2 are rejected, as there is again no evidence that inhalant use precedes, or is a gateway 
to, alcohol, cigarette, or marijuana use for white males in the 7th–8th grade transition period.  
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5.2.2 White Females 
5.2.2.1 6th–7th Grade Transition 
Table 5.17 provides goodness-of-fit measures for various LTA models for white 
females transitioning from 6th to 7th grade. All of the G2 values are substantially smaller 
than the degrees of freedom, indicating good overall fit. A seven-stage model was estimated, 
but a review of the ρ parameters suggested that two of the seven latent stages were 
redundant, so it was excluded. The AIC and BIC estimates designate different models as 
having the best model fit, with the AIC favoring the six-stage model and the BIC favoring 
the four-stage model. Cross-validation results are similarly ambiguous; the five-stage model 
cross-validates best for one of the random samples, and the four-stage model was the better 
fit for the other sample.  
Table 5.17 Goodness-of-Fit for Various Models, White Females, 6th–7th Grade 





4 (N, A, AC, 
ACIM) 
119.66 (230) 169.66 273.16 510.314 125.811 
5 (N, A, C, AC, 
ACIM) 
99.41 (221) 167.41 308.17 102.182 238.859 
6 (N, A, C, AC, 
ACI, ACIM) 
77.05 (212) 163.05 341.07 343.126 141.211 
Notes: A = alcohol only; AC = alcohol + cigarettes; ACI = alcohol + cigarettes + inhalants; ACIM = alcohol + 
cigarettes + inhalants + marijuana; N = no use. 
N = 464.  
Model labels are based on the ρ parameters for the model. 
Seven-stage model included two redundant latent stages (only six unique latent stages). 
Given the lack of a clearly superior model based on the measures of relative fit, the ρ 
parameters for each model were examined to determine how well the latent stages are 
measured. In these baseline models, measurement is unconstrained: the ρ parameters are 
freely estimated (although the parameter estimates are held constant for both time periods). 
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Initial LTA estimates for the four- and five-stage models indicated that for the ACIM stage, 
measurement of the marijuana item was particularly weak; the item-response probability of a 
“yes” response was approximately .50 for the marijuana item, given membership in the 
ACIM latent stage. When a six-stage model was estimated, measurement was greatly 
improved. The lowest item-response probability in the six-stage model was .80. The 
probability of responding “yes” to each of the four drug use items, given membership in one 
of the six latent stages, is presented in Table 5.18.  
Table 5.18 Freely Estimated ρ Parameters for Response “Yes,” Six-Stage Model, 
White Females, 6th–7th Grade 
Item 
Latent Stage 











Ever used alcohol .02 1.00 .00 .82 1.00 1.00 
Ever used cigarettes .00 .00 .84 .96 .90 1.00 
Ever used inhalants .03 .05 .34 .00 .85 .80 
Ever used 
marijuana 
.00 .01 .05 .02 .00 1.00 
Note: ρ parameters are constrained equal for both time points, so the estimates are the same for both grades. 
The three models were analyzed using DA (with 100 imputations) to determine 
whether the ρ (Rho) parameter estimates were consistent across imputations. For the four-
stage model, the interpretation changed; the ACIM stage was relabeled ACI because of the 
low probability of a “yes” response to the marijuana item. The five-stage model was 
consistent, although the measurement of the marijuana item remained poor. The six-stage 
model was consistent across imputations, and the measurement remained strong for each of 
the six stages. The six-stage model identified here is identical to the model identified for the 
7th–8th grade sample (presented below), which provides some validation for the six-stage 
model here.  
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Although the relative measures of model fit failed to clearly delineate an optimal 
model, the six-stage model appears to provide a good representation of the data. It is 
consistent with the model obtained for the 7th–8th grade sample and is also consistent with 
the originally hypothesized model. Selection of this model allows for a direct assessment of 
the gateway relationship between inhalants, as part of the ACI latent stage, and marijuana, a 
component of the ACIM latent stage.  
For these reasons, the six-stage model was selected as the final model for white 
females transitioning from 6th to 7th grade. The stages represent “no drug use” (N), “alcohol 
only” (A), “cigarettes only” (C), “alcohol + cigarettes” (AC), “alcohol + cigarettes + 
inhalants” (ACI), and “alcohol + cigarettes + inhalants + marijuana” (ACIM).  
Based on these results, it appears that inhalants serve a more important role for white 
females than for white males. There is evidence that inhalant use may precede marijuana use 
for some white females transitioning from 6th to 7th grade. The presence of both an ACI and 
an ACIM stage means that the probability of transitioning from inhalant use to marijuana use 
can be directly assessed.  
Parameter constraints for the final model. To obtain final parameter estimates for 
the six-stage model and to ensure model identification, constraints were placed on the 
measurement (ρ) and transition (τ) matrices as described previously for the white male 
samples. Table 5.19 illustrates the constraints placed on the ρ parameters, and Table 5.20 
provides the parameter constraints for the τ matrix.  
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No use 2 7 11 15 
A 5 7 11 15 
C 2 9 11 15 
AC 5 9 11 15 
ACI 5 9 13 15 
ACIM 5 9 13 17 







No use 4 8 12 16 
A 6 8 12 16 
C 4 10 12 16 
AC 6 10 12 16 
ACI 6 10 14 16 
ACIM 6 10 14 18 
Notes: A = alcohol only; AC = alcohol + cigarettes; ACI = alcohol + cigarettes + inhalants; ACIM = 
alcohol + cigarettes + inhalants + marijuana; C = cigarettes. 
Each unique number is freely estimated. Same numbers are constrained to be equal. For instance, the 
probability of responding “Yes” to the alcohol ever use item given membership in any of the A, AC, 
ACI, or ACIM latent stages is constrained to be equal. This constraint ensures that the meaning of the 
alcohol use item is held constant across latent stages. Estimates are also constrained to be equal for both 
time points (measurement invariance). 
Table 5.20 Constraints on τ Parameters for White Females, 6th–7th Grade  
 No Use A C AC ACI ACIM 
No use FR FR FR FR FR FR 
A 0 FR 0 FR FR FR 
C 0 0 FR FR FR FR 
AC 0 0 0 FR FR FR 
ACI 0 0 0 0 FR FR 
ACIM 0 0 0 0 0 FR 
Note: A = alcohol; AC = alcohol + cigarettes; ACI = alcohol + cigarettes + inhalants; ACIM = alcohol + 
cigarettes + inhalants + marijuana; FR = freely estimated; 0 = fixed to zero (not estimated). 
To ensure that the final model, with the applied constraints, is the proper solution for 
the six-stage model, the model was analyzed 100 separate times, using random start values. 
The originally identified six-stage model was the most frequently obtained result, with 58 out 
of 100 analyses producing the same result. It also had the lowest (best) G2 of 219.60. Three 
alternate models also emerged, one with four distinct stages (N, A, C, AC) that was obtained 
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34 times (G2 = 425.97) and two alternate six-stage models. The first, obtained six times (G2 = 
452.60), included the stages N, A, C, AC, AI, and AIM. The second was obtained twice (G2 
= 594.48) and included the stages N, A, C, AC, CI, and CIM.  
The assumption of measurement invariance was tested via a χ2 difference test for the 
difference between the model with the ρ parameters constrained to be equal (invariant) for 
both time points (G2 = 109.049, 228 df) and the model without the measurement invariance 
constraint (G2 = 97.594, 220 df). The difference of 11.46, with 8 degrees of freedom, is not 
significant (p = .177), supporting the decision to constrain measurement across times.  
Final model results, white females, 6th–7th grade.  
ρ parameters (model measurement). The final ρ parameter estimates and 95% 
confidence intervals are presented in Table 5.21. In general, the measurement of the latent 
stages is strong. The probability of responding “yes” to the inhalant use item, given 
membership in the ACI or ACIM latent stage, is .76, which is the lowest probability but still 
sufficiently large to indicate accurate measurement.  
Table 5.21 Final ρ Parameter Estimates and 95% Confidence Intervals for Response 
“Yes,” Six-Stage Model, White Females, 6th–7th Grade  
Item 
Latent Stage 


































































Note: Point estimates and 95% confidence intervals based on data augmentation. 
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δ parameters: probabilities of latent stage membership. The estimated proportions of 
adolescents in each of the six latent substance use stages in 6th and 7th grades are presented 
in Table 5.22 and illustrated in Figure 5.5. In 6th grade, the majority of white females are 
estimated to be either non-users (61%) or to have tried only alcohol (21%). The estimated 
prevalence of never use in 7th grade is 37%, a sharp decrease from the 6th grade. 
Membership prevalence in all other stages, except “cigarettes only,” increases from 6th to 7th 
grade. The increase is most pronounced for the ACIM stage. At both grades, prevalence of 
inhalant use is greater than prevalence of marijuana use; in 6th grade, the prevalence of 
inhalant use is approximately 7% (.04 + .03) while the prevalence of marijuana use is 3%. By 
7th grade, these estimates increase to 19% (.07 + .12) and 12% for inhalant and marijuana 
use, respectively. This model suggested that the inclusion of a “cigarettes-only” stage was 
warranted. Prevalence in this stage is very low: only 3% at both grades.  
Table 5.22 Final δ Parameter Estimates for Six-Stage Model, White Females, 6th–
7th Grade  
Latent Stage 6th Grade 7th Grade 
No use .61  .37 
Alcohol .21 .25 
Cigarettes .03  .03 
Alcohol + cigarettes .09 .14 
Alcohol + cigarettes + inhalants .04  .07 
Alcohol + cigarettes + inhalants + marijuana .03 .12 
Note: Values do not sum to 1 due to rounding error. 
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Note: N = no use; A = alcohol only; C = cigarettes only; AC = alcohol + cigarettes; ACI = alcohol + cigarettes 
+ inhalants; ACIM = alcohol + cigarettes + inhalants + marijuana. 
τ parameters: transition probabilities. The τ matrix for white females transitioning 
from 6th to 7th grade is presented in Table 5.23, and the final six-stage transition model is 
illustrated in Figure 5.6. The overall probability of transitioning from one stage to a more 
advanced stage is .357. For non-users in 6th grade, the most common transition is to alcohol 
use, which is consistent with the literature on the gateway hypothesis and with the other 
samples in this study. 
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Table 5.23 τ Parameter Estimates, White Females, 6th–7th Grade 
Latent Stage 
in 6th Grade 
Latent Stage in 7th Grade  
N A C AC ACI ACIM 
Advance 
Rate 













Alcohol (A) — .671  
(.54, .78) 








































— —  — — 1.00  
Overall 
advance rate 
      .357 
Notes: The τ parameter estimates represent the probability of transitioning to the column “latent stage by 7th 
grade,” conditional on membership in the row “latent stage in 6th grade.” 
Dash (—) indicates that parameter was fixed to zero to represent the onset model. 
Point estimates and 95% confidence intervals based on data augmentation. 
Individuals in the alcohol-only stage in 6th grade are 2.3 times more likely to 
transition to the ACI stage than to the ACIM stage; individuals in the cigarettes-only stage in 
6th grade are 1.2 times more likely to transition to the ACI stage than to the ACIM stage. 
Conversely, individuals in the AC stage in 6th grade are 8.3 times more likely to transition to 
the ACIM stage than to the ACI stage in 7th grade.  
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Figure 5.6 Final Six-Stage Model for White Females, 6th–7th Grade, with 



















Inhalants are present in two of the six stages for white females transitioning from 6th 
to 7th grade, suggesting that the gateway drug use sequence can be extended to include 
inhalants for this group. The presence of both an ACI and an ACIM stage allows for an 
assessment of the transition probability from inhalant use in 6th grade to marijuana use in 7th 
grade. Individuals in the ACI stage in 6th grade had a .31 (31%) probability of transitioning 
to the ACIM stage by 7th grade. Given that there is no other stage that includes marijuana 
use, these results suggest that while the ever use of inhalants (in conjunction with alcohol and 
cigarette ever use) increases the probability of transitioning to marijuana use, there is no 
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evidence that marijuana use precedes or increases the likelihood of transitioning to inhalant 
use. 
These results therefore provide support for Hypothesis 1.1: inhalant use appears to 
precede marijuana use for a significant number of white female adolescents transitioning 
from the 6th to 7th grade. To examine Hypothesis 1.2, which posits that inhalants operate as 
a partial gateway to marijuana use, a series of equations, based on an operational definition 
of the gateway hypothesis, are tested in the following section. 
Is inhalant use a gateway to marijuana use for white females in 6th–7th grade? For 
a complete gateway relationship between inhalants and marijuana to exist, the probability of 
trying marijuana at Time 2, conditional on not having tried inhalants at Time 1, would equal 
zero; in other words, everyone who tries marijuana at Time 2 would have tried inhalants at 
Time 1. Additionally, the probability of trying marijuana at Time 2, conditional on having 
tried inhalants at Time 1, would be greater than zero, suggesting that inhalant use at Time 1 
has increased the probability of marijuana use at Time 2 (Maldonado-Molina, 2005). The 
first condition is not directly testable in this case because the only marijuana use stage also 
includes inhalants. So while the large, direct transition probabilities from the “cigarettes-
only” and “alcohol + cigarettes” stages to the ACIM stage suggests that inhalant use may not 
always precede marijuana use, it also appears that marijuana use is rarely, if ever, used 
without having also previously or concurrently used inhalants in this sample of white female 
adolescents.  
The absence of an ACM stage suggests that inhalants do always precede marijuana 
use for this sample; the direct AC to ACIM transition may exist because the transition from 
inhalants to marijuana use is obscured by the spacing of measurements in this analysis. In 
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other words, it is possible that all those in the ACIM stage first used inhalants, including 
those who appear to transition directly from the AC stage, but this not directly verifiable by 
these data. 
A partial gateway relationship between inhalants and marijuana exists if the risk for 
marijuana use is increased once inhalants are used, even if inhalant use does not universally 
precede marijuana use. Furthermore, evidence of a partial gateway relationship between 
inhalants and marijuana requires that having tried marijuana is not associated with an 
increased risk of inhalant use (Maldonado-Molina, 2005). The results indicate that using 
inhalants (ACI) in 6th grade is associated with a high (.309) probability of transitioning to 
marijuana use (ACIM) by 7th grade. Based on this model, there is no evidence that using 
marijuana in 6th grade increases the probability of using inhalants in 7th grade.  
A total of five equations are used to assess a complete gateway relationship. Because 
the complete gateway relationship has been eliminated as an option based on the final model 
selected, the final two equations (4 and 5) are tested to determine whether a partial gateway 
relationship exists:  
       ___ 
  Ρ(mart’|inht) > Ρ(mart’|inht)  Equation 4 
     ___ 
  Ρ(inht’|mart) < Ρ(inht’|mart)  Equation 5 
 
where   
Ρ(mart’|inht) is the probability of trying marijuana at a later time conditional on 
having tried inhalants at an earlier time, 
  ___ 
Ρ(mart’|inht) is the probability of trying marijuana at a later time conditional on not 
having tried inhalants at an earlier time,  
 
Ρ(inht’|mart) is the probability of trying inhalants at a later time conditional on having 




           ___ 
Ρ(inht’|mart) is the probability of trying inhalants at a later time conditional on not 
having tried marijuana at an earlier time. 
 
Equation 4 tests whether the probability of trying marijuana at a later time conditional 
on having tried inhalants at an earlier time is greater than the probability of trying marijuana 
at a later time conditional on not having tried inhalants at an earlier time. The first part of this 
equation was calculated by estimating the overall probability of membership in the stage that 
includes the use of marijuana (ACIM) in 7th grade, conditional on having used inhalants 
(ACI) in 6th grade.  
This estimate is derived by multiplying the conditional probability of transitioning 
from ACI to ACIM (.309) times the estimated proportion of the overall sample that has tried 
inhalants but not marijuana—those who were in the ACI stage at baseline (6th grade) as 
represented by the δ (latent stage membership) estimate for the ACI stage in 6th grade (.036). 
The resulting number represents the overall probability of transitioning from ACI to ACIM 
in this sample. In other words, 3.6% of the sample was estimated to be in the ACI stage at 6th 
grade. Of these, 30.9% were estimated to transition to the ACIM stage. This product (.036* 
.309 = 0.011) is then divided by the overall probability of using inhalants in 6th grade, which 
is the sum of the prevalence (δ) estimates for the ACI and the ACIM stages in 6th grade (.036 
+ .032 = .068); including this estimate in the equation accounts for the fact that some 
adolescents have used both inhalants and marijuana at 6th grade. So, (.036*.309)/.068 = .164.  
The second part of Equation 4 was estimated by calculating the probability of 
membership in the ACIM stage in 7th grade, conditional on membership in all of the stages 
except the ACI stage. This involves multiplying each of the transition probabilities from 
stages that do not include inhalants (N, A, C, AC) to marijuana (ACIM) by the baseline 
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probability (δ) of being in each of those respective stages. So, N (.606 * .058) + A (.206 * 
.067) + C (.028 * .163) + AC (.092 * .298) = .081. This number is then divided by the 
probability of not using inhalants in 6th grade (1 – 0.068 = .932). So, .081/.932 = .087. Based 
on the results for Equation 4 (.164 > .087), there is evidence to suggest a partial gateway 
relationship between inhalants and marijuana, direct support for Hypothesis 1.2.  
Equation 5 does not need to be estimated in this case—there is no evidence that 
marijuana use precedes inhalant use in this sample, and therefore no stages are present in the 
model to facilitate testing Equation 5. The probability of using inhalants at 7th grade, 
conditional on having used marijuana at 6th grade equals zero and is clearly less than the 
probability of transitioning to inhalant use at 7th grade conditional on not using marijuana at 
6th grade (which is the sum of the transition probabilities from the N, A, C, and AC stages to 
the ACI and the ACIM stages).  
 
5.2.2 7th–8th Grade Transition 
Table 5.24 presents goodness-of-fit measures for various LTA models for white 
females transitioning from 7th to 8th grade. This is the one instance in the overall study 
where a clearly superior model, based on overall and relative fit measures and on the 
measurement properties of the model, is selected. Both the AIC and BIC suggest that the six-
stage model provides the best fit to the data; the additional step of cross-validation was not 
taken because of the clear superiority of this model. The G2 value is substantially smaller 
than the degrees of freedom, which is unique among the four 7th–8th grade samples. The 
stages were easily identifiable and well-measured and are the same as those identified for the 
6th–7th grade white female sample: “no drug use” (N), “alcohol only” (A), “cigarettes only” 
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(C), “alcohol + cigarettes” (AC), “alcohol + cigarettes + inhalants” (ACI), and “alcohol + 
cigarettes + inhalants + marijuana” (ACIM).  
Table 5.24 Goodness-of-Fit for Various Models, White Females, 7th–8th Grade 
Model G2 (df) AIC BIC 
4 (N, A, AC, ACIM) 255.99 (230) 305.99 427.51 
5 (N, A, C, AC, ACIM) 216.64 (222) 282.64 443.04 
6 (N, A, C, AC, ACI, ACIM) 135.04 (212) 217.04 416.33 
Notes: A = alcohol; AC = alcohol + cigarettes; ACIM = alcohol + cigarettes + inhalants + marijuana; ACM = 
alcohol + cigarettes + marijuana; AIC = alcohol + inhalants + cigarettes; C = cigarettes; N = no use. 
N = 954. 
Model labels are based on the ρ parameters for the model. 
Cross-validation was not performed because of the clear superiority of the six-stage model. 
Seven-stage model included two redundant latent stages (only six unique latent stages). 
For the six-stage model, the probability of responding “yes” to each of the four drug 
use items, given membership in one of the four stages, is presented in Table 5.25. When this 
six-stage model was analyzed using DA (with 100 imputations), the ρ (Rho) parameter 
estimates suggested consistent measurement of the six latent stages across imputations. 
Table 5.25 Freely Estimated ρ Parameters for Response “Yes,” Six-Stage Model, 
White Females, 7th–8th Grade  
Item 
Latent Stage 











Ever used alcohol .00 .88 .32 1.00 .92 1.00 
Ever used cigarettes .01 .05 .95 1.00 .82 1.00 
Ever used inhalants .02 .02 .09 .07 .96 .59 
Ever used marijuana .00 .00 .08 .05 .26 .96 
Note: ρ parameters are constrained equal for both time points, so the estimates are the same for both grades. 
As discussed for the 6th–7th grade sample, the selected model allows for an 
examination of the potential partial gateway relationship between inhalant use and marijuana 
use. These preliminary results suggest that inhalants may play an important role in drug use 
sequencing for the females in this study.  
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Parameter constraints for the final model. To obtain final parameter estimates for 
the six-stage model and to ensure model identification, constraints were placed on the 
measurement (ρ) and transition (τ) matrices in the same way as for the 6th–7th grade model. 
Table 5.26 illustrates the constraints placed on the ρ parameters, and Table 5.27 provides the 
parameter constraints for the τ matrix.  



















No Use 2 7 11 15 
A 5 7 11 15 
C 2 9 11 15 
AC 5 9 11 15 
ACI 5 9 13 15 
ACIM 5 9 13 17 







No Use 4 8 12 16 
A 6 8 12 16 
C 4 10 12 16 
AC 6 10 12 16 
ACI 6 10 14 16 
ACIM 6 10 14 18 
Notes: A = alcohol only, AC = alcohol + cigarettes, ACIM = alcohol + cigarettes + inhalants + marijuana. 
Each unique number is freely estimated. Same numbers are constrained to be equal. For instance, the 
probability of responding “Yes” to the alcohol ever use item given membership in any of the A, AC, ACI, or 
ACIM latent stages is constrained to be equal. This constraint ensures that the meaning of the alcohol use 
item is held constant across latent stages. Estimates are also constrained to be equal for both time points 
(measurement invariance). 
Table 5.27 Constraints on τ Parameters for White Females, 7th–8th Grade  
 No Use A C AC ACI ACIM 
No use FR FR FR FR FR FR 
A 0 FR 0 FR FR FR 
C 0 0 FR FR FR FR 
AC 0 0 0 FR FR FR 
ACI 0 0 0 0 FR FR 
ACIM 0 0 0 0 0 FR 
Notes: A = alcohol; AC = alcohol + cigarettes; ACI = alcohol + cigarettes + inhalants; ACIM = alcohol + 
cigarettes + inhalants + marijuana; FR = freely estimated; 0 = fixed to zero (not estimated) 
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To ensure that the final model, with the applied constraints, is the proper solution for 
the six-stage model, the model was analyzed 100 separate times, using random start values. 
The selected six-stage model was the most frequently obtained result, with 55 out of 100 
analyses producing the same result, and had the lowest (best) G2 of 648.25. Four alternate 
models also emerged. The second most frequently derived model (36 times) included just 
four latent stages: “no use,” “alcohol only,” “cigarettes only,” and “alcohol + cigarettes.” The 
G2 for this model was 1,009.25. The three remaining models had G2 values of 1,106.99  
(7 times), 1,347.39 (1 time), and 1563.98 (1 time). As both the most frequently obtained and 
best fitting model, the selected six-stage model is retained for final parameter estimation.  
The assumption of measurement invariance was tested via a χ2 difference test for the 
difference between the model with the ρ parameters constrained to be equal (invariant) for 
both time points (G2 = 188.020, 228 df) and the model without the measurement invariance 
constraint (G2 = 183.444, 220 df). The difference of 4.58, with 8 degrees of freedom, is not 
significant (p = .802), supporting the decision to constrain measurement across times.  
Final model results, white females, 7th–8th grade. 
ρ parameters (model measurement). The final ρ parameter estimates and 95% 
confidence intervals are presented in Table 5.28. Measurement is strong across the latent 
stages, although the inhalant use item is less well measured (as is the case for the other 
samples as well). Reviewing the original freely estimated ρ parameters (see Table 5.25), 
membership in the ACI stage is associated with a very high probability of responding yes to 
the inhalant use item (.96) while membership in the ACIM stage is associated with a .59 
probability of responding yes to the inhalant use item. With the constraints, the interpretation 
of the ρ parameters for inhalants is as follows: given membership in one of the latent stages  
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Table 5.28 Final ρ Parameter Estimates for Response “Yes,” Six-Stage Model, White 
Females, 7th–8th Grade  
Item 
Latent Stage 


































































Note: Point estimates and 95% confidence intervals based on data augmentation. 
that include inhalants (ACI and ACIM), the probability of responding “yes” to the inhalant 
use item is .64. 
δ parameters: probabilities of latent stage membership. Table 5.29 and Figure 5.7 
show the estimated proportion of adolescents in each of the six latent substance use stages in 
7th and 8th grades. In 7th grade, 41% of the white females in the sample are expected to be 
in the “no use” latent stage, while one-quarter are expected to be in the alcohol-only stage. 
Based on this model, at baseline (7th grade), the overall estimated prevalence is 16% for 
inhalant use and 9% for marijuana use. Both the ACI and ACIM stages increase in 
prevalence from 7th to 8th grade.  
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Table 5.29 Final δ Parameter Estimates for Six-Stage Model, White Females, 7th–
8th Grade  
Latent Stage 7th Grade 8th Grade 
No use .41 .30 
Alcohol .24 .25 
Cigarettes .03 .01 
Alcohol + cigarettes .15 .17 
Alcohol + cigarettes + inhalants .07 .09 
Alcohol + cigarettes + inhalants + marijuana .09 .18 
Note: Values do not sum to 1 due to rounding error. 

















Note: N = no use; A = alcohol only; C = cigarettes only; AC = alcohol + cigarettes; ACI = alcohol + cigarettes 
+ inhalants; ACIM = alcohol + cigarettes + inhalants + marijuana. 
τ parameters: transition probabilities. The τ parameters express the probability of 
transitioning from one latent stage to another between grade 7 and grade 8. The τ matrix is 
presented in Table 5.30, and the six-stage transition model is illustrated in Figure 5.8. 
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Table 5.30 τ Parameter Estimates, White Females, 7th–8th Grade 
Latent Stage 
in 7th grade 
Latent Stage in 8th grade Advance 
Rate N A C AC ACI ACIM 













Alcohol (A) — .743  
(.66, .81)












































      .253 
Notes: The τ parameter estimates represent the probability of transitioning to the column “latent stage in 8th 
grade,” conditional on membership in the row latent stage in 7th grade. 
Dash (—) indicates that parameter was fixed to zero to represent the onset model. 
Point estimates and 95% confidence intervals based on data augmentation. 
These results indicate that transitions from any of the latent stages to inhalant use 
(ACI) are relatively small for the 7th–8th grade sample, suggesting that a majority of the 
individuals in the ACI stage were in it prior to this transition period. Individuals in the 
“cigarettes-only” and “alcohol + cigarettes” stages have relatively high probabilities of 
transitioning to the ACIM stage by the 8th grade: 26% and 30%, respectively. The transition 
from ACI to ACIM is moderately large (.174) but not as large as the transition in the 6th–7th 
grade model.  
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Figure 5.8 Final Six-Stage Model for White Females, 7th–8th Grade, with 




















The same latent transition model identified for white females transitioning from 6th to 
7th grade is found here for the 7th to 8th grade transition. Again, inhalants are present in two 
of the six stages for white females transitioning from 6th to 7th grade, suggesting that the 
gateway drug use sequence can be extended to include inhalants for this group. Individuals in 
the ACI stage in 7th grade had a .17 (17%) probability of transitioning to the ACIM stage by 
8th grade, a lower probability than for the earlier transition (.31) but still significant. Given 
that there is no other stage that includes marijuana use, these results suggest that while the 
ever use of inhalants (in conjunction with alcohol and cigarette ever use) increases the 
probability of transitioning to marijuana use, there is no evidence that marijuana use precedes 
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or increases the likelihood of transitioning to inhalant use, thus providing evidence in support 
of Hypothesis 1.1. 
Is inhalant use a gateway to marijuana use for white females in 7th–8th grade? 
The presence of an ACI stage and the absence of an ACM stage again suggest that 
inhalant use precedes marijuana use for white females. Using the same equations described 
for white females in the 6th–7th grade sample, it is possible to formally assess whether 
inhalant use in 7th grade is a partial gateway to marijuana use in the 8th grade. This involves 
testing whether the probability of using marijuana in 8th grade conditional on having used 
inhalants in 7th grade is greater than the probability of using marijuana in 8th grade 
conditional on not having used inhalants in 7th grade. The first step was to estimate the 
probability of membership in the stage that includes the use of marijuana (ACIM) in 8th 
grade, conditional on having used inhalants (ACI) in 7th grade (.073 * .174), divided by the 
probability of using inhalants in 6th grade (.165). So, (.073*.174)/.165 = .077.  
The second step was to calculate the probability of membership in the ACIM stage in 
8th grade, conditional on membership in all of the stages except the ACI stage. So, N(.410 * 
.030) + A (.244 * .073) + C (.028 * .259) + AC (.154 * .297) = .083, divided by the 
probability of not using inhalants in 6th grade (.835). So, .083/.835 = .099.  
Comparing these two estimates as described in Equation 4 (.077 < .099), it appears 
that while inhalant use is associated with an increased probability of transitioning to 
marijuana use, there is not evidence to support the hypothesis (1.2) that there is a partial 
gateway relationship between inhalants and marijuana, given the criteria used in this study.  
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5.2.3 African American Males 
5.2.3.1 6th–7th Grade Transition 
Table 5.31 provides goodness-of-fit measures for various LTA models for African 
American males transitioning from 6th to 7th grade. A three-stage model was included 
because of the instability of the estimates for the other models, which suggested an even 
more parsimonious model was needed. It is interesting to note that all of the models include a 
stage that was not present for the other samples: “Cigarettes + Marijuana.” Also, inhalants do 
not appear in any of the stages for any of the tested models. 
Table 5.31 Goodness-of-Fit for Various Models, African American Males, 6th–7th 
Grade 





3 (N, AC, ACM) 200.66 (238) 234.66 300.86 243.981 172.343 
4 (N, AC, CM, 
ACM) 
173.68 (232) 219.68 310.62 240.787 171.441 
5 (N, C, AC, CM, 
ACM) 
150.58 (222) 216.58 345.09 248.790 165.185 
6 (N, A, C, AC, 
CM, ACM) 
131.08 (213) 213.08 372.75 249.606 179.826 
Notes: A = alcohol only, AC = alcohol + cigarettes, ACM = alcohol + cigarettes + marijuana; C = cigarettes;  
N = no use. 
N = 363. 
Model labels are based on the ρ parameters for the model. 
As a general rule, G2 values that are less than the degrees of freedom suggest a good 
overall fit. In this case, all of the models appear to fit the data well. The AIC identifies the 
six-stage model as best-fitting, whereas the BIC favors the three-stage model. The four-stage 
model has the lowest cross-validation G2 for one of the random split samples, whereas the 
five-stage model is lower for the other. Clearly, a good deal of ambiguity is present, and 
selection of the model requires an examination of the measurement properties and 
consistency.  
145 
When freely estimated (no constraints), the ρ parameters for the three-stage model 
indicate that it has the best measurement of the candidate models. These estimates are 
presented in Table 5.32. The latent stage labels are based on the pattern of ρ estimates.  
Table 5.32 Freely Estimated ρ Parameters for Response “Yes,” Four-Stage Model, 









Ever used alcohol .13 .77 .74 
Ever used cigarettes .07 .68 .92 
Ever used inhalants .04 .16 .36 
Ever used marijuana .02 .11 1.00 
Note: ρ parameters are constrained equal for both time points, so the estimates are the same for both grades. 
Measurement of the latent stages for the other models (four-, five-, and six-stage 
models) indicated that measurement of certain latent stages was not strong, although the 
stages were clearly identifiable and not redundant. To examine how consistent these 
estimates were, DA was conducted with 100 imputations. The results of these runs provided 
support for the three-stage model. The ρ (Rho) parameter estimates across the imputed data 
sets for the three-stage model suggest that the measurement of the three latent stages is 
consistent across imputations; that is, the same three stages are present, and the measurement 
quality is similar to that obtained in the original LTA.  
The more complex models were unstable across the imputed data sets. In fact, for 
each model, the same three stages are the only ones that remain clearly identifiable across the 
imputed data sets. Despite initial evidence that additional stages may be warranted, the data 
appear to only support three stages that are stable. Based on this collection of evidence, for 
African American males transitioning from 6th to 7th grade, the three-stage model was 
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selected as the final model. The stages represent “no drug use” (N), “alcohol + cigarettes” 
(AC), and “alcohol, cigarettes, and marijuana” (ACM).  
These preliminary results suggest that for African American males transitioning from 
6th to 7th grade in this sample, the gateway drug use model cannot be expanded to include 
inhalants. Indeed, although there are clearly African American males who have used 
inhalants in this sample (based on descriptive frequencies presented in Table 4.5), the 
proportion appears to be so low, and/or the consistency of reporting inhalant use so poor, that 
inhalants are excluded from the models. The results do suggest a potential “new” stage 
(“Cigarettes + Marijuana”) although unstable estimates favored a more parsimonious, three-
stage model. 
Parameter Constraints for the Final Model. To obtain final parameter estimates for 
the three-stage model and to ensure model identification, constraints were placed on the 
measurement (ρ) and transition (τ) matrices. Table 5.33 illustrates the constraints placed on 
the ρ parameters. The matrix is constrained so that the probability of responding “yes” and 
the probability of responding “no” to a drug use item, conditional on latent stage 
membership, is estimated. In this case, a total of 14 parameters are estimated, as opposed to a 
total possible number of 48 (24 x 2 time points) parameters. 
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Probability of responding 
“no” given latent stage 
membership 
No use 2 7 11 15 
AC 5 9 11 15 
ACM 5 9 11 17 
      
Probability of responding 
“yes” given latent stage 
membership 
No use 4 8 12 16 
AC 6 10 12 16 
ACM 6 10 12 18 
Note: AC = alcohol + cigarettes; ACM = alcohol + cigarettes + marijuana.  
Each unique number is freely estimated. Same numbers are constrained to be equal. For instance, the 
probability of responding “Yes” to the alcohol ever use item given membership in either the A or ACM latent 
stage is constrained to be equal. This constraint ensures that the meaning of the alcohol use item is held 
constant across latent stages. Estimates are also constrained to be equal for both time points (measurement 
invariance). 
The transition matrix (τ) (Table 5.34) reflects the fact that this is an onset (ever-use) 
model. In this case, an individual is free to progress to a later drug use stage but cannot revert 
to an earlier stage (e.g., someone who reported ever using alcohol at Time 1 cannot be in the 
“no use” stage at Time 2). Based on the gateway hypothesis, it is assumed that while an 
individual can transition from “no use” to one of the more advanced stages, the probability of 
transitioning will be greater for those who have tried alcohol or alcohol and cigarettes. 
Table 5.34 Constraints on τ parameters for African American Males, 6th–7th Grade  
 No Use AC ACM 
No use FR FR FR 
AC 0 FR FR 
ACM 0 0 FR 
Notes: AC = alcohol + cigarettes; ACM = alcohol + cigarettes + marijuana; FR = freely estimated; 0 = fixed to 
zero (not estimated). 
To ensure that the final model, with the applied constraints, is the proper solution for 
the three-class model, the model was analyzed 100 separate times, using random start values. 
Two models emerged: the selected three-stage model and an alternate two-stage model (N + 
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AC). The three-stage model was the most frequent solution; 63 of the 100 analyses supported 
the three-stage model. Additionally, the G2 associated with the three-stage model (291.48) 
was lower than the G2 associated with the two-stage model (305.90). 
The assumption of measurement invariance was tested via a χ2 difference test for the 
difference between the model with the ρ parameters constrained to be equal (invariant) for 
both time points (G2 = 257.423, 243 df) and the model without the measurement invariance 
constraint (G2 = 243.200, 236 df). The difference of 14.223, with 7 degrees of freedom, is not 
significant (p = .0572), supporting the decision to constrain measurement across times.  
Final model results, African American males, 6th–7th grade.  
To obtain final parameter estimates and standard errors, DA was conducted. Whereas 
DA was used earlier to assess the stability of the unconstrained model across 100 imputed 
data sets, here DA was applied to the final constrained model, and the results were combined 
to generate final parameter estimates that take into account the uncertainty present across the 
imputed data sets.  
ρ parameters (model measurement). The final ρ parameter estimates, specifically the 
probability of responding “yes” to each item, along with 95% confidence intervals, are 
presented in Table 5.35. The values were constrained to be equal across time (measurement 
invariance), so the ρ parameters are the same for both time points. To achieve identification 
and model stability, additional constraints were imposed such that only two parameters are 
estimated for each item; the probability of responding “no” can be obtained by subtracting 
the parameters in Table 5.35 from 1.00. 
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Table 5.35 Final ρ Parameter Estimates for Response “Yes,” Four-Stage Model, 









Ever used alcohol .21 (.17, .27) .77 (.69, .83) .77 (.69, .83) 
Ever used cigarettes .08 (.04, .14) .88 (.78, .94) .88 (.78, .94) 
Ever used inhalants .13 (.10, .15) .13 (.10.15) .13 (.10.15) 
Ever used marijuana .04 (.02, .07) .04 (.02, .07) .84 (.54, .97) 
Note: Point estimate and 95% confidence intervals based on data augmentation.  
Most of the parameter estimates are near 0 and 1, indicating that the latent variable 
“substance use” is being measured accurately. For instance, the probability of responding 
“yes” to the alcohol item given membership in one of the two alcohol use stages is .77 (95% 
CI: .69, .83). This estimate is lower than estimates for the alcohol item found in the other 
samples but is still indicative of positive measurement. The probability of responding “yes” 
to the inhalant item, despite the fact that none of the latent stages include inhalants, is .13—
larger than similar estimates from the other samples and indicative of the measurement error 
associated with the fact that respondents who responded “yes” to the inhalant item are not 
placed in a latent stage; they are treated as measurement error.  
δ parameters: probabilities of latent stage membership. Table 5.36 presents the 
estimated proportion of adolescents in each of the four latent substance use stages in 6th and 
7th grades. These estimates are illustrated in Figure 5.9. In 6th grade, nearly 70% of the 
African American males in the sample are expected to be in the “no use” latent stage. 
Membership in the AC stage is more prevalent than in the ACM stage in 6th grade, but this is 
reversed in 7th grade when 26% are estimated to be in the ACM stage and 22% in the AC 
stage.  
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Table 5.36 Final δ Parameter Estimates for Three-Stage Model, African American 
Males, 6th–7th Grade  
Latent Stage 6th Grade 7th Grade 
No use .69  .52 
Alcohol + cigarettes .19  .22 
Alcohol + cigarettes + marijuana .12  .26 
 















τ parameters: transition probabilities. The τ parameters express the probability of 
transitioning from one latent stage to another between grade 6 and grade 7. The τ matrix is 
presented in Table 5.37. 
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Table 5.37 τ Parameter Estimates, African American Males, 6th–7th Grade 
 Latent Stage in 7th Grade Advance 
Rate Latent Stage in 6th Grade N AC ACM 












Alcohol + cigarettes + marijuana (ACM) — — 1.0  
Overall advance rate    .259 
Notes: The τ parameter estimates represent the probability of transitioning to the column “latent stage in 7th 
grade,” conditional on membership in the row “latent stage in 6th grade.” 
Dash (—) indicates that parameter was fixed to zero to represent the onset model. 
Point estimate and 95% confidence intervals based on data augmentation. 
An estimated 74.5% of African American males remain in the “no use” stage between 
6th and 7th grade. Among those who transition out, 16% transition to the AC stage and 9.5% 
transition to the ACM stage. The transition probability from AC in 6th grade to ACM in 7th 
grade is very large: 43% of those in the AC stage in 6th grade are estimated to transition to 
marijuana use by the 7th grade.  
Figure 5.10 Final Three-Stage Model for African American Males, 6th–7th Grade, 











A three-stage model was stable and provided a good overall fit (G2 value less than the 
degrees of freedom) for African American males transitioning from 6th to 7th grade. This 
model does not include any stages where inhalant is present, suggesting that the gateway 
drug use sequence cannot be extended to include inhalants for this group.  
5.2.3.2 7th–8th Grade Transition 
Table 5.38 presents goodness-of-fit measures for various LTA models for African 
American males transitioning from 7th to 8th grade. Unlike the 6th–7th grade sample, all of 
the G2 values are larger than the degrees of freedom, evidence that none of the models appear 
to fit the data especially well. A seven-stage model was estimated, but a review of the ρ 
parameters suggested that two of the seven latent stages were redundant, so it is excluded. 
The stages present in the four-, five-, and six-stage models are very similar to those identified 
for African American males in the 6th–7th grade sample. 
 Table 5.38 Goodness-of-Fit for Various Models, African American Males, 7th–8th 
Grade 







4 (N, AC, CM, ACM) 379.84 
(231) 
427.84 537.17 279.615 301.432 




390.89 541.21 306.824 305.015 




352.00 543.32 238.503 276.855 
Notes: A = alcohol only, AC = alcohol + cigarettes, ACIM = alcohol + cigarettes + inhalants + marijuana; ACM 
= alcohol + cigarettes + marijuana; N = no use. 
N = 703. 
Model labels are based on the ρ parameters for the model. 
Seven-stage model included two redundant latent stages (only six unique latent stages). 
The AIC and BIC estimates designate different models as having the best model fit, 
with AIC favoring the six-stage model and BIC favoring the four-stage model. Cross-
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validation results support the six-stage model, as it has the lowest cross-validation G2 for 
both random samples.  
The ρ parameters for each model were examined to determine how well the latent 
stages are measured. In these baseline models, measurement is unconstrained: the ρ 
parameters are freely estimated (although the parameter estimates are held constant for both 
periods). Initial LTA estimates for the four-, five-, and six-stage models indicate generally 
strong measurement of the latent stages, with measurement for the six-stage model appearing 
to be the strongest; each of the stages is clearly distinguishable, and the ρ estimates are all 
close to 0 and 1. For the six-stage model, the probability of responding “yes” to each of the 
four drug use items, given membership in one of the four stages, is presented in Table 5.39.  
Table 5.39 Freely Estimated ρ Parameters for Response “Yes,” Six-Stage Model, 
















Ever used alcohol .08 .83 .72 .36 1.00 .80 
Ever used cigarettes .06 .14 .95 .58 .96 .87 
Ever used inhalants .01 .20 .03 .23 .10 1.00 
Ever used 
marijuana 
.00 .08 .00 .80 .92 .65 
Note: ρ parameters are constrained equal for both time points, so the estimates are the same for both grades. 
When the six-stage model was analyzed using DA (with 100 imputations), the ρ 
(Rho) parameter estimates and identified stages were consistent across imputations. Given 
that the six-stage model appears to have the best relative fit (based on the AIC, and the two 
cross-validation G2s) and because the measurement appears to be strong and consistent, it 
was selected as the final model for African American males transitioning from 7th to 8th 
grade. The stages represent “no drug use” (N), “alcohol only” (A), “alcohol + cigarettes” 
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(AC), “cigarettes + marijuana (CM), “alcohol + cigarettes + marijuana” (ACM), and “alcohol 
+ cigarettes + inhalants + marijuana” (ACIM).  
These preliminary results suggest a relatively important role for marijuana in this 
sample. The presence of the CM stage, hinted at for the 6th–7th grade sample and confirmed 
here, is not a typical stage described in the literature on the gateway hypothesis and is an 
important distinction between this sample and the other race/gender samples. Unlike the 6th–
7th grade sample, there is evidence to suggest that the gateway model for African American 
males in 7th–8th grade can be expanded to include inhalants (based on the presence of an 
ACIM stage); but there is no evidence to suggest that inhalant use precedes, or is a gateway 
to, alcohol, cigarette, or marijuana use for African American males in the 7th–8th grade 
transition period.  
Parameter Constraints for the Final Model. To obtain final parameter estimates for 
the six-stage model and to ensure model identification, constraints were placed on the 
measurement (ρ) and transition (τ) matrices. Table 5.40 presents the constraints placed on the 
ρ parameters, and Table 5.41 presents the parameter constraints for the τ matrix.  
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Probability of responding 
“no” given latent stage 
membership 
No use 2 7 11 15 
A 5 7 11 15 
AC 5 9 11 15 
CM 2 9 11 17 
ACM 5 9 11 17 
ACIM 5 9 13 17 
      
Probability of responding 
“yes” given latent stage 
membership 
No use 4 8 12 16 
A 6 8 12 16 
AC 6 10 12 16 
CM 4 10 12 18 
ACM 6 10 12 18 
ACIM 6 10 14 18 
Notes: A = alcohol; AC = alcohol + cigarettes; ACM = alcohol + cigarettes + marijuana; ACM = alcohol + 
cigarettes + inhalants + marijuana; CM = cigarettes + marijuana. 
Each unique number is freely estimated. Same numbers are constrained to be equal. For instance, the 
probability of responding “yes” to the alcohol ever use item given membership in any of the A, AC, ACM, or 
ACIM latent stages is constrained to be equal. This constraint ensures that the meaning of the alcohol use 
item is held constant across latent stages. Estimates are also constrained to be equal for both time points 
(measurement invariance). 
Table 5.41 Constraints on τ Parameters for African American Males, 7th–8th Grade  
 No Use A AC CM ACM ACIM 
No use FR FR FR FR FR FR 
A 0 FR FR 0 FR FR 
AC 0 0 FR 0 FR FR 
CM 0 0 0 FR FR FR 
ACM 0 0 0 0 FR FR 
ACIM 0 0 0 0 0 FR 
Notes: A = alcohol; AC = alcohol + cigarettes; ACM = alcohol + cigarettes + marijuana; ACM = alcohol + 
cigarettes + inhalants + marijuana; CM = cigarettes + marijuana; 0 = fixed to zero (not estimated). 
To ensure that the final model, with the applied constraints, is the proper solution for 
the six-stage model, the model was analyzed 100 separate times, using random start values. 
The originally identified six-stage model was the most frequently obtained result, with 42 out 
of 100 analyses producing the same result. There were four alternate solutions. The original 
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solution did not have the lowest (best) G2 (612.29). An alternate model with just four stages 
(N, A, C, AC) had a lower G2 (599.69) and was the solution 30 times. There is significant 
inconsistency in this model, as evidenced by the fact that fewer than 50% of the models 
converged to the original solution, an alternate model had a lower G2, and there were four 
alternate models estimated. Although as the most commonly derived model (and the model 
most consistent with the study hypotheses) the six-stage model is selected, interpretation of 
the results should be particularly cautious given these findings.  
The assumption of measurement invariance was tested via a χ2 difference test for the 
difference between the model with the ρ parameters constrained to be equal (invariant) for 
both time points (G2 = 383.934, 229 df) and the model without the measurement invariance 
constraint (G2 = 367.57, 221 df). The difference of 16.364, with 8 degrees of freedom, is 
significant (p = .0375), suggesting that the measurement invariance constraint is not 
supported by the data. However, although the ρ parameter estimates are generally weaker 
(closer to .50) in 8th grade, the same six stages are still interpretable. The measurement 
invariance constraint aids the interpretation of the results, so despite evidence that this 
assumption may be violated, the constrained model is retained.  
Final model results, African American males, 7th–8th grade. 
ρ parameters (model measurement). The final ρ parameter estimates and 95% 
confidence intervals are presented in Table 5.42. Overall measurement is modestly strong—
all of the estimates are near .80, indicating that latent stage membership is predictive of 
responses to the drug use items.  
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Table 5.42 Final ρ Parameter Estimates for Response “Yes,” Six-Stage Model, 







































































 (.70, .84) 
Note: Point estimates and 95% confidence intervals based on data augmentation. 
δ parameters: probabilities of latent stage membership. Table 5.43 and Figure 5.11 
show the estimated proportion of African American male adolescents in each of the six latent 
substance use stages in 7th and 8th grades. Notable is the finding that prevalence for the 
“Alcohol + Cigarettes + Marijuana” (ACM) stage is second only to the “no use” stage in 7th 
and 8th grades. By 8th grade, 26% of the sample is expected to be in the ACM stage.  
Table 5.43 Final δ Parameter Estimates for Six-Stage Model, African American 
Males, 7th–8th Grade  
Latent Stage 7th Grade 8th Grade 
No use .45 .37 
Alcohol .08 .07 
Alcohol + cigarettes .17 .14 
Cigarettes + marijuana .03 .03 
Alcohol + cigarettes + marijuana .18 .26 
Alcohol + cigarettes + inhalants + marijuana .10 .13 
Note: Values do not sum to 1 due to rounding error. 
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τ parameters: transition probabilities. The τ parameters express the probability of 
transitioning from one latent stage to another between grade 7 and grade 8. The τ matrix is 
presented in Table 5.44, and the final six-stage model is presented in Figure 5.12. In general, 
transitioning to a more advanced stage is rare in this sample: 84.7% remain in the same stage 
from 7th to 8th grade. Respondents in the “Alcohol + Cigarettes” stage in 7th grade appear to 
be substantially more likely than others to transition to a more advanced stage by 8th grade; 
22.9% transition to the ACM stage. Very few African American males in this sample 
transition to inhalant use (ACIM). 
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Table 5.44 τ Parameter Estimates, African American Males, 7th–8th Grade 
Latent Stage in 
7th Grade 
Latent Stage in 8th Grade Advance 
Rate N A AC CM ACM ACIM 

























— — .695 
(.49, .85)





























— —  — — 1.00  
Overall advance 
rate 
      .153 
Notes: The τ parameter estimates represent the probability of transitioning to the column “latent stage in 8th 
grade,” conditional on membership in the row “latent stage in 7th grade.” 
Dash (—) indicates that parameter was fixed to zero to represent the onset model. 
Point estimates and 95% confidence intervals based on data augmentation. 
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Figure 5.12 Final Six-Stage Model for African American Males, 7th–8th Grade, with 




















Unlike the results for the 6th to 7th grade transition, for African American males 
transitioning from 7th to 8th grade, there is evidence to suggest that the gateway drug use 
sequence can be extended to include inhalants. The lone stage including inhalants (ACIM) 
suggests that, for this sample, inhalant use only occurs in conjunction with other gateway 
drug use. There is no evidence that inhalant use precedes marijuana use (Hypothesis 1.1) or 
by extension that inhalants serve as a partial gateway to marijuana use (Hypothesis 1.2). 
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5.2.4 African American Females 
5.2.4.1 6th–7th Grade Transition 
Table 5.45 presents goodness-of-fit measures for various LTA models for African 
American females transitioning from 6th to 7th grade. All of the models have G2 values that 
are less than the degrees of freedom, suggesting a good overall fit. In this case, all of the 
models appear to fit the data well. The AIC favors the six-stage model, whereas the BIC and 
both cross-validation G2s clearly favor the four-stage model. Based on these results, the four-
stage model appears to provide the best combination of fit and parsimony.  
Table 5.45 Goodness-of-Fit for Various Models, African American Females, 6th–7th 
Grade 







4 (N, A, C, AC) 134.55 (231) 182.55 274.37 182.627 139.174 
5 (N, A, C, AC, 
ACM) 
118.74 (222) 184.74 310.99 289.214 149.168 
6 (N, A, C, AC, AI, 
ACM) 
101.23 (216) 179.23 328.44 203.691 167.056 
7 (N, A, C, AC, AI, 
CI, ACM) 
89.74 (210) 179.74 351.91 577.627 157.919 
Notes: A = alcohol; AC = alcohol + cigarettes; ACIM = alcohol + cigarettes + inhalants + marijuana; ACM = 
alcohol + cigarettes + marijuana; AI = alcohol + inhalants; C = cigarettes; CI = cigarettes + inhalants; N = no 
use. 
N = 339. 
Model labels are based on the ρ parameters for the model. 
For the four-stage model, the probability of responding “yes” to each of the four drug 
use items, given membership in one of the four stages, is presented in Table 5.46. The latent 
stage labels are based on the pattern of ρ estimates.  
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Table 5.46 Freely Estimated ρ Parameters for Response “Yes,” Four-Stage Model, 
African American Females, 6th–7th Grade  
Item 
Latent Stage 
No Use Alcohol Cigarettes 
Alcohol + 
Cigarettes
Ever used alcohol .00 .66 .32 1.00 
Ever used cigarettes .01 .09 1.00 1.00 
Ever used inhalants .03 .11 .19 .27 
Ever used marijuana .01 .05 .17 .35 
Note: ρ parameters are constrained equal for both time points, so the estimates are the same for both grades. 
When each of the models was analyzed using DA (with 100 imputations), additional 
support for the four-stage model emerged. The ρ (Rho) parameter estimates for the four-stage 
model suggest that the measurement of the four latent stages is consistent across imputations 
—that is, the same four stages are present and the measurement quality is similar to that 
obtained in the original LTA—while the more complex models were unstable across the 
imputed data sets. In fact, for each (five, six, and seven latent stages) model, the same four 
stages are the only ones that remain identifiable across the imputed data sets. Based on this 
collection of evidence, for African American females transitioning from 6th to 7th grade, the 
four-stage model was selected as the final model. The stages represent “no drug use” (N), 
“alcohol only” (A), “alcohol + cigarettes” (AC), and “alcohol + cigarettes + inhalants + 
marijuana” (ACIM).  
These preliminary results suggest that for African American females transitioning 
from 6th to 7th grade, only stages including alcohol and cigarettes are present. Given that the 
basic frequencies of use for these two substances (see Table 4.4) clearly indicate that these 
substances are used by nontrivial numbers of African American females, it is likely that the 
failure to identify a stable model that includes the use of these drugs reflects inconsistency in 
reporting or insufficient sample size/power to detect them.  
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Parameter constraints for the final model. To obtain final parameter estimates for 
the four-stage model and to ensure model identification, constraints were placed on the 
measurement (ρ) and transition (τ) matrices. Table 5.47 illustrates the constraints placed on 
the ρ parameters, and Table 5.48 illustrates the constraints placed on the τ matrix.  















Probability of responding 
“no” given latent stage 
membership 
No use 2 7 11 15 
A 5 7 11 15 
C 2 9 11 15 
AC 5 9 11 15 
      
Probability of responding 
“yes” given latent stage 
membership 
No use 4 8 12 16 
A 6 8 12 16 
C 4 10 12 16 
AC 6 10 12 16 
Note: A = alcohol; AC = alcohol + cigarettes; C = cigarettes. 
Each unique number is freely estimated. Same numbers are constrained to be equal. For instance, the 
probability of responding “yes” to the alcohol ever use item given membership in either the A or AC latent 
stage is constrained to be equal. This constraint ensures that the meaning of the alcohol use item is held 
constant across latent stages. Estimates are also constrained to be equal for both time points (measurement 
invariance). 
Table 5.48 Constraints on τ Parameters for African American Females, 6th–7th 
Grade  
 No Use A C AC 
No use FR FR FR FR 
A 0 FR 0 FR 
C 0 0 FR FR 
AC 0 0 0 FR 
Notes: A = alcohol; AC = alcohol + cigarettes; C = cigarettes; FR = freely estimated. 
0 = fixed to zero (not estimated). 
To ensure that the final model, with the applied constraints, is the proper solution for 
the four-class model, the model was analyzed 100 separate times, using random start values. 
The identical four stages were identified for all 100 solutions. However, the order of the 
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stages (the transition matrix) differed, with four different solutions. The original model, 
based on the gateway hypothesis, assumes that no “backward” movement is allowed. Three 
of the solutions included backward movement (for instance, from alcohol use to no use). 
However, because these three alternate models are conceptually impossible for an onset 
model, the original model is selected as the final model.  
The assumption of measurement invariance was tested via a χ2 difference test for the 
difference between the model with the ρ parameters constrained to be equal (invariant) for 
both time points (G2 = 302.679, 241 df) and the model without the measurement invariance 
constraint (G2 = 264.724, 235 df). The difference of 37.955, with 6 degrees of freedom, is 
significant (p < .0001), indicating that the measurement invariance assumption is not 
supported by the data. However, the same four stages are present and well-measured at both 
time points. To facilitate interpretation, measurement invariance is assumed for the final 
model, with the caveat that relaxing this constraint would improve the fit of the model.  
Final model results, African American females, 6th–7th grade. To obtain final 
parameter estimates and standard errors, DA was conducted. DA was applied to the final 
constrained model, and the results were combined to generate final parameter estimates that 
take into account the uncertainty present across the imputed data sets.  
ρ parameters (model measurement). The final ρ parameter estimates, specifically the 
probability of responding “yes” to each item, along with 95% confidence intervals, are 
presented in Table 5.49. The values were constrained to be equal across time (measurement 
invariance), so the ρ parameters are the same for both time points. To achieve identification 
and model stability by reducing the number of parameters estimated, additional constraints 
were imposed such that only two parameters are estimated for each item. The probability of 
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responding “no” can be obtained by subtracting the parameters in Table 5.49 from 1.00. The 
probabilities for “yes” responses to both the alcohol and cigarette use items, given 
membership in one of the latent stages, are quite high (.91–.93). 
Table 5.49 Final ρ Parameter Estimates for Response “Yes,” Four-Stage Model, 
African American Females, 6th–7th Grade  
Item 
Latent Stage 
No Use Alcohol Cigarettes 
Alcohol + 
Cigarettes 
Ever used alcohol .09 (.05, .17)  .91 (.82, .97) .09 (.05, .17) .91 (.82, .97) 
Ever used cigarettes .03 (.01, .08) .03 (.01, .08) .93 (.80, .99) .93 (.80, .99) 
Ever used inhalants .13 (.10, .15) .13 (.10, .15) .13 (.10, .15) .13 (.10, .15) 
Ever used marijuana .12 (.10, .15) .12 (.10, .15) .12 (.10, .15) .12 (.10, .15) 
Note: Point estimate and 95% confidence intervals based on data augmentation. 
δ parameters: probabilities of latent stage membership. δ parameters representing 
the probability of being in a certain latent stage at each grade are presented in Table 5.50 and 
illustrated in Figure 5.13. Prevalence for the “no use” stage (64%) was substantially greater 
than for the other latent stages in grade 6. By 7th grade, the prevalence for the “alcohol + 
cigarettes” stage is highest (44%). 
Table 5.50 Final δ Parameter Estimates for Four-Stage Model, African American 
Females, 6th–7th Grade  
Latent Stage 6th Grade 7th Grade 
No use .64 .41 
Alcohol .12  .10 
Cigarettes .04  .05 
Alcohol + cigarettes  .20  .44 
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τ parameters: transition probabilities. The τ parameters express the probability of 
transitioning from one latent stage to another between grade 6 and grade 7. The τ matrix is 
presented in Table 5.51, with the final model illustrated in Figure 5.14. Individuals in the 
“No Use” stage in 6th grade have a .251 probability of transitioning directly to the “Alcohol 
and Cigarettes” (AC) stage in 7th grade. Those in the “Alcohol only” (A) stage in 6th grade 
were more likely to transition to the AC stage (.552) than to remain in the same stage.  
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Table 5.51 τ Parameter Estimates, African American Females, 6th–7th Grade 
Latent Stage in 6th  
Grade 
Latent Stage in 7th Grade Advance 
Rate N A C AC 









Alcohol (A) — .448  
(.23, .68) 
— .552  
(.32, .77) 
.552 





Alcohol + cigarettes 
(AC) 
— — — 1.0  
Overall advance rate     .299 
Notes: A = alcohol, AC = alcohol + cigarettes; C = cigarettes; N = no use. 
The τ parameter estimates represent the probability of transitioning to the column “latent stage in 7th grade,” 
conditional on membership in the row “latent stage in 6th grade.” 
Dash (—) indicates that parameter was fixed to zero to represent the onset model. 
Point estimate and 95% confidence intervals based on data augmentation. 
Figure 5.14 Final Four-Stage Model for African American Females, 6th–7th Grade, 










As with African American males in the 6th to 7th grade transition, based on these 
results, there is no evidence that the gateway hypothesis can be extended to include inhalants 
for African American females. The final four-stage model did not include any stages with 
inhalants; therefore, for this population, there is no evidence to support the study hypotheses 
regarding inhalants.  
5.2.4.2 7th–8th Grade Transition 
Table 5.52 provides goodness-of-fit measures for various LTA models for African 
American females transitioning from 7th to 8th grade. Based on the initial results, it appeared 
that the five- or six-stage model provided the best fit for the data. The five-stage model had 
the lowest BIC, whereas the six-stage model had the lowest AIC and G2 on one of the cross-
validation samples. Unlike the 6th–7th grade African American female sample, it appears 
that both inhalants and marijuana are included in the drug use sequence for this sample. 
However, the results were unstable (as described below), and an alternate four-stage model 
was required. This alternate model is similar to the model identified for the 6th–7th grade 
transition period for African American females, with the addition of marijuana and the 
exclusion of a cigarettes-only stage.  
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Table 5.52 Goodness-of-Fit for Various Models, African American Females, 7th–8th 
Grade 





4 (N, AC, AI, ACM) 293.77 (232) 339.77 445.47 235.131 254.046 
4b (N, A, AC, ACM) 285.59 (230) 335.59 450.49 c c 
5 (N, A, AC, AI, 
ACM) 
233.85 (224) 295.85 438.32 230.825 244.051 
6 (N, A, C, I, AC, 
ACM) 
208.00 (216) 286.00 465.24 192.890 242.112 
7 (N, A, C, I, AC, 
ACI, ACM) 
191.52 (210) 289.52 514.71  238.770 227.180 
a Model labels are based on the ρ parameters for the model. 
b During model validation, the models originally identified were unstable. This alternate four-stage model (N, 
A, AC, ACM) was the only model that remained stable across 100 random validation samples. When four-, 
five-, six-, or seven-stage models were estimated with random start values, interpretation of the ρ values 
identified this alternate four-stage model.  
c Cross-validation was not performed on this model, as it is the only model that provides stable measurement for 
this subsample. 
N = 732. 
Notes: A = alcohol; AC = alcohol + cigarettes; ACIM = alcohol + cigarettes + inhalants + marijuana; ACM = 
alcohol + cigarettes + marijuana; AI = alcohol + inhalants; C = cigarettes; CI = cigarettes + inhalants; I = 
inhalants; N = no use. 
Each of the models was analyzed using DA (with 100 imputations) to determine 
whether the models are stable. The results indicated that, regardless of the number of stages 
included, only four stages were clearly and consistently identifiable based on the ρ parameter 
estimates. The freely estimated (unconstrained) ρ parameters for this alternate model are 
presented in Table 5.53. 
Table 5.53 Freely Estimated ρ Parameters for Response “Yes,” Four-Stage Model, 
African American Females, 7th–8th Grade 
Item 
Latent Stage 






Ever used alcohol .02 .88 .82 .91 
Ever used cigarettes .04 .00 .82 .95 
Ever used inhalants .04 .18 .14 .20 
Ever used marijuana .01 .10 .06 .95 
Note: ρ parameters are constrained equal for both time points, so the estimates are the same for both grades. 
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Parameter constraints for the final model. To obtain final parameter estimates for 
the four-stage model and to ensure model identification, constraints were placed on the 
measurement (ρ) and transition (τ) matrices. Table 5.54 illustrates the constraints placed on 
the ρ parameters, and Table 5.55 provides the parameter constraints for the τ matrix. 
To ensure that the final model, with the applied constraints, is the proper solution for 
the four-class model, the model was analyzed 100 separate times, using random start values. 
Two models emerged: the selected four-stage model and an alternate three-stage model (N + 
C + AC). The four-stage model was the most frequent solution; 61 of the 100 analyses 
supported the four-stage model. Additionally, the G2 associated with the four-stage model 
(583.29) was substantially lower than the G2 associated with the three-stage model (635.41).  
The assumption of measurement invariance was tested via a χ2 difference test for the 
difference between the model with the ρ parameters constrained to be equal (invariant) for 
both time points (G2 = 349.256, 239 df) and the model without the measurement invariance 
constraint (G2 = 344.382, 232 df). The difference of 4.874, with 7 degrees of freedom, is not 
significant (p = .8994), supporting the decision to constrain measurement across times.  
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No use 2 7 11 15 
A 5 7 11 15 
AC 5 9 11 15 
ACM 5 9 11 17 






No use 4 8 12 16 
A 6 8 12 16 
AC 6 10 12 16 
ACM 6 10 12 18 
Notes: A = alcohol; AC = alcohol, cigarettes; ACM = alcohol, cigarettes, and marijuana. 
Each unique number is freely estimated. Same numbers are constrained to be equal. For instance, the 
probability of responding “yes” to the alcohol ever use item given membership in either the A, AC, or ACM 
latent stage is constrained to be equal. This constraint ensures that the meaning of the alcohol use item is held 
constant across latent stages. Estimates are also constrained to be equal for both time points (measurement 
invariance). 
Table 5.55 Constraints on τ Parameters for African American Females, 7th–8th 
Grade  
 No Use A AC ACM 
No use FR FR FR FR 
A 0 FR FR FR 
AC 0 0 FR FR 
ACM 0 0 0 FR 
Notes: A = alcohol; AC = alcohol + cigarettes; ACM = alcohol + cigarettes + marijuana; FR = freely estimated; 
0 = fixed to zero (not estimated). 
Final model results, African American females, 7th–8th grade. To obtain final 
parameter estimates and standard errors, DA was conducted on the final constrained model, 
and the results were combined to generate final parameter estimates that take into account the 
uncertainty present across the imputed data sets.  
ρ parameters (model measurement). The final ρ parameter estimates, specifically the 
probability of responding “yes” to each item, along with 95% confidence intervals, are 
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presented in Table 5.56. The values were constrained to be equal across time (measurement 
invariance), so the ρ parameters are the same for both time points. To achieve identification 
and model stability, additional constraints were imposed such that only two parameters are 
estimated for each item; the probability of responding “no” can be obtained by subtracting 
the parameters in Table 5.56 from 1.00. Most of the parameter estimates are near 0 and 1, 
indicating that the latent variable “substance use” is being measured accurately.  
Table 5.56 Final ρ Parameter Estimates for Response “Yes,” Four-Stage Model, 
African American Females, 7th–8th Grade 
Item 
Latent Stage 








.03 (.00, .14)  .87 (.84, .90) .87 (.84, .90) .87 (.84, .90) 
Ever used 
cigarettes 
.08 (.05, .12) .08 (.05, .12) .89 (.85, .92) .89 (.85, .92) 
Ever used 
inhalants 
.13 (.11, .15) .13 (.11, .15) .13 (.11, .15) .13 (.11, .15) 
Ever used 
marijuana 
.03 (.01, .05) .03 (.01, .05) .03 (.01, .05) .87 (.77, .94) 
Note: Point estimate and 95% confidence intervals based on data augmentation. 
δ parameters: probabilities of latent stage membership. Table 5.57 and Figure 5.15 
show the estimated prevalence for each of the four latent substance use stages in 7th and 8th 
grades. Most notable is the finding that the prevalence in the ACM stage nearly doubles from 
7th to 8th grade; by 8th grade, the ACM stage is the most prevalent at 30%. 
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Table 5.57 Final δ Parameter Estimates for Four-Stage Model, African American 
Females, 7th–8th Grade  
Latent Stage 7th Grade 8th Grade 
No use .41 .28 
Alcohol .13  .13 
Alcohol + cigarettes .30  .29 
Alcohol + cigarettes + marijuana .16  .30 
 



















τ parameters: transition probabilities. The τ parameters express the probability of 
transitioning from one latent stage to another between grade 7 and grade 8. The τ matrix is 
presented in Table 5.58. Membership in either the A or AC latent stage in 7th grade is 
associated with a relatively strong probability of transitioning to the ACM stage in 8th grade: 
.217 and .242, respectively. The final model is presented in Figure 5.16. 
Consistent with the findings for the 6th to 7th grade transition, there is no evidence to 
suggest that the gateway hypothesis can be extended to include inhalants for African 
American females transitioning from 7th to 8th grade. Subsequently, the study hypotheses 
(1.1 and 1.2) pertaining to the relationship between inhalants and marijuana are not supported 
here for African American adolescents. 
Table 5.58 τ Parameter Estimates, African American Females, 7th–8th Grade 
Latent Stage in 7th  
Grade 
Latent Stage in 8th Grade Advance 
Rate N A AC ACM 





















Alcohol + cigarettes + 
marijuana (ACM) 
— — — 1.0  
Overall advance rate     .237 
Notes: A = alcohol; AC = alcohol + cigarettes; ACM = alcohol + cigarettes + marijuana. 
The τ parameter estimates represent the probability of transitioning to the column “latent stage in 8th grade,” 
conditional on membership in the row “latent stage in 7th grade.” 
Dash (—) indicates that parameter was fixed to zero to represent the onset model. 
Point estimate and 95% confidence intervals based on data augmentation. 
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Figure 5.16 Final Four-Stage Model for African American Females, 7th–8th Grade, 















5.2.5 Summary of Results for Research Question 1 
Separate LTA models were identified for each of the race/gender combinations in this 
study (white males, white females, African American males, and African American females) 
at two transitions. This provides evidence in support of study Hypothesis 1.3: “drug use 
sequencing models will differ by race and gender…” It appears that, based on these results, 
drug use sequencing patterns differ by race and gender for this sample when inhalants are 
considered as part of the gateway drug use sequence. 
The number and type of stages differed by sample, precluding direct comparisons 
between samples. In general, each of the samples had similar probabilities for membership in 
the “no use” stage (Table 5.59), although white males in the 6th–7th grade transition period 
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were significantly less likely to be in the “no use” stage (i.e., they were more likely to have 
used one or more drugs).  
Table 5.59 Prevalence of Membership in the “No Use” Latent Stage (δ) at Baseline 
for Each Group  
 Prevalence of “No Use” Stage Membership at Baseline 
6th–7th Grade 7th–8th Grade 
White males .486 (.427, .546) .360 (.320, .401) 
White females .606 (.553, .658) .410 (.373, .448) 
African American males .692 (.617, .764) .447 (.396, .499) 
African American females .638 (.566, .709) .405 (.358, .453) 
Note: 95% confidence intervals in parentheses.  
Also similar were the overall probabilities of transitioning out of a current stage into a 
later stage, with the exception of white females. Table 5.60 includes estimates of the overall 
probability of advancing to a later stage for each of the two transition periods. White females 
had a higher estimated overall advance rate at both periods, although the disparity is most 
pronounced for the 6th–7th grade period; 35.7% of white females in this sample moved from 
one latent stage at 6th grade to a more “advanced” stage by 7th grade.  
Table 5.60 Estimated Overall Advance Rate for Each Group 
Sample 
Overall Advance Rate 
6th–7th Grade 7th–8th Grade 
White males .267 .200 
White females .357 .253 
African American males .259 .153 
African American females .299 .237 
Note: The overall advance rate is an estimate of the overall probability of transitioning from any stage to a later 
stage. 
Models were identified for each of the four samples and for both transition periods. 
Models that included inhalants were identified for white males and white females at both 
transition periods and for African American males in the 7th to 8th grade transition period, 
suggesting that the gateway hypothesis can be extended to include inhalants (Research 
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Question 1). However, evidence in support of the hypothesis that “inhalant use will precede 
marijuana use for a significant number of adolescents” (Hypothesis 1.1) was only obtained 
for white females. For white females, the results suggest that inhalant use at either the 6th or 
7th grade increases the probability of marijuana use by the following grade, as evidenced by 
the transition probability from the ACI to the ACIM stage.  
The hypothesis that inhalants operate as a partial gateway to marijuana use 
(Hypothesis 1.2) was supported only for white females in the 6th–7th grade transition, 
although evidence suggested that inhalant use at 7th grade does increase the probability of 
transitioning to marijuana use at 8th grade for the later transition period. There was no 
evidence of a gateway role for inhalants for the other groups. Table 5.61 summarizes the 
final models selected for each group and indicates whether the models included inhalants 
(Research Question 1), whether inhalant use appears to precede marijuana use for a 
significant number of adolescents (Hypothesis 1.1), and whether there was evidence for a 
(partial) gateway relationship between inhalants and marijuana (Hypothesis 1.2).  
Based on the LTA models identified here, Research Question 2, which examines the 
prospective relationship between inhalants and other gateway drugs, can be addressed only 
for white females. Specifically, models identified for white females allow for an investigation 
of the strength of association between inhalant use at one grade and the probability of 
transitioning to marijuana use at the following grade.  
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Table 5.61 Final Selected Models for Each Sample 




















White males 4 N, A, AC, 
ACIM 
Yes No No 5 N, A, AC, 
ACM, 
ACIM 
Yes No No 
White females 6 N, A, C, 
AC, ACI, 
ACIM 
Yes Yes Yes 6 N, A, C, 
AC, ACI, 
ACIM 




3 N, AC, 
ACM 
No No No 6 N, A, AC, 
CM, ACM, 
ACIM 




4 N, A, C, 
AC 
No No No 4 N, A, AC, 
ACM 
No No No 
a Although evidence for a partial gateway relationship was not present, the use of inhalants at baseline (7th grade) was associated with a significant probability of 
transitioning to marijuana use at 8th grade for white females. 
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5.2 Research Question 2: Does the Probability of Transitioning from Inhalant Use to 
Other Drug Use Remain after Controlling for Demographic Factors and Key 
Psychosocial Predictors of Adolescent Drug Use? 
For white females, there appears to be a strong association between inhalant use and 
transitioning to later marijuana use; for the 464 white females in the 6th–7th grade sample, 
there is evidence to support a partial gateway relationship, whereas for the 954 in the 7th–8th 
grade sample, there is evidence to support a relationship, but not a gateway relationship, 
between inhalants and marijuana. To determine whether these associations persist after 
controlling for factors that may represent common liabilities for drug use transitions, LTA 
with covariates was conducted.  
A total of 13 variables were entered one at a time to determine the independent 
effects of each factor on the transition probability from inhalant use to marijuana use. 
Variables that were found to be associated with a decrease in the probability of transitioning 
from inhalant use to marijuana use were entered into multivariate models. Frequencies and 
response codes for each of the covariates are listed in Appendix A. Scales were recoded into 
dichotomous variables to ease interpretation of results, to facilitate estimation with small 
sample sizes, and because most of the variables were highly skewed. Age remains 
continuous, and the sensation-seeking variable was reverted to the original scale for the 6th–
7th grade sample due to problems with model convergence using the dichotomous measure.  
The variables are coded so that high scores indicate high risk. “Protective factors” 
such as religiosity are reverse coded so that high scores indicate low scores on the variable.  
Covariates are included in LTA models via a logistic link function, resulting in 
logistic regression coefficients. Covariates can be included as predictors of both the initial 
status (δ) and the transition probabilities (τ), resulting in two additional sets of parameters (β 
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—beta parameters) estimated by the LTA. In this case, the δ and τ parameters are calculated 
as functions of β parameters and covariates. The interpretation of a transition probability 
when covariates are included becomes the probability of transitioning to status B at time t + 
1, given membership in status A at time t and the effect of the covariates.  
Given that the transition probability estimate for an LTA with covariates model is a 
function of both Time 1 status and the covariates, it is possible to determine if, after adding 
covariates, the relationship between inhalants and marijuana remains; such a finding would 
be consistent with gateway theory. If, on the other hand, the transition probability diminishes 
to zero, this would suggest that responses to the covariates fully account for the relationship. 
This facilitates the analysis for Research Question 2: by including covariates, it is possible to 
determine whether the probability of transitioning to marijuana use, given previous inhalant 
use, remains after controlling for the covariates. The primary parameter of interest is the 
transition probability (τ) estimate for the ACI to ACIM transition. The extent to which 
inhalant use serves as a gateway to marijuana use will be determined by assessing whether 
the transition probability decreases substantially as a result of adding covariates.  
While analyses without covariates allow for missing data and include all cases via 
maximum likelihood estimation, missing values on the covariates are not allowed, and cases 
with missing values on the covariates are deleted listwise. The amount of missing data for the 
covariates is modest but not trivial; for the 6th–7th grade sample, the frequency of missing 
data for the covariates ranged from 0 to 4.1%, and 10.1% of this sample were missing data on 
at least one covariate. For the 7th–8th grade sample, the frequency of missing data for the 
covariates ranged from 0 to 9.6%, and 15.5% of the sample were missing data for at least one 
of the covariates. Additionally, DA or other methods for producing standard errors, 
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establishing statistical significance, and conducting hypothesis testing are not currently 
available. Therefore, these results should be interpreted as preliminary and suggestive rather 
than definitive. 
For consistency, the covariates were included to predict both (a) baseline (time 1) 
latent stage membership (the δ parameters) and (b) the probability of transitioning from the 
ACI stage to the ACIM stage (the τ parameters); other transition probabilities were not the 
focus of this study and were therefore not estimated. Because the focus for this research 
question is the transition from inhalant use (ACI) to marijuana use (ACIM), the results 
described in detail specifically relate to that portion of the analysis. However, odds ratios for 
the effect of each predictor on baseline stage membership are presented in Appendices B (for 
the 6th–7th grade transition) and C (for the 7th–8th grade transition). The “no use” stage was 
specified as the reference group, so odds ratios larger than 1.0 indicate an increased risk of 
membership in a latent stage relative to the non-users. The presented odds ratios are for 
covariates entered separately (unconditional estimates).  
In general, the results suggest that scores on the covariates representing greater levels 
of risk are associated with increased odds of being in one of the drug use stages, and the 
findings are especially strong for the more advanced drug use stages (AC, ACI, and ACIM). 
The results are fairly uniform; the size of the odds ratios increases as the stages advance. The 
odds ratios are generally largest for individuals in the ACIM stage, and are larger for the ACI 
stage than for the AC stage for most covariates.  
SAS Proc LTA provides an omnibus test for the overall significance of the covariates 
on latent status membership at baseline (the δ parameters). For each covariate, the specified 
model, where baseline stage membership is predicted by the covariate, is compared to the 
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model where that covariate has been removed. The p-value is obtained by comparing twice 
the difference in log-likelihood values for the two models to a chi-square distribution (Lanza 
et al., 2008). A significant p-value for a covariate suggests that a model that includes the 
covariate as a predictor of baseline latent stage membership provides a superior overall fit 
than a model without the covariate. It is important to note that these p-values do not relate to 
the effect of the covariates on the transition probabilities; p-values for that component of the 
model are not currently available for SAS Proc LTA. These results are included here to give 
a general indication of whether the covariates are significantly associated with baseline stage 
membership, thus improving model fit.  
Results from omnibus significance tests for each of the individual covariates are 
presented in Table 5.62. For the 6th–7th grade sample, grade point average (GPA) and 
academic aspirations were not significantly associated with baseline latent stage membership. 
For the 7th–8th grade sample, all of the variables were significant (p < .05).  
Table 5.62 Omnibus Significance Tests for Baseline Covariates 
 p-value 
Covariate 6th–7th Grade 7th–8th Grade 
Age p < .0238 (N = 464) p < .0423 (N = 954)
Social values p < .0001 (N = 461) p < .0001 (N = 872)
Grade point average p < .9147 (N = 449) p < .0009 (N = 875)
School attachment p < .0010 (N = 457) p < .0001 (N = 883)
Mother’s disapproval of drug use p < .0001 (N = 452) p < .0001 (N = 863)
Religiosity p < .0024 (N = 454) p < .0024 (N = 874)
Perceived drug use at school p < .0001 (N = 450) p < .0001 (N = 875)
Any drug use, five closest friends p < .0001 (N = 461) p < .0001 (N = 888)
Tolerant of any drug use, five closest friends p < .0001 (N = 460) p < .0001 (N = 883)
Perceived availability of drugs p < .0001 (N = 447) p < .0001 (N = 874)
Academic aspirations p < .0721 (N = 458) p < .0001 (N = 871)
Problem behavior p < .0004 (N = 460) p < .0001 (N = 880)
Sensation seeking p < .0001 (N = 445) p < .0001 (N = 862)
Note: Omnibus significance based on beta parameter test (Type III) for baseline covariates, based on change in 
2*(log-likelihood). 
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5.2.1 Effects of the Individual Covariates on the Transition from the ACI Stage to the 
ACIM Stage (Bivariate Analyses) 
To assess the degree to which each covariate independently influences the transition 
from the ACI stage to the ACIM stage, separate LTA-with-covariates models were run, each 
with only one of the covariates included (bivariate analysis). Table 5.63 presents odds ratios 
for the 6th–7th grade and the 7th–8th grade transitions. For these analyses, the odds ratios 
reflect the odds of transitioning from the ACI to the ACIM stage relative to remaining in the 
same stage at both time points. All of the covariates except for age and sensation-seeking (at 
6th grade) are dichotomous, and all are scaled so that the high score indicates greater general 
“risk.” Examining these odds ratios would allow us to address the following question: Do 
respondents with scores indicating greater risk on the covariate have greater odds of 
transitioning from the ACI stage to the ACIM stage than those with lower risk scores? 
This question is not the focus of the current study, because the research question of 
interest deals with whether the probability of transitioning from the ACI to the ACIM stage 
remains after controlling for the effects of the covariates. No a priori hypotheses were made 
regarding the expected effects of these covariates on the transition, aside from the hypothesis 
that the probability of transitioning will remain after controlling for the effects of the 
covariates.  
These results are presented to provide an example of the results that are produced via 
this analytic approach but are not interpreted in detail. For the 6th–7th grade transition 
period, low social values (OR = 1.60), low school attachment (OR = 1.52), a mother without 
a perceived strong disapproval of any drug use (OR = 10.83), having close friends who use 
drugs (OR = 2.03), high perceived availability of drugs (OR = 5.22), and high sensation-
seeking (OR = 1.20) were associated with increased odds of transitioning from the ACI stage 
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to the ACIM stage. For example, respondents who reported having one or more close friends 
who use drugs had odds of transitioning from the ACI to the ACIM stage that were two times 
greater than the odds for someone with no close friends who use drugs. Similarly, 
respondents with higher than average perceived availability of drugs had more than five 
times greater odds of transitioning from ACI to ACIM than did those with lower than 
average perceived availability. 
These results should be interpreted with great caution; although the original sample 
size for the two samples were relatively large (464 and 954 for the 6th–7th and 7th–8th grade 
samples, respectively), these analyses are focused only on those who were in the ACI stage at 
baseline, a substantially smaller sample size. For the 6th–7th grade sample, based on the 
results reported in Section 5.1, approximately 19 females (~4%) are estimated to be in the 
ACI stage at baseline. Of these, roughly 6 (~31%) are expected to transition to the ACIM 
stage. For the 7th–8th grade sample, 67 (~7%) females are estimated to be in the ACI stage at 
baseline, with 11 expected to transition to the ACIM stage.  
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Table 5.63 Odds Ratios Reflecting the Effects of the Covariates on Transitioning 
from Inhalant Use (ACI) to Marijuana Use (ACIM) for White Females in 
the 6th–7th and 7th–8th Grade Samples 
Covariate 
Odds Ratios  
6th–7th Grade 7th–8th Grade 
Age 1.01 1.00 
(low) Social values 1.60 1.11 
(low) Grade point average  0.67 (1.49) 1.80 
(low) School attachment 1.52 2.76 
(low) Mother’s disapproval of drug use 10.83 0.42 (2.38) 
(low) Religiosity 0.56 (1.79) 4.83 
(high) Perceived drug use at school 0.34 (2.94) 0.22 (4.55) 
(yes) Any drug use, five closest friends 2.03 1.22 
(yes) Tolerant of any drug use, five closest 
friends 
0.50 (2.00) 0.13 (7.63) 
(high) Perceived availability of drugs 5.22 6.75 
(low) Academic aspirations 0.25 (5.00) 2.46 
(high) Problem behavior 0.59 (1.69) 2.23 
(high) Sensation seekinga 1.20 9.82 
a Sensation seeking is a continuous variable in the 6th–7th grade analyses; it is binary in the 7th–8th grade 
analyses. 
Note: Inverse odds ratios are displayed in parentheses. 
For the 7th–8th grade transition period, all but four of the covariates are associated 
with increased odds of transitioning from ACI to ACIM. As with the 6th–7th grade 
transition, high perceived drug use at school and having any friends who are perceived to be 
tolerant of drug use are associated with lower odds of transitioning.  
Again, the primary purpose of these analyses is to determine whether the probability 
of transitioning from inhalant use (ACI) to marijuana use (ACIM) remains after controlling 
for each of the covariates. In an LTA without covariates, the transition probability τ is 
interpreted as the probability of transitioning to a stage at time t + 1, given membership in a 
previous stage at time t. With covariates added to the model, the transition probability 
reflects the probability of transitioning to a stage at time t + 1, given membership in a 
previous stage at time t and controlling for the effect of the covariate. A covariate may 
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increase (or decrease) the odds of transitioning from the ACI stage to the ACIM stage, as 
illustrated in Appendices B and C; how the covariate affects the transition probability is a 
related but different matter and is the primary focus of this LTA-with-covariates. 
Table 5.64 presents the transition probabilities for the ACI to ACIM transition, for 
both transition periods, after controlling for each of the covariates separately. The original 
transition probabilities for the 6th–7th and 7th–8th grade transitions were 0.29 and 0.19, 
respectively. For both transition periods, several covariates are associated with decreases in 
the transition probability, suggesting that the covariates partially explain the probability of 
transitioning from the ACI stage to the ACIM stage. The largest effect for the 6th–7th grade 
transition is for the covariate measuring whether the adolescent perceives that his or her 
mother strongly disapproves of any drug use; inclusion of this covariate causes the transition 
probability to drop from 0.29 to 0.11, a 62% decrease. Sensation seeking has the largest 
effect on the transition probability for the 7th–8th grade period (reducing the probability 
from 0.19 to 0.13, a 32% decrease).  
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Table 5.64 Probabilities of Transitioning to Marijuana Use (ACIM) at Time 2, Given 




6th–7th Grade 7th–8th Grade 
No Covariate (Baseline Model) 0.29 0.19 
Age 0.29 0.19 
(low) Social values  0.19 0.20 
(low) Grade point average 0.26 0.15 
(low) School attachment 0.29 0.16 
(low) Mother’s disapproval of drug use 0.11 0.17 
(low) Religiosity 0.22 0.15 
(high) Perceived drug use at school 0.34 0.23 
(yes) Any drug use, five closest friends 0.28 0.17 
(yes) Tolerant of any drug use, five closest friends 0.38 0.29 
(high) Perceived availability of drugs 0.18 0.15 
(low) Academic aspirations 0.27 0.15 
(high) Problem behavior 0.31 0.14 
(high) Sensation seeking 0.26 0.13 
 
5.2.2 Multivariate Effects of the Covariates on the Transition from the ACI Stage to the 
ACIM Stage  
As a final test of whether the transition from ACI to ACIM remains after controlling 
for covariates, a series of multivariate models were estimated. The covariates were rank-
ordered based on the extent to which they decreased the transition probability in the bivariate 
analyses reported above. The variables were then entered sequentially, starting with the top-
ranked variable and then adding the next ranked variable. Results of these multivariate 
analyses are provided separately for the 6th–7th (Table 5.65) and the 7th–8th (Table 5.66) 
grade transition periods. The results indicate that for the 6th–7th grade transition, a model 
containing both the mother’s disapproval of drug use measure and the perceived availability 
of drugs measure had the strongest impact on the size of the transition probability—dropping 
it to 0.09.  
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Table 5.65 Probabilities of Transitioning to Marijuana Use (ACIM) in 7th Grade, 







Odds Ratios Reflecting 
the Effects of Covariates 




Unconditional (No Covariates) (N 
= 464) 
0.29   
Model 1 (N = 452) 0.11   
Mother’s disapproval of drug 
use 
 10.83 p < .0001 
Model 2 (N = 437) 0.09   
Mother’s disapproval of drug 
use 
 9.26 p < .0001 
Perceived availability of drugs  5.00 p < .0001 
Model 3 (N = 435) 0.12   
Mother’s disapproval of drug 
use 
 3.97 p < .0001 
Perceived availability of drugs  2.84 p < .0001 
Social values  1.24 p < .0001 
Model 4 (N = 429) 0.14   
Mother’s disapproval of drug 
use 
 2.61 p < .0001 
Perceived availability of drugs  1.81 p < .0001 
Social values  1.43 p < .0001 
Religiosity  1.09 p < .0774 
Model 5 (N = 421) 0.19   
Mother’s disapproval of drug 
use 
 1.30 p < .0304 
Perceived availability of drugs  1.05 p < .0037 
Social values  1.11 p < .0052 
Sensation seeking  1.05 p < .0001 
Model 6 (N = 421) 0.20   
Mother’s disapproval of drug 
use 
 1.23 p < .2338 
Perceived availability of drugs  1.04 p < .1615 
Social values  1.05 p < .0128 
(continued) 
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Table 5.65 Probabilities of Transitioning to Marijuana Use (ACIM) in 7th Grade, 







Odds Ratios Reflecting 
the Effects of Covariates 




Sensation seeking  1.04 p < .0130 
Any drug use, five closest friends  1.02 p < .0029 
Model 7 (N = 417) 0.20   
Mother’s disapproval of drug 
use 
 1.20 p < .2398 
Perceived availability of drugs  1.02 p < .2677 
Social values  1.05 p < .0291 
Sensation seeking  1.02 p < .0641 
Any drug use, five closest 
friends 
 1.03 p < .0136 
Religiosity  1.01 p < .9914 
 
For the 7th–8th grade transition, none of the multivariate models resulted in a greater 
decrease in the transition probability than evidenced for a model including only sensation 
seeking as a covariate. The overall decrease associated with covariates is less in the 7th–8th 
grade transition (compared to the 6th–7th grade transition), although the initial transition 
probability is lower for the 7th–8th grade transition to begin with. After controlling for 
covariates that were found to be associated with a decrease in the transition probability, the 
“adjusted” probability of transitioning from ACI to ACIM was 0.09 at 6th–7th grade and 
0.13 at 7th–8th grade.  
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Table 5.66 Probabilities of Transitioning to Marijuana Use (ACIM) in 8th Grade, 















Covariates) (N = 954) 
0.19   
Model 1 (N = 862) 0.13   
Sensation seeking  9.82 p < .0001 
Model 2 (N = 852) 0.14   
Sensation seeking  5.16 p < .0001 
Problem behavior  1.19 p < .0001 
Model 3 (N = 836) 0.15   
Sensation seeking  2.60 p < .0001 
Problem behavior  0.84 p < .0008 
Perceived availability 
of drugs 
 2.70 p < .0001 
Model 4 (N = 822) 0.17   
Sensation seeking  1.86 p < .0001 
Problem behavior  1.07 p < .0008 
Perceived availability 
of drugs 
 1.81 p < .0001 
Academic aspirations  1.30 p < .1549 
Model 5 (N = 826) 0.16   
Sensation seeking  1.71 p < .0001 
Problem behavior  0.67 p < .0006 
Perceived availability 
of drugs 
 2.34 p < .0001 
Religiosity  2.11 p < .0025 
Model 6 (N = 818) 0.18   
Sensation seeking  1.43 p < .0001 
Problem behavior  0.79 p < .0015 
Perceived availability 
of drugs 
 1.70 p < .0001 
Religiosity  1.59 p < .0029 




Table 5.66 Probabilities of Transitioning to Marijuana Use (ACIM) in 8th Grade, 





Probability (ACI to 
ACIM) 
Odds Ratios Reflecting 
the Effects of Covariates 




Model 7 (N = 816) 0.18   
Sensation seeking  1.22 p < .0001 




 1.37 p < .0001 
Religiosity  1.32 p < .0102 
GPA  0.99 p < .0713 
School attachment  1.21 p < .1452 
Model 8 (N = 806) 0.16   
Sensation seeking  1.30 p < .0001 




 1.37 p < .0001 
Religiosity  1.25 p < .0639 
GPA  1.19 p < .1138 
Mother’s 
disapproval of drug 
use 
 0.83 p < .0001 
Model 9 (N = 812) 0.16   
Sensation seeking  1.36 p < .0001 




 1.45 p < .0001 
Religiosity  1.25 p < .0762 
Mother’s 
disapproval of drug 
use 
 0.84 p < .0032 
Any drug use, five 
closest friends 
 0.97 p < .0001 
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These analyses sought to address Research Question 2 (Does the probability of 
transitioning from inhalant use to other drug use remain after controlling for demographic 
factors and key psychosocial predictors of adolescent drug use?) by examining the effects of 
covariates on the probability of transitioning from the ACI to the ACIM stage. The stated 
hypothesis for this study (Hypothesis 2.1), based on the gateway hypothesis, is as follows: 
The probability of transitioning from inhalant use will remain after controlling for baseline 
drug use, demographic factors, and common liability variables. For both transition periods, 
the transition probability remained positive after controlling for covariates; a finding that the 
transition probability remains after controlling for covariates provides some evidence in 
support of a gateway relationship between inhalants and marijuana by suggesting that there is 
an independent effect of inhalant use on transitioning to marijuana use. 
However, although the transition probability remains after controlling for covariates, 
the size of the probability does diminish substantially, by 62% for the 6th–7th grade 
transition and by 32% for the 7th–8th grade transition. This provides at least some support 
for the competing common-liability view of drug use, that underlying characteristics, 
particularly characteristics that increase opportunities to use drugs, explain the relationship 
between drugs.  
It is possible that additional unmeasured covariates would further decrease the effect 
of inhalants, and without statistical significance testing, it is not currently possible to 
determine if the reduction in the probability is significant. But based on these preliminary 
results, it appears that there is a direct effect of using inhalants on transitioning to marijuana 
use among white female adolescents in this sample.
 CHAPTER 6 
DISCUSSION 
This study used latent transition analysis (LTA) to explore the relationship between 
adolescent inhalant use and the use of the three drugs most commonly referred to as 
“gateway drugs”: alcohol, cigarettes, and marijuana. Although a few studies (e.g., Dinwiddie, 
Reich, & Cloninger, 1991a; Schutz, Chilcoat, & Anthony, 1994; Johnson, Schutz, Anthony, 
& Ensminger, 1995) have documented a prospective relationship between inhalant use and 
later hard drug use (particularly heroin use), to date no studies have used longitudinal data 
and stage-based analytic techniques to examine whether the drug use sequence for gateway 
drugs can be extended to include inhalants; doing so was the primary purpose of the current 
study. This chapter discusses the major study findings, study strengths and limitations, and 
implications and areas of future research.  
6.1 Summary of Findings 
6.1.1 Summary of Findings for Research Question 1: Can the Gateway Hypothesis be 
Extended to Include Inhalants for African American and White, Male and Female 
Adolescents in Grades 6 through 8?  
The traditional, widely reported, and empirically tested gateway hypothesis posits that 
drug use occurs in a sequential manner, beginning with the use of legal, widely available 
drugs and progressing to the use of “hard” drugs. Analyses to date have focused on alcohol, 
cigarettes, and marijuana as the primary gateway drugs. Among adolescent populations, these 
substances are relatively easy to obtain and national prevalence estimates (primarily for 
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secondary school students) consistently indicate that these are the most widely used 
substances.  
A review of data for younger adolescents (in grades prior to and including 8th grade) 
suggests that inhalants may be as commonly used as marijuana for some segments of the 
young adolescent population (Johnston, O’Malley, Bachman, & Schulenberg, 2005; Wu, 
Pilowsky, & Schlenger, 2004; Johnston, O’Malley, & Bachman, 2001). Inhalants are widely 
available and may serve as entrée to experiences with drugs and with drug-using peers. 
Inhalants share these characteristics with the other gateway drugs. If, as the gateway 
hypothesis posits, drug use typically begins with the use of the most widely available and 
widely used drugs, then inhalants may operate as an important unidentified gateway drug. 
For these reasons—the relatively high prevalence of inhalant use among young 
adolescents and the wide availability of inhalants in general—it was hypothesized that 
inhalant use would precede marijuana use for a significant number of adolescents in this 
sample (Hypothesis 1.1) and more formally that inhalant use would operate as a partial 
gateway to marijuana use (Hypothesis 1.2).  
Moreover, previous research has suggested that there may be important differences in 
general drug use sequencing by gender and race (Kandel & Yamaguchi, 2002; Yamaguchi & 
Kandel, 2002). As this study is the first to evaluate where inhalants fit within the gateway 
drug use sequence, it was deemed necessary to determine whether the drug use sequence that 
includes inhalants differs by race and gender. Therefore, the analyses were carried out 
separately for four groups (white males, white females, African American males, and African 
American females) and at two transition periods (6th–7th grade and 7th–8th grade). It was 
hypothesized that the gateway drug use sequence would differ for the groups, with inhalants 
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serving a more prominent role in the drug use sequence for whites and for females 
(Hypothesis 1.3).  
Three key findings emerged from this analysis of Research Question 1: (1) there are 
clear differences in gateway drug use sequencing between the four groups, (2) a model of 
gateway drug use sequencing that includes inhalants can be identified for white males and 
white females at both the 6th to 7th and the 7th to 8th grade transition periods and for African 
American males in the 7th to 8th grade transition, but (3) evidence that inhalant use may 
operate as a partial gateway to marijuana use was only observed for white females during the 
6th to 7th grade transition. 
6.1.1.1 Differences in Gateway Drug Use Sequencing  
Separate models of gateway drug use transitions were identified for each gender/race 
group, indicating that important variations in drug use sequencing exist between the groups. 
For the 6th to 7th grade transition, models were identified for each group that appeared to fit 
the data relatively well based on the G2 value being lower than the model degrees of 
freedom—a rough rule-of-thumb indicating good overall model fit. For the 7th–8th grade 
transition, only the model identified for white females appeared to have a good fit to the data; 
when considering responses patterns for four drug use measures (alcohol, cigarettes, 
inhalants, and marijuana), the analyses failed to identify a well-fitting model for white males 
and African American males and females.  
Approximately 49% of white males in the 6th grade sample were in the “No Use” 
latent stage, a number that was significantly less than for the other groups. This finding is 
consistent with published national prevalence estimates that suggest in general that white 
male adolescents have among the highest drug use prevalence rates. This finding suggests 
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that 6th grade may be late in white male adolescent development to assess gateway drug use 
initiation—a high prevalence of these adolescents have already initiated drug use by this 
time.  
Conversely, the 6th–7th grade transition period appears to be an especially important 
time for white female drug use development. Sixty-one percent of white females were 
estimated to still be in the “no use” latent stage at 6th grade, and the overall advance rate for 
white females (0.36) was substantially larger than for the other groups. The advance rate is 
an overall measure of the probability of progressing to a more advanced latent stage, and for 
white females this number suggests that 36% of the respondents transitioned to a more 
advanced stage between the 6th and 7th grades, compared to 27%, 26%, and 30% of white 
males, African American males, and African American females, respectively. 
Although previous studies have not considered inhalants within a gateway drug use 
sequence, the finding that drug use patterns differ by race and/or gender has been reported. 
For instance, previous research has indicated that cigarette use is a stronger predictor of 
transitioning to marijuana for females than for males (Kandel & Yamaguchi, 2002). 
Similarly, there is some evidence from previous research that alcohol and cigarettes are 
weaker predictors of marijuana use among African American adolescents and that ethnic 
minority groups are less likely to follow the traditionally espoused gateway sequence 
(Yamaguchi & Kandel, 2002).  
In the United States, male and female adolescents have similar prevalence rates for 
inhalant use, whereas females typically have lower rates of use for other drugs; inhalant use 
appears to be on the rise among adolescent females, while remaining stable for males 
(Substance Abuse and Mental Health Services Administration [SAMHSA], 2007). This 
197 
suggests that inhalants may serve an especially important role for female adolescents, a 
supposition supported here by the finding that inhalants are an important part of drug use 
sequencing for white females. The finding that inhalants were not an important part of the 
gateway sequence for African Americans likely in part reflects the fact that African 
American adolescents have substantially lower rates of inhalant use than whites (CDC, 
2006). 
An initial indication of these gender/race differences was evidenced in the observed 
response patterns for the four groups. For the current study, four dichotomous items were 
assessed at two time points, resulting in a possible total of 256 (24*2) unique response 
patterns; a high number of unique response patterns is indicative of heterogeneity of 
responses for a group, whereas a low number increases the likelihood that a parsimonious 
model describing the drug use sequence can be identified. White females had low numbers of 
unique observed response patterns relative to the other groups, suggesting greater 
homogeneity in drug use sequencing. In contrast African American females, and most clearly 
African American males, exhibited a great deal of heterogeneity in their drug use response 
patterns over time.  
The general effect of this increased heterogeneity was to increase the instability of the 
estimates for the models; stringent efforts made in this study to identify the best fitting and 
most stable models for each group may therefore have resulted in models that were 
conservative. It was certainly more difficult to identify stable models for African American 
adolescents in these analyses, and, despite frequency estimates indicating that inhalants were 
in fact used (albeit to a lesser degree than for white adolescents), the selected models failed 
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to include inhalants in any of the stages (except for African American males transitioning 
from 7th to 8th grade). 
It should be noted that the models selected and analyzed for this study are essentially 
models that best fit the data after adjusting for measurement error. Measurement error likely 
had a significant impact on model selection and study findings. As a latent variable approach, 
LTA adjusts for measurement error, an important advantage of this approach. When not 
adjusted for, measurement error for categorical data results in misclassification of 
individuals, with a tendency in transition models to make it appear that there has been more 
change over time than has really occurred (Collins, 2002). LTA adjusts for measurement 
error, potentially giving a more realistic, and certainly a more conservative, estimate of the 
amount of change.  
In this study, there is a great deal of measurement error associated with the transition 
matrix. Descriptive analyses suggest that a high percentage of respondents who report ever 
use of a substance at baseline report never use for the same drug at the next time point. This 
type of response inconsistency, known as “recanting,” is very common in longitudinal studies 
(Fendrich, 2005). Because the models estimated were “onset” models, the transition matrix 
was constrained to allow for only two possibilities: remaining in the same stage or 
transitioning to a more advanced stage over time. Responses that fail to conform to these 
restrictions (for instance, reporting alcohol use at baseline but “no use” at the next time point) 
are treated as measurement error in LTA.  
Recanting rates differ across substances and between the four race/gender groups. 
Recanting is far more prevalent for inhalants than for the other three substances for all of the 
groups—rates of recanting on the inhalant use item range from 28.5% for white females 
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transitioning from 7th to 8th grade to 51.8% for African American females for the same 
transition period. This finding is in line with several studies that have found a consistent and 
positive association between recanting prevalence and the perceived social stigma of a drug 
(Pedersen, 1990; Fendrich & Mackesy-Amiti, 2000; Percy, McAlister, Higgins, et al., 2005; 
Fendrich & Vaughn, 1994; Fendrich & Kim, 2001; Stueve & O’Donnell, 2000) and 
specifically that respondents were more likely to recant inhalants than marijuana, alcohol, or 
tobacco (Fendrich & Mackesy-Amiti, 2000; Percy, McAlister, Higgins, et al., 2005; Stueve 
& O’Donnell, 2000).  
African American males and females in this sample more frequently recanted on all 
of the substances, with the notable exception that African American males at both time points 
recanted less frequently than the other adolescent groups on the marijuana use item. Again, 
this finding is consistent with a number of previous studies that have consistently 
demonstrated that African American respondents are more likely than white respondents to 
retract drug use responses (Fendrich & Mackesy-Amiti, 2000; Fendrich & Vaughn, 1994; 
Fendrich & Kim, 2001; Fendrich & Rosenbaum, 2003; Siddiqui, Mott, Anderson, & Flay, 
1999; Mensch & Kandel, 1988).  
The fact that LTA accounts for measurement error is a significant advantage of the 
approach overall—it provides a more principled way of handling measurement error that is 
“vastly preferable to the often used ad hoc alternative of attempting to identify data that are 
subject to error and discarding or revising them” (Lanza, et al., 2005, p. 85). However, the 
overall fit for these models of drug use sequencing is decreased in the presence of 
measurement error (Lanza & Collins, 2002), and the measurement parameters (ρ) are 
weakened (Tang, Lanza, & Collins, 2001). Given the higher rates of recanting for the African 
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American sample, it is likely that the models selected are overly conservative and that the 
absence of an inhalant-use stage reflects in part the impact recanting had on the measurement 
parameters.  
Together, these findings highlight the importance of considering group differences for 
these analyses. An alternative approach facilitated by LTA would have been to identify a 
single model for the full sample, and then include a latent grouping variable representing the 
four race/gender groups. This approach would allow for a direct comparison of the latent 
stage membership and the transition probabilities, but would assume that the same drug use 
sequence was appropriate for each group. Results from this study indicate that there are 
important differences between the four groups, a finding that could only be elucidated by 
conducting the analyses separately.  
6.1.1.2 Inhalant Use in the Gateway Drug Use Sequence 
For white males at both transition periods and African American males in the 7th–8th 
grade transition, models were identified that included inhalants—indicating that the gateway 
model may be extended to include inhalants for these groups. This finding is consistent with 
Hypothesis 1.1, although the overall fit for these models was poor, except for white males in 
the 6th–7th grade sample. As noted above, the poor model fit may in part reflect the large 
amount of measurement error present, particularly for African American males.  
For both groups, inhalant use was present as part of a latent stage including the use of 
all four of the gateway drugs (ACIM). In other words, based on these analyses, it appears that 
inhalants are primarily used by adolescents who have also used alcohol, cigarettes, and 
marijuana, and there is no evidence that inhalants operate as a gateway to marijuana 
(Hypothesis 1.2). In the 6th grade, an estimated 9% of white males were in the ACIM stage. 
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By the 8th grade, the prevalence was estimated at 19%; 13% of African Americans in 8th 
grade were estimated to be in the ACIM stage.  
During the 7th–8th grade transition, the best-fitting models for both white and 
African American males included a separate latent stage representing the ever-use of alcohol, 
cigarettes, and marijuana, but not inhalants (ACM). The model for African American males 
also included a separate “cigarettes and marijuana” (CM) stage. For white males who have 
used marijuana, more have also used inhalants than not. Conversely, a majority of African 
American males in this sample who have used marijuana have not also used inhalants. For 
both groups, transitioning from one of the marijuana use stages to the inhalant use stage 
(ACIM) was very rare; 3% of white males in the ACM stage at 7th grade transitioned to the 
ACIM stage at 8th grade and 2% of African American males made the same transition. This 
finding conforms to the commonly cited finding that inhalant use peaks during early 
adolescence; it also suggests that marijuana use does not increase the probability of inhalant 
use. 
Although not directly testable via these models, it appears that inhalant use may be 
related to marijuana use among white males but less so for African American males. It is 
possible, particularly in the case of white males, that samples from earlier ages are necessary 
to better identify the gateway sequence between inhalants and marijuana. But given that 
marijuana use does not appear to substantially increase the probability of transitioning to 
inhalant use, along with the relatively high proportion of marijuana users who have also used 
inhalants, it is conceivable that inhalant use may increase the probability of marijuana use for 
white males. 
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Results for white females in this study were unique in that at both time points a latent 
stage including alcohol, cigarettes, and inhalants (ACI) was present along with the ACIM 
stage, evidence in support of Hypothesis 1.1. In the 6th grade, prevalence in the ACI stage 
(4%) was slightly greater than prevalence in the ACIM stage (3%). By 8th grade, an 
estimated 9% of white female adolescents were in the ACI stage, a notable increase. 
However, the estimate for the ACIM stage in 8th grade rose sharply, to 18%, by 8th grade, 
suggesting that the 6th–8th grade time span is an important time of risk for marijuana 
initiation. It should be noted that because these models are adjusted for measurement error, 
the estimates can be viewed as conservative and are likely robust.  
The LTA model identified for white females is the only model that allows for a direct 
assessment of the gateway relationship between inhalants and other drugs (specifically 
marijuana), which is a primary aim of this study (Hypothesis 1.2). Therefore, a discussion of 
the results for white females is the focus for the remainder of this section. 
6.1.1.3 Inhalant Use as a (Partial) Gateway to Marijuana Use for White Females 
Using a recently proposed operational definition of the gateway hypothesis 
(Maldonado-Molina, 2005), this study is the first to formally identify a potential “partial” 
gateway relationship between inhalant use and marijuana use for white adolescent females. 
For the 6th to 7th grade transition, the use of inhalants (in conjunction with having ever used 
alcohol or cigarettes) during the 6th grade was associated with a 0.31 probability of 
transitioning to marijuana use by the 7th grade. The probability of transitioning from 
inhalants to marijuana was greater than the reverse possibility (marijuana to inhalants), which 
did not exist in this model. The probability of transitioning to marijuana use at 7th grade 
given inhalant use in 6th grade was also greater than the probability of transitioning to 
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marijuana having never used inhalants (for a “complete” gateway relationship to exist, all 
individuals who transition to marijuana use would have needed to have first used inhalants).  
In sum, these results suggest a partial gateway relationship, where inhalant use 
operates as a partial gateway to marijuana for some white female adolescents during the 6th 
to 7th grade transition. Criteria for a partial gateway relationship were not met for the 7th to 
8th grade transition; however, the probability of transitioning to marijuana use by 8th grade 
given inhalant use in 7th grade was large (0.17), suggesting that inhalant use increases the 
probability of transitioning to marijuana use in this later period as well. 
Coupled with recent findings that inhalant use is increasing for white females while 
remaining stable for the U.S. adolescent population as a whole (SAMHSA, 2007), the results 
of this study suggest that white female adolescents transitioning into secondary school and 
the teen years represent an important population-at-risk for inhalant use initiation.  The use of 
inhalants also appears to place these female adolescents at an increased risk of initiating 
marijuana use.  
6.1.2  Summary of Findings for Research Question 2: Is Inhalant Use Associated with 
Gateway Drug Use Transitions when Controlling for Demographic Factors and 
Key Psychosocial Predictors of Adolescent Drug Use? 
The latent transition model identified for white females includes a direct pathway 
from the ACI stage to the ACIM stage. Evidence for this model suggests that inhalants may 
operate as a partial gateway to marijuana use for young white female adolescents. To more 
fully investigate the prospective relationship between inhalant use and marijuana use for this 
sample of white females, LTA-with-covariates was conducted. 
Three criteria for assessing the causal influence of the use of one drug on the use of 
other drugs have been proposed (Kandel & Jessor, 2002). The first criterion is evidence that 
those who use a drug or drugs are significantly more likely to have used the supposed 
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gateway drug. The second criteria is evidence that the use of the gateway drug typically 
precedes the use of the other drugs—the probability of transitioning from the gateway drug to 
the other drug(s) should be significantly greater than the probability of transitioning from the 
use of the later drug(s) to the supposed gateway drug (Maldonado-Molina, 2005). These 
criteria form the basis for the partial gateway condition described earlier.  
The third and final proposed criteria for assessing causal influence is evidence that 
the association between early gateway drug use and later other drug use remains significant 
after controlling for potentially confounding variables, particularly factors that might be 
common causes of both gateway and later drug use. Critics of the original gateway 
hypothesis argue that while there is evidence that drug use tends to occur in a certain order, 
drug use transition probabilities are the result of factors such as an underlying propensity and 
increased opportunities to engage in problem behavior (e.g., Jessor & Jessor, 1977; Donovan 
& Jessor, 1985; Jessor, 1987, 1991; Donovan et al., 1988; Costa, Jessor, & Donovan, 1989; 
Donovan, Jessor, & Costa, 1991). 
No identified studies have yet investigated inhalants as a gateway drug, and few 
studies have explored whether the transition probabilities between the traditional gateway 
drugs remain after controlling for the influence of potentially confounding variables thought 
to represent common liabilities for drug use (Rebellon & Van Gundy, 2006; Tarter et al., 
2006). Therefore, this study represents a first attempt at assessing the causal influence of 
inhalant use on marijuana use for white female adolescents by accounting for the effects of a 
wide range of covariates on the probability of transitioning from inhalant use (ACI) to 
marijuana use (ACIM). 
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At both transition periods, several covariates were associated with a decrease in the 
probability of transitioning to marijuana use, given inhalant use at the prior time. This latter 
finding indicates that the predictive relationship between inhalants and marijuana is at least 
partially confounded by other factors.  
For the 6th to 7th grade transition period, controlling for an adolescent’s perception of 
whether their mother disapproves of all drug use and their perception of whether they have 
easy access to drugs resulted in a large decrease in the size of the transition probability 
between the ACI and ACIM latent stages, from 0.29 to 0.09. Accounting for the effects of 
these two variables resulted in the lowest estimated transition probability; adding additional 
covariates did not further decrease the transition probability.  
The finding that the perceived availability measure is associated with a decrease in 
the transition probability is particularly noteworthy given the important differences in 
availability between inhalants and marijuana. One of the critiques of the gateway hypothesis 
is that the typical sequence of drug use may simply reflect the degree to which substances are 
available. Alcohol and cigarettes are widely available and have consistently been shown to 
precede marijuana use for the majority of adolescents who try it.  
According to the gateway hypothesis, alcohol and cigarette use predict later 
marijuana use; critics of this view argue instead that the ordering is an artifact related to 
when adolescents are able to access particular classes of drugs. Inhalants, like alcohol and 
cigarettes, are very widely available, whereas marijuana is far less ubiquitous. It is possible 
that the probability of transitioning from inhalant use to marijuana use may have more to do 
with whether marijuana is available to the adolescent—those with access to marijuana may 
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be more likely to transition to use while those without access to marijuana remain in drug use 
stages that reflect the more widely available drugs.  
Controlling for perceived access to drugs, along with perceived mother’s disapproval 
of drug use, accounts for a good portion of the relationship between inhalant use and 
marijuana use in this sample. However, no combination of covariates reduces the transition 
probability altogether, leaving open the possibility that either the relationship has not been 
accounted for by other covariates that were not included in this study, or that previous 
inhalant use (along with alcohol and cigarette use) has an independent and robust influence 
on the probability of transitioning to marijuana use. The fact that so many covariates that 
have been identified as potential measures of general liabilities for drug use were included in 
this study, and that no combination of covariates was identified that could fully diminish the 
transition probability, is strong evidence in support of the partial gateway possibility.  
During the 7th to 8th grade transition period, high versus low sensation-seeking 
personality was associated with a decrease in the transition probability, from 0.19 to 0.13. 
Adding variables did not further reduce the probability, suggesting that sensation-seeking 
may be particularly important in terms of predicting the transition from inhalant use to 
marijuana use. High versus low sensation seekers had greater odds of transitioning from the 
ACI to the ACIM latent stage, and accounting for sensation-seeking appears to lessen the 
predictive effect of inhalants on transitioning to marijuana use.  
It is plausible that among this population of white female adolescents, marijuana use 
is perceived as more risky than inhalant use. Indeed, inhalants are widely available, and 
although the abuse of inhalants is technically classified as illicit, the products that are inhaled 
can be legally purchased. Adolescent females with high sensation-seeking propensity are 
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clearly more likely to try marijuana use than low sensation-seekers; for this sample, it 
appears that sensation-seeking distinguishes between inhalant use and marijuana use.  
Factors such as sensation-seeking and perceived and actual availability of drugs may 
differentiate white females from other demographic groups, particularly white males, and 
may in part explain why inhalants are potentially an important gateway drug for this group. It 
is possible that on average, white females have lower sensation-seeking propensity compared 
to males and are therefore more likely to experiment with drugs that are particularly easy (or 
legal) to obtain. Indeed, for this study sample males had significantly higher mean sensation 
seeking scores at both 6th and 7th grades. At 6th grade, males had an average sensation 
seeking score (on a scale ranging from 0 to 12) of 5.07 (SD = 3.68), while the average for 
females was 3.61 (SD = 3.37), a difference that was highly significant (p <.001). Similarly, at 
7th grade the average sensation-seeking scale score for males was 5.53 (SD = 3.84) and for 
females was 4.20 (SD = 3.58), again a statistically significant difference (p <.001). 
Zuckerman and Kuhlman (2000) reported that in a U.S. college student sample, men 
demonstrated higher risk-taking tendency than women, a finding that was mediated by 
gender difference in the personality trait of impulsive sensation seeking. An earlier study 
similarly found that U.S. men tend to score higher on novelty-seeking than women 
(Cloninger, Przybeck, & Svrakic, 1991). Again, inhalants can be easily obtained, the effects 
of inhalant use tend to wear off quickly (so the use of inhalants can be easily concealed), and 
the perceived legal and social risks associated with inhalant use are likely lower than for 
drugs like marijuana. Perhaps gender differences in sensation seeking and other personality 
characteristics in part explain the finding that inhalants play a particularly important role in 
gateway drug use sequencing for white female adolescents. 
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 In attempting to explain the finding that white females have similar inhalant use 
prevalence rates as white males, it has been posited that adolescent males’ “overall higher 
likelihood of involvement with drugs may relate to their more frequent exposure to situations 
in which these drugs are available. Inhalants may be an exception because boys and girls 
have the same level of access to them” (NIDA, 2005b, p. 7). For the sample analyzed for this 
dissertation, based on Mann-Whitney test results, there were no significant differences in 
perceived access between males and females at 6th or 7th grade for alcohol and cigarettes. 
There was also no difference by gender in perceived access to inhalants at 6th grade. Males 
did have statistically higher median scores for perceived access to inhalants at 7th grade  
(p <.001) and for marijuana at both 6th grade (p <.01) and 7th grade (p <.001). These 
findings support the argument that females and males may have similar access to inhalants, 
particularly in early adolescence (6th grade), whereas marijuana use is clearly perceived as 
more available among males than females in this sample. 
The finding of gender similarity in inhalant use highlights the potential importance of 
availability and access as predictors of adolescent inhalant use. Adolescent males, through 
earlier involvement in drugs and associations with drug-using peers, likely have greater 
opportunities to use drugs and are therefore more likely to exhibit, as a whole, more 
advanced drug use sequencing than females. Van Etten and Anthony (2001) found that across 
age, race, region, and urban status subgroups, after controlling for opportunities to use drugs, 
women were as likely as men to initiate drug use; inhalants may serve as a particularly 
important gateway for females because of their wide availability. Again, it is noteworthy that 
after controlling for perceived access to drugs, inhalants still appeared to have an important 
effect on transitioning to marijuana use for white females. 
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Interesting differences in median perceived access to each of the drugs in this study 
were also found between white and African American adolescents; white adolescents had 
significantly higher median scores for perceived access to inhalants at both 6th (p <.05) and 
7th (p <.002) grades, whereas African Americans had higher scores for perceived access to 
marijuana at both grades (p <.002 and p <.001, respectively). These findings may reflect 
important contextual differences in drug use availability by race, potentially supporting the 
findings in this study that inhalants appear to be more important in gateway drug use 
sequencing for white adolescents than for African American adolescents, whereas marijuana 
appears to be important for African Americans, particularly African American males.  
 Finally, although the inclusion of covariates does appear to attenuate the partial 
gateway relationship between inhalants and marijuana (a finding consistent with a “common-
cause” critique of the gateway hypothesis), for white females, a non-zero probability of 
transitioning to marijuana use given previous inhalant use remains. Inhalants appear to have a 
unique and important place in white female adolescent drug use sequencing. The results of 
this study build on previous research that suggests inhalants are a particularly important class 
of drugs for white females by empirically demonstrating, for the first time, a partial gateway 
relationship between inhalant use and marijuana use.  
6.2 Strengths and Limitations 
6.2.1 Strengths 
This study used longitudinal data from a general population sample of young white 
and African American adolescents to examine the role inhalants play in gateway drug use 
sequencing. Much of the previous work on the gateway hypothesis has been based on cross-
sectional data, preventing an examination of the temporal order by which drugs are initiated 
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(Kandel, 2002). The use of longitudinal data allows for a direct examination of gateway 
relationships and patterns of drug use during a period of adolescence (6th–8th grade) when 
gateway drug use initiation tends to peak. 
Although the gateway hypothesis has not been previously extended to include 
inhalants, it served as the theoretical basis for this study. The gateway hypothesis is 
intrinsically a stage-based model; drug use sequencing is posited to consist of discrete stages 
of development rather than reflecting a continuum of behavior. An appropriate analysis of 
research questions based on the gateway hypothesis therefore requires an analytic approach 
suited to the examination of discrete stages. LTA, a longitudinal extension of latent class 
analysis, is uniquely suited to the analysis of models that reflect changes in discrete stages of 
behavior over time.  
Recent advances in LTA software allowed for the inclusion of covariates in the 
model. This study demonstrates how, by including covariates in the analysis, it is possible to 
test the extent to which a transition probability is related to membership in an earlier stage, 
versus the effects of the covariates. Specifically, this study included covariates to determine 
whether the probability of transitioning from inhalant use to marijuana use for white females 
remained after controlling for covariates that may represent “common causes” of drug use. 
This approach holds great promise for testing the gateway hypothesis.  
The study sample included data for 6th graders. Given the focus on gateway drugs, 
which are often initiated during early adolescence, the availability of data for these young 
adolescents was beneficial. Indeed, the results of this study suggest that the 6th–7th grade 
transition period, when many in the sample were transitioning into middle school, may be 
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particularly important for investigating drug use transitions, especially for the white female 
sample.  
Separating the sample by race and gender was crucial—clear differences in the latent 
transition models were identified for each of the four study groups, suggesting that general 
population approaches may obscure these differences. This approach allowed for the 
discovery that for white females, inhalants appear to be an important drug in the early 
gateway sequence, whereas for other adolescents, particularly African American adolescents, 
inhalants appear to be far less important. This finding likely would have been obscured had 
the analyses been conducted for the full sample rather than separately for the four groups. 
6.2.2 Limitations 
The decision to divide the sample into four race/gender groups resulted in sample 
sizes available for analyses that were significantly reduced. Coupled with the substantial 
variation (heterogeneity) in the response patterns, particularly for African American males 
and females, these reduced samples may have precluded identifying accurate models or 
stable estimates. At present, there is no accepted means of conducting statistical power 
testing for complex latent class and latent transition models (Lanza, Flaherty, & Collins, 
2003).  
A rough rule of thumb for ensuring sufficient sample sizes is that the ratio of sample 
size to number of cells in the contingency table should not fall much below .2 (Collins, 
2002). These analyses involved contingency tables with 256 cells, suggesting that a sample 
size of at least 51 would be needed. However, the measurement of the parameters in the 
model has a strong effect on sample size requirements—as measurement of the rho (ρ) 
parameters weakens, larger sample sizes are needed (Collins, 2002). LTA is a large sample 
approach; it is reasonable to assume that the instability present in the current analyses may in 
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part reflect insufficient sample sizes, particularly during the 6th–7th grade transition, and for 
African American males and females. Ideally, these analyses would be replicated with 
substantially larger samples. 
 The current study used an onset approach to the examination of gateway drug use 
sequencing. The substance use measures used for this study examined whether adolescents 
have ever used or tried alcohol, cigarettes, inhalants, or marijuana. It is possible that 
variations in the dosage or intensity of use of each substance are related to the likelihood of 
transitioning from one drug use stage to another. For example, Collins (2002) has reported 
that heavy drinking/drunkenness represents an important transitional stage between having 
ever tried alcohol and trying marijuana. In the current data set, lifetime (“ever use”) measures 
were available for each of the four substances. A measure of past 3-month drunkenness was 
also available, but because it reflected only recent behavior and not lifetime onset, it was not 
included in the model.  
A potential limitation of this study relates to the decision to consider transitions 
between grades in school. The assumption made here was that the major movement in drug 
use would be between grades rather than within grades. Considering transitions between 
grades simplified the interpretation of the model and is consistent with other research in this 
area. This is an important assumption because the duration between observations influences 
whether transitions between the initiation of drugs can be observed. It is possible that drug 
use transitions occur quickly—for instance, that the initiation of alcohol and cigarette use 
occurs within a short time interval. It is possible in that case that the current study design 
would obscure the ordering on drug initiation.  
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For example, there were instances in this study where direct, unexpected transitions 
from an early stage to a later stage (i.e., from “Alcohol Only” to “Alcohol, Cigarettes, 
Marijuana, and Inhalants”) were present. However, these transitions may simply reflect the 
fact that intermediate drug use stages occurred during the period between study observations. 
The data set used for these analyses includes data collected every 6 months; future analyses 
could investigate whether using more closely spaced data increases the likelihood of 
identifying distinct ordered stages. 
Indeed, the issue of spacing likely had direct effects on my assessment of the gateway 
relationship between inhalants and marijuana for white females. One criterion for a gateway 
relationship to exist between inhalants and marijuana is that the probability of transitioning 
from inhalants to marijuana must be greater than the probability of transitioning from all 
other stages (not including inhalants) to marijuana. I therefore calculated two probabilities, 
the probability of transitioning from inhalants to marijuana and the probability of 
transitioning from any stage without inhalants to marijuana, and compared them directly.  
But based on the six-stage model found for white females, there is no evidence of any 
stage that includes marijuana but not inhalants, and the only stage that includes marijuana 
also includes inhalants (the ACIM stage). Thus, based on this model, inhalant use appears to 
always precede marijuana use for white females in this sample (otherwise, there would be a 
stage, such as ACM, that precedes the ACIM stage). This would be evidence for a complete, 
rather than a partial, gateway relationship.  
The direct transitions from stages that do not include inhalants (N, A, C, AC) to 
marijuana (ACIM) could therefore be interpreted as the conditional probability of passing 
through the ACI stage to the ACIM stage rather than as actual direct transitions, the 
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assumption being that we have missed the intermediate transitions due to the spacing of our 
measurements. Under this assumption, there would be evidence supporting a complete 
gateway relationship at both grade transitions, rather than the partial relationship I report for 
the 6th–7th grade transition (and the lack of a relationship at the 7th–8th grade transition). 
However, because it is not possible to directly assess, for those individuals in the ACIM 
stage, whether inhalants preceded marijuana, a more conservative approach was taken. Using 
more closely spaced observations may provide an opportunity to more clearly elucidate the 
transitions between stages.  
The study sample was drawn from 14 schools in three counties of North Carolina. 
Samples drawn from schools are susceptible to clustering effects, whereby findings are 
confounded by similarities among students within schools, a violation of the standard data 
analysis assumption that observations are independently sampled (Lanza, Flaherty, & 
Collins, 2002). Inhalant use may be especially prone to cluster effects, because of a reported 
tendency for localized, temporary epidemics of inhalant use (Mackesy-Amiti & Fendrich, 
2000).  
The current versions of the statistical programs used for this study do not yet 
accommodate random effects or sampling weights to account for this clustering. Therefore, 
estimates of the prevalence of drug use and the probability of membership in each latent drug 
use stage should be interpreted with caution as they reflect the unadjusted probabilities. 
The degree of similarity (clustering) is typically measured by the intracluster (or 
intraclass) correlation coefficient (ICC). Ignoring significant ICCs can lead to incorrect  
p-values, confidence intervals that are not wide enough, and biased estimates (Hox, 2002), 
with a net effect of increasing the probability of a Type I error, sometimes substantially 
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(Murray, Alfano, Zbikowski, Padgett, Robinson, & Lesges, 2002). A direct means of 
accounting for possible clustering is not currently available in LTA. However, to determine 
the degree to which clustering was present for these data, I estimated the ICC for white and 
African American respondents on measures of alcohol, cigarette, inhalant, and marijuana use 
(the study outcome variables) at 6th grade. Multilevel (random intercept) logistic regression 
using the NLMIXED procedure (SAS, 2003) was used to estimate the ICC (Bauer & Curran, 
2006).  
Small, medium, and large values of the ICC are generally reported as .05, .10, and 
.15, respectively (Hox, 2002). In these models, 1,630 respondents were nested within 13 
schools. Results (not shown) suggested that less than 0.1% of the variance in inhalant use at 
grade 6 was due to clustering at the school-level; this estimate was not significant (ICC = 
0.0007, p <.95). Similar estimates for alcohol (ICC = 0.0008, p < .88) and cigarettes (ICC = 
0.0141, p < .38) were obtained. For marijuana, the ICC was estimated at 0.1113 (p <.46), 
indicating that 11.1% of the variance in marijuana use at grade 6 is attributable to 
characteristics at the school level.  
No prior studies have reported ICC estimates for school-level inhalant use and few 
have reported on marijuana use. Ennett et al. (1997) reported clustering estimates at the 
school level of .012 for current marijuana use. Several studies have reported ICCs for 
measures of smoking and alcohol that range from –0.0002 to 0.09 (Murray & Hannan, 1990; 
Murray, Rooney, Hannan, et al., 1994; Murray & Short, 1996, 1997; Siddiqui, Hedecker, 
Flay, & Hu, 1996; Ennett, Flewelling, Lindrooth, & Norton, 1997; Murray, Clark, & 
Wagenaar, 2000; Murray, Alfano, Zbikowski, et al., 2002; Scheier, Griffen, Doyle, & Botvin, 
2002). Specifically, Murray et al. (2002) found in a review of the literature that ICCs for 
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cigarette use typically range from 0.005 to 0.05, averaging around 0.01 to 0.02. The estimate 
for the current study is in line with these previous estimates. 
These estimates provide some indication that clustering on the outcomes of interest is 
very minor for alcohol, cigarettes, and inhalants. The estimate of the magnitude of the ICC 
for marijuana suggests that a medium ICC is present, although this result was not significant. 
Overall, it is likely that clustering would have only minor effects for these analyses, but 
future enhancements to LTA software that allow for the inclusion of random effects and/or 
sampling weights will facilitate a more robust handling of clustered data. 
All of the measures used in the study are self-report measures. While some 
investigators have found that in general self-reported substance use data are valid (Colon, 
Robles, & Sahai, 2001, 2002; Needle, McCubbin, Lorence, & Hochhauser, 1983), it is 
possible that the inhalant use item in particular is subject to a variety of recall errors and 
reporting biases, including lack of understanding of the type of drugs being used (some youth 
may not consider some activities, like whip cream sniffing, to be inhalant use) and lack of 
candor related to the possibility that inhalants are seen as an “immature” class of drugs and 
are less socially acceptable (Kurtzman, Otsuka, & Wahl, 2001; Johnston, O’Malley, 
Bachman, & Schulenberg, 2006).  
It has been proposed that broad questions about “inhalant use,” such as the one used 
for the survey analyzed in this study, may lead to substantial underreporting of actual use 
(Howard, Walker, Walker, Cottler, & Compton, 1999) due to the extremely broad number of 
substances this term entails. For instance, in a study of inhalant use in Texas, 24% of 7th 
graders indicated that they sometimes “sniffed” or “huffed” one or more of a large list of 
common inhalants. But when the same youth were later asked a general question about their 
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“inhalant use,” about one-half indicated that they had never used inhalants (Fredlund, 1992). 
Similarly, qualitative data from an unpublished focus group project suggested that youth 
often confuse the term “inhalants” with smoking cigarettes, marijuana, or crack or snorting 
heroin or cocaine (Wolfe, 1995).  
Evidence for the importance of question wording has also emerged from comparisons 
between the three most important national youth surveys: the Youth Risk Behavior Survey 
(YRBS), the Monitoring the Future (MTF) survey, and the National Household Survey on 
Drug Abuse (NHSDA). Both the YRBS and the MTF ask two questions about lifetime and 
past 30 day use of “inhalants.” But NHSDA asks 11 separate questions to assess the use of 10 
named substances as well as the use of inhalants other than the ones listed. Lifetime use is 
defined as answering “yes” to any of the 11 questions. This difference in question wording 
leads to higher overall prevalence rates in NHSDA versus MTF and YRBS. This is 
particularly noteworthy in that, for most other drugs, YRBS usually produces the greatest 
prevalence estimates, and YRBS and MTF produce estimates higher than NHSDA. It appears 
that respondents may not clearly recognize all of the substances that the term “inhalant” 
encompasses (Brener, Grunbaum, Kann, McManus, & Ross, 2004). In any event, it is likely 
that this reporting bias would result in either lower initial estimates of inhalant use or higher 
rates of recanting. In both cases, given that LTA produces estimates that are adjusted for 
measurement error, this would yield overly conservative estimates—any inhalant-specific 
findings likely represent especially strong effects. 
The LTA-with-covariates has a couple of unique limitations. The current software 
(SAS PROC LTA) does not produce standard errors or statistical tests for the parameter 
estimates, precluding any statistical hypothesis testing. Future iterations of the software will 
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likely include Bayesian estimation (i.e., data augmentation) to accommodate a variety of 
hypothesis tests (Lanza & Collins, 2008). Also, models that include covariates delete cases 
with any missing values. Although missingness on the covariates was modest for this study, 
this “listwise” deletion may bias results if missingness on the covariates is not missing at 
random. It is conceptually possible to use a multiple imputation to derive less biased 
estimates in the presence of missing data, but this has not yet been demonstrated with SAS 
PROC LTA. 
Finally, the generalizability of the study findings may be limited. As noted earlier, the 
sample for this study was drawn from schools in three counties in North Carolina. Although 
the study had a very high participation rate across data collection waves and is therefore very 
representative of school-attending adolescents from these three counties, the population in 
these counties is more rural, has a higher proportion of racial/ethnic minorities, and is more 
economically disadvantaged than either the state of North Carolina or the United States. 
Therefore, the study findings should not be generalized beyond the three counties but instead 
should be viewed as a preliminary investigation from a relatively large, general population 
sample of adolescents that contributes to our overall understanding of the role inhalants may 
play in adolescent drug use sequencing.  
6.3 Implications and Future Research 
The results of this study provide initial evidence to suggest that white females, 
particularly those in the early years of middle school, are at an elevated risk for inhalant use 
initiation and, in a finding unique to this study, that this early use of inhalants is associated 
with an increased probability of transitioning to marijuana use. This finding is preliminary 
and needs to be replicated with other samples—particularly nationally representative 
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samples, larger samples, and samples that are young enough to allow for the identification of 
early stages of drug use initiation.  
The gateway hypothesis remains a widely accepted model for drug use development 
and has served as a key rationale for prevention programming and drug use interventions. 
Despite cautions from developmental researchers, including proponents of the gateway 
hypothesis, there has been a tendency to assume that the gateway sequence represents a 
causal sequence. There is limited evidence to support this notion. Therefore, the primary 
utility of the gateway hypothesis may be to frame research on drug use sequencing. Using the 
general tenets of the gateway hypothesis, this study has demonstrated that for white females 
only, inhalant use may operate as a before-unidentified gateway drug, by both preceding and 
increasing the probability of transitioning to marijuana use. This study also demonstrated that 
the inclusion of covariates thought to represent antecedents of adolescent drug use 
substantially, although not fully, decreased the gateway relationship between inhalants and 
marijuana. Although the range of covariates examined was large, there are undoubtedly a 
number of variables related to drug use that were not included. Future research should 
attempt to better understand how contextual and individual characteristics influence the 
gateway drug use sequence.   
This study demonstrated the utility and importance of separately analyzing the data 
based on gender and race. Replicating these analyses with other racial/ethnic groups 
(particularly Hispanic and Native American adolescents) is warranted, although as evidenced 
here, the samples need to be sufficiently large and should include young (6th grade or 
younger) adolescents. For this study, the 6th–7th grade transition period was clearly 
important for white females. However, a high percentage of white males had already initiated 
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drug use by this time. Even younger samples may be necessary to adequately explicate the 
early gateway drug use sequence.  
The problem of recanting was illustrated in this study. Future longitudinal studies of 
adolescent drug use should be especially cognizant of this issue and should attempt to 
identify ways of improving response consistency among respondents and accounting for 
recanting in the analyses. LTA, a latent variable approach, provides a principled way of 
addressing this type of measurement error. However, given the especially high rates of 
recanting on the inhalants item, and for African American adolescents, it is possible that the 
results of this study are overly conservative. Certainly, the results for African American 
adolescents should be viewed cautiously given the very high measurement error. Effort 
should also be made by researchers to include detailed questions about inhalants rather than 
the more general questions typically used in national surveys. Misunderstanding of what 
substances the term “inhalants” include may in part explain higher rates of recanting relative 
to the gateway drugs.  
Given recent trends suggesting that inhalant use is rising among white females 
(Substance Abuse and Mental Health Services Administration [SAMHSA], 2007) and that 
inhalants are the most commonly used illicit substance among young adolescents (e.g., 
Johnston et al., 2007), there is strong rationale for focusing prevention efforts on inhalants, a 
largely ignored substance in current prevention curricula. The traditional rationale for 
focusing prevention efforts primarily on alcohol, tobacco, and marijuana has been that these 
substances serve as gateways to more “serious” drug use; the finding that inhalants may 
operate as a partial gateway to marijuana use for white females transitioning from 6th to 7th 
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grade argues for an increased focus on inhalants in prevention programming, at least for 
white female adolescents. 
Recent advances in LTA and LTA software allow for the inclusion of dichotomous 
and continuous covariates, greatly expanding the types of models that can be estimated. This 
study has demonstrated the utility of conducting LTA-with-covariates to examine the degree 
to which covariates (competing factors) explain drug use transition probabilities and thereby 
directly test the gateway hypothesis that the use of a gateway drug increases the probability 
of using illicit drugs. Given the ongoing debate between proponents of the gateway 
hypothesis and critics who argue for a common-cause explanation for drug use patterns, this 
approach should be considered to look at the more commonly described gateway transitions 
from alcohol and/or cigarettes to marijuana and from marijuana to hard drug use. As future 
enhancements to current LTA software are made, including Bayesian estimation to allow for 
the production of standard errors and subsequent hypothesis testing (Lanza et al., 2005), this 
approach holds great promise for testing the gateway hypothesis.  
In sum, this study adds to a relatively small body of research on adolescent inhalant 
use. Inhalant use is a prevalent and serious issue for young adolescents, and evidence 
suggesting that inhalant use rates are remaining stable for U.S. adolescents, and even 
increasing for females, is cause for concern. Inhalants, like the other “gateway” drugs, are 
widely available and are often used early in adolescent development. This study, the first to 
examine directly where and how inhalant use fits within adolescent gateway drug use 
sequencing, has produced results suggesting that for white females, inhalant use is prevalent 
and is associated with an increased probability of transitioning to marijuana use, even after 
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controlling for factors thought to represent general liabilities for adolescent drug use. LTA is 







DESCRIPTIVE STATISTICS FOR COVARIATES 




Dichotomous Covariates Code Label Frequency (Valid %) 
Frequency 
(Valid %) 
Social values 0 “Above 
average” 
301 (65.3) 611 (70.1) 
1 “Below 
average” 
160 (34.7) 261 (29.9) 
. Missing 3 82 
Grade point average 0 “Above 
average” 
274 (61.0) 506 (57.8) 
1 “Below 
average” 
175 (37.7) 369 (42.2) 
. Missing 15 79 
School attachment 0 “Above 
average” 
229 (49.4) 411 (46.5) 
1 “Below 
average” 
228 (49.1) 472 (53.5) 
. Missing 7 71 
Mother’s disapproval of all 
drug use 
0 Yes 412 (91.2)  751 (87.0) 
1 No 40 (8.8%) 112 (13.0) 
. Missing 12 91 
Religiosity 0 “Above 
average” 
298 (65.6) 539 (61.7) 
1 “Below 
average” 
156 (34.4) 335 (38.3) 
. Missing 10 80 
Perceived drug use at school 0 “Below 
average” 
283 (62.9) 537 (61.4) 
1 “Above 
average” 
167 (37.1) 338 (38.6) 
. Missing 14 79 
     
Any drug use, five closest 
friends 
0 “0 or 1” 382 (82.9%) 695 (78.3) 
1 “> 1” 79 (17.1) 193 (21.7) 
. Missing 3 66 
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Descriptive Statistics for Covariates (continued) 




Tolerant of any drug use, five closest 
friends 
0 “0 or 1” 353 (76.7) 635 (71.9) 
1 “> 1” 107 (23.1) 248 (28.1) 
. Missing 4 71 
     
Perceived availability of drugs 0 “Below 
average” 
280 (62.6) 507 (58.0) 
1 “Above 
average” 
167 (37.4) 367 (42.0) 
. Missing 17 80 
     
Academic aspirations (importance of 
graduating high school and/or college) 
0 “Important” 405 (88.4) 759 (87.1) 
1 “Not 
important” 
53 (11.6) 112 (12.9) 
. Missing 6  83 
     
     
Problem behavior 0 “Below 
average” 
307 (66.7) 601 (68.3) 
1 “Above 
average” 
153 (33.3) 279 (31.7) 
. Missing 4 74 
     
Sensation seeking 0 “Below 
average” 
246 (55.3) 470 (54.5) 
1 “Above 
average” 
199 (44.7) 392 (45.5) 
. Missing 19 92 
     




Sensation seekingb   3.47 (3.33) 4.31 (3.67) 
N   445 862
Missing   19 92
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Descriptive Statistics for Covariates (continued) 





Age   11.97 (.45) 12.98 (.46) 
N   464 954
Missing   0 0
a Continuous covariates are standardized.  
b For white females in the 6th–7th grade sample, estimation with the binary sensation-seeking measure failed. 
Using the continuous version of the measure facilitated estimation. The binary version of the measure is 




ODDS RATIOS FOR PREDICTORS OF STAGE MEMBERSHIP (Δ) AT BASELINE 
FOR WHITE FEMALES IN THE 6TH–7TH GRADE SAMPLE 





















Age — 1.05 1.00 1.07 1.36 1.59 
Social values — 3.01 2.08 6.65 2.79 1,111.34 
GPA — 0.96 1.00 1.39 0.56 1.32 
School 
attachment 
— 1.79 3.94 1.98 0.44 13.41 
Mother’s 
disapproval 
of drug use 
— 4.10 10.24 14.21 23.15 13.44 
Religiosity — 2.16 1.40 0.75 2.03 7.23 
Perceived 
drug use at 
school 
— 1.92 1.64 4.09 5.94 1,114.33 
Any drug use, 
five closest 
friends 










— 2.21 1.19 6.03 9.06 1,303.71 
Academic 
aspirations 
— 1.11 1.56 1.22 4.14 6.29 
Problem 
behavior 
— 1.56 2.59 2.79 5.72 4.50 
Sensation 
seeking 
— 2.09a 3.11a 2.31a 4.64a 5.00a 
Note: Dashes (—) indicate reference category. 
a To facilitate model convergence, sensation-seeking is treated as a continuous variable in the 6th–7th grade 
analyses; it is binary in the 7th–8th grade analyses. 
231 
APPENDIX C 
ODDS RATIOS FOR PREDICTORS OF STAGE MEMBERSHIP (Δ) AT BASELINE 
FOR WHITE FEMALES IN THE 7TH–8TH GRADE SAMPLE 
Covariate 




















Age — 0.96 1.04 1.09 1.02 1.21 
Social values — 3.13 0.33 4.18 11.63 13.71 
GPA — 0.85 0.95 1.68 2.33 1.87 
School 
Attachment 




— 3.93 11.78 14.97 8.28 23.07 
Religiosity — 2.46 1.29 2.67 4.06 3.13 
Perceived drug 
use at school 
— 1.13 4.30 2.39 4.57 8.93 
Any drug use, 
five closest 
friends 
— 2.83 7.84 11.90 31.21 76.63 
Tolerant of any 
drug use, five 
closest friends 




— 1.54 1.36 4.81 15.05 38.14 
Academic 
aspirations 
— 1.26 3.24 2.48 3.12 4.96 
Problem 
Behavior 
— 1.40 1.21 2.42 5.98 7.62 
Sensation 
Seeking 
— 2.45 3.41 7.56 22.16 22.19 
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